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This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
Occult Breast Cancer and Changing Patterns 
of Surgical Practice
Until Egan’s landmark paper in I960,1 
breast cancer was diagnosed mainly by 
physical examination. Egan demonstrated 
that “ occult” breast cancer could be 
detected by mammography in patients 
who had no clinically palpable lesion. 
This observation was greeted with great 
skepticism by many surgeons and even 
some radiologists. The troubling fact is 
that even today there are many physicians 
who think that if they cannot feel a lesion, 
it’s not there. No one claims that 
breast examination can be done by mam­
mography alone. It remains complemen­
tary to a competent clinical examination. 
A clinically suspicious lesion should never 
be ignored because the mammogram 
appears normal. However, to deny the 
value of mammography in picking up 
nonpalpable lesions is simply to ignore 
established findings. Clinicians who hold 
this view must be obtaining less than 
optimal films and inexpert radiologic 
interpretation.
The concept of minimal breast cancer, 
advanced by Gallager and M artin,2 
offered the promise that earlier recogni­
tion would result in better survival, gener­
ally with less surgery. Many minimal
breast cancers are occult and therefore 
found only on mammography. Mam­
mography may be considered as part of 
the work-up in women with symptomatic 
breast disease or may be done routinely 
in selected asymptomatic women (screen­
ing). The commonest occult abnormality 
is a cluster of microcalcifications, with or 
without a nodular density. Sometimes 
architectural distortion without calcifica­
tions may be the clue to a malignant 
lesion.
In this issue (pages 329 and 330) Maho­
ney describes his technique of intraope­
rative localization of these tumours.
To localize these lesions, we, at the 
Mount Sinai Hospital in Toronto, favour 
a technique of simple needle-guided 
localization which has been developed to 
a fine art within our Department of Radi­
ology. Credit must go to Dr. Imre Simor 
for his diagnostic acumen and enthusiasm 
in instituting the technique and teaching 
it to others. Basically, it is the method 
described by Libshitz and colleagues.3 It 
is simple, efficient and satisfactory. Fol­
lowing localization, two-view mammo­
graphy is done to correlate the position 
of the needle to the suspect lesion. We
accept a deviation of 1 cm in either plane. 
This can easily be corrected at surgery. 
Needles are held in place with Steristrips, 
and no needle has ever become dislodged 
in moving the patient from the radiol­
ogy department to the operating room. 
Under anesthesia, toluidine blue is 
injected through the needle as it is with­
drawn. The dye has effectively replaced 
the needle. Toluidine blue does not 
diffuse into the tissues and in several 
hundred procedures has not caused a sin­
gle reaction. Incisions are made in the 
areola whenever possible. Some surgeons 
advocate a blind resection of the quad­
rant harbouring the suspicious area. This 
results in an unacceptable and unneces­
sary deformity, and the suspicious area 
may still be missed. We see no merit in 
placing a needle into the area of suspicion 
without then taking a two-view mammo­
gram to define the relation of the needle 
to the suspect lesion. Clearly, close and 
harmonious teamwork must exist between 
surgeon and radiologist. Roentgenogra­
phy of the excised tissue is mandatory to 
confirm that the microcalcifications seen 
in the mammogram are present in the 
specimen. The pathologist is able to cut
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blocks more accurately if he examines the 
specimen roentgenogram and has tissue 
calcifications marked. We obtain a mam­
mogram of the breast 3 months after the 
biopsy to prove that the appropriate tis­
sue has been excised.
Between January 1977 and December 
1983, we performed 595 such needle- 
guided surgical biopsies and found 84 car­
cinomas (14%). Of these, 60 (71%) were 
infiltrating and 24 (29%) were noninva- 
sive. Carcinoma was found in 24% of the 
biopsies done for lesions with microcal­
cifications. The incidence of diseased 
nodes in the patients with invasive carci­
noma was almost 25%, half that usually 
found in patients with lesions detected 
clinically. Although this is still a high inci­
dence, better survival can presumably be
expected in such patients. Occult cancers 
must not be considered as less than real 
cancers. Women harbouring suspicious 
m am m ographic lesions should be 
managed aggressively. A cancer detection 
rate of one in five is quite acceptable for 
clinically diagnosed lesions and should 
not present a philosophical problem in the 
management of lesions detected by mam­
mography. Concern expressed by some 
clinicians that this aggressive stance will 
induce undue patient apprehension and 
morbidity is unfounded. In our ex­
perience, practically all patients wish to 
have a biopsy if it is recommended, and 
feel greatly relieved when the lesion is 
found to be benign. Those patients who 
are found to have a malignant lesion are 
happy that it was detected and treated at
an earlier stage than would have been pos­
sible if its discovery had awaited the 
development of a palpable mass.
A.A. Bassett, md, frcsc, facs
Director, Breast Treatment Unit,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont.
M5G 1X5
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Morbidity Audit, Canadian Society for Vascular Surgery
One of the primary objectives of the 
Canadian Society for Vascular Surgery is 
to monitor standards of care for patients 
with vascular disease by the development 
of a national vascular registry. As a step 
towards this objective, we established a 
30-day hospital morbidity audit in 1982, 
the concept being to monitor selected, 
commonly performed vascular opera­
tions.
The audit form (Fig. 1) records the 
number of procedures performed, any 
reoperations (revision, hemorrhage, 
amputation) and the major complications 
(wound infections, graft failure and 
death) that occur in hospital or within 30 
days of the operation. Since the audit is 
keyed to procedures that are billed, the 
information can be filled out from the 
ward complication book, office surgery 
book or from billing cards. Surgeons who 
do not have a complication book are 
advised to note complications with their 
billing cards at least every 3 months. Our 
aim is to direct orderly documentation of 
complications to identify problem areas. 
The form can be completed in about an 
hour if the information is organized.
The present audit does not collect 
information on symptoms (claudication 
versus salvage), outflow or patient selec­
tion, which obviously can skew the case 
load, complications and results. It does 
give a score-card whereby each surgeon 
can quickly assess the year’s work and 
compare it with the national experience. 
As the years go by, he can look back on 
his personal profile. As members of the 
society develop more experience with the
audit, it will be possible to introduce addi­
tional important variables to the data col­
lected, but this will require more docu­
mentation at the time the case is processed 
initially and needs enthusiastic partici­
pation.
The individual data collected by the 
audit are completely confidential. About 
half of the active members of the society
reported in 1982 (63) and 1983 (59). An 
audit report (Fig. 2) is generated from the 
form on an IBM PC (International Busi­
ness Machines, Inc.) using Lotus 1-2-3 
(Lotus Development Corp., Cambridge, 
Mass.) software. This report is circulated 
to the membership annually with the 
names of the members who participated. 
The reported results are good and speak
Canadian Society for Vascular Surgery 
3Q Day / Hospital Morbidity Audit
RUPTU RED  
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30 day/hospital morbidity is "early morbidity" and usually 
includes the first office visit. This is an audit of selected 
operations and complications. (We know you do more surgery!).
DIRECTIONS:
1) Chart only the most important procedure at each operation.
2) If the patient returned to surgery for a 
operation (not revision), count it as another "ca
3) Please note cause of each death.
4) To allow correlation of complications, amputation and 
death on individual patients please:
a) Use a single line for each complicated patient, 
charting all his/her complications on that line. 1- once, 2-
b) Use a second form if there are more than 5 patients 
who had a complication in any section.
c) If there was an amputation despite a patent 
reconstruction, chart ”0 "  under occluded. If not charted 0  the 
reconstruction is considered occluded "1" (please chart). All 
other blanks are considered 0 and need not be charted.
•Complicated cases : monitored complications only. The 
r in this box will equal the number of lines you used in eac
section if the form is completed correctly.
•Occluded : this reconstruction was occluded at discharge c 
30 days.
•T.N.D. : Transient Neurological Deficit.
FIG. 1—Audit form is completed each year by members of Canadian Society for Vascular 
Surgery. It tabulates common procedures performed and major complications.
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well for the state of vascular surgery in 
Canada. The consequences of revision 
and thrombectomy are summarized (Fig. 
2), again stressing the importance of case 
selection and technical expertise. The 
audit has given useful national informa­
tion and provides an opportunity for self 
assessment. It has also identified surgeons 
who may be willing to participate in 
future cooperative prospective studies. 
The concept of a national audit is cer­
tainly applicable to other surgical dis­
ciplines.
The executive would like to thank the 
following members who contributed to 
the 1983 audit: F.M. Ameli, H.FI. Au,
V. K. Balachandra, G.G. Barber, H. 
Basian, P. Blundell, G. Bondar, K. Chiu,
W. Chung, J.C. Coles, A.R. Downs, 
R.S. Dunn, E.T. French, P.D. Fry, J.L. 
Gilmour, M.M. Goldbach, M.R. Gold­
berg, K. Grant, A.C. Heide, H.R. Hil­
debrand, M. Hunting, W.L.M. King, 
K.W. Johnston, B.J. Lawlor, J. Las- 
sonde, F. Laurendeau, I.H. Lipton, H.K. 
Litherland, G.D. Maddison, R. Mag- 
gisano, J.B. Marchuk, D. Marois, T. 
Maxwell, J. McGoey, N. McKenzie, G. 
Meads, R. Moffat, V. Moonje, J.E. 
Morin, F.G. Murphy, D.S. Mulder, 
N.V. Perera, W. Pisesky, J. Provan, J. 
Rankin, G. DeRose, R. Ritchie, P.H . 
Roy, A. Salvian, P.A. Shah, T.K. Scobie, 
J.G. Sladen, H .J. Scott, J.F. Symes, J. 
Sweeney, R.D. Weisel, P. Walker, D. 
Wooster, J. Wellington.
J oseph G. Sladen , m d , frcsc
Department of Surgery,
St. Paul’s Hospital,
1081 Burrard St.,
Vancouver, BC 
V6Z 1Y6
C S V S
A U D I T 8 3
Amputated
Operation Cases COMPLICATED Rev/T Hg Inf Occl BK AK MORTALITY
(%) (%)
Aortic Aneurysm 721 50 (6.9) 10 5 10 3 0 2 31 (4.3)
Ruptured AA 231 90 (39.0) 6 6 2 1 0 2 83 (35.9)
Aortofemoral 926 60 (6.5) 23 3 11 11 7 9 21 (2.3)
Femorofemoral 258 17 (6.6) 9 0 3 9 2 3 5 (1.9)
Axillofemoral 128 38 (29.7) 13 2 5 15 1 4 14 (10.9)
Fem-pop vein 664 71 (10.7) 18 6 19 37 8 6 7 (1.1)
Fem-pop synth 476 66 (13.9) 18 1 3 40 8 11 13 (2.7)
Fem-tibial 190 60 (31.6) 24 3 2 43 15 14 5 (2.6)
Profundaplasty 259 21 (8.1) 6 1 5 6 4 6 2 (0.8)
Totals 3853 473 127 27 60 165 45 57 181
(7=) TND Stroke (%)
Carotid end'y 545 32 (5.9) 5 9 2 1 8 12 5 (0.9)
2.2%
M O R B I D I T Y  O F  T H  R O M  B E C  T O M  Y / R  E V 1S I O N
d u r i n g  h o s p i t a l  s t a y
a f t e r  v a s c u l a r  r e c o n s t r u c t i o n
Amputated
Operation Rev/T Hg Inf Occl BK AK MORTALITY
(%) m
Aortic Aneurysm 10 0 0 1 (10.0) 0 1 2 (20.0)
Ruptured AA 6 0 0 0 (0.0) 0 0 3 (50.0)
Aortofemoral 23 0 1 4 (17.4) 1 1 2 (8.7)
Femorofemoral 9 0 1 2 (22.2) 0 0 1 (11.1)
Axillofemoral 13 1 1 4 (30.8) 1 0 1 (7.7)
Fem-pop vein 18 2 3 9 (50.0) 2 0 0 (0.0)
Fem-pop synth 18 1 1 7 (38.9) 4 2 3 (16.7)
Fem-tibial 24 0 0 16 (66.7) 5 6 2 (8.3)
Profundaplasty 6 0 0 0 (0.0) 0 2 0 (0.0)
TNI Stroke
Carotid end'y 5 1 0 0 (0.0) 1 2 0 (0.0)
(59 surgeons reported)
FIG. 2—This audit report is generated from audit form on personal computer and circu­
lated to membership annually. COMPLICATED = one or more of following complications: 
Rev/T = revision and/or thrombectomy, Hg = hemorrhage (requiring operation), Inf = infec­
tion (wound, graft), Occl = occluded, BK = below knee, AK = above knee; MORTALITY 
= died within 30 days or during hospital stay; TND = transient neurologic deficit.
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Occult Breast Cancer
To the editors.—In response to Bassett’s 
editorial in this issue (pages 297 and 298), 
any woman who has an occult breast 
lesion discovered by mammography has 
a 10% to 15% chance of harbouring a 
small, invasive breast cancer. Most of 
these lesions are now detected through 
screening programs of asymptomatic 
volunteers, but there is no conclusive evi­
dence that this leads to better survival. 
There is good evidence, however, that 
survival following lumpectomy and axil­
lary dissection is the same as that follow­
ing total mastectomy and axillary dissec­
tion.1 It seems only fair, then, that these 
women should receive the benefits of 
“ conservative surgery” if at all possible. 
It is the only reward we can offer them 
for their participation in such programs.
The surgical technique of lumpectomy 
has been well documented. An incision is 
made directly over the lesion; the lesion 
is removed with 1 cm of surrounding nor­
mal breast tissue; the resection margins 
are carefully identified; the defect in the 
breast tissue is not repaired; the skin is 
closed with subcuticular suture and Steri- 
strips. Drains must not be used if a per­
fect cosmetic result is to be achieved.
Since these lesions are usually not pal­
pable during the operative procedure, 
frozen sections are inappropriate and the 
actual diagnosis must await the findings 
of paraffin sections. If the option of a 
lumpectomy is to be preserved for those 
who turn out to have an invasive cancer, 
all lesions should be removed by the 
appropriate technique. This can be done 
if the localizing needle is sutured into 
position in the breast tissue and remains 
palpable throughout the procedure but is 
usually impossible if Bassett’s technique 
is followed. A circumareolar incision will 
not necessarily be directly over the lesion; 
if the dye is visualized in the breast tis­
sue, the area of normal tissue around the 
suspect cancer has probably been vio­
lated. Thus, it may be very difficult to 
define the margins of the excision for the
pathologist who cannot then assess if the 
lumpectomy is adequate.
Whether a radiologist and the radiol­
ogy department are involved in the nee­
dle localization procedure will depend on 
the resources available to the operating 
surgeon. As long as the needle is inserted 
into the breast tissue through the skin 
immediately overlying the calculated loca­
tion of the lesion, it can be secured by a 
suture and a proper lumpectomy per­
formed.
L. Mahoney, md, ms(tor), frcsc, facs
Ste. 403,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
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Head Injuries
To the editors.—I wish to thank Dr. 
Schwartz (Can JSurg 1985; 28: 197-8) for 
his thoughtful comments on our article 
on head injuries (Can J  Surg 1985; 28: 
79-83). His two questions deal with 
quotes from other papers. In the first 
instance, Jennett and colleagues' 
reported that intracranial pressure 
monitoring had no effect on mortality 
and that, as a whole, patients treated 
more intensively did less well as a group 
than might have been expected. On page 
82, in the last paragraph under “ Treat­
ment” , we noted that Becker and his 
associates2 did not agree. With so many 
variables, conclusions are difficult, but 
our impressions resulting from the out­
come in these two groups would confirm 
Jennett’s observation. It is interesting that 
since our article appeared, Becker’s 
group3 have reported that “ while the use 
of barbiturates in high doses can lower 
ICP [intracranial pressure] and may be 
required when all other methods fail,
based on our data, we cannot recommend 
the prophylactic use of pentobarbital 
coma in the treatment of patients with 
severe head injury. In addition, we believe 
that its use is accompanied by significant 
side effects that can potentially worsen 
the condition of a patient with severe head 
injury.”
Regarding Dr. Schwartz’s second ques­
tion, again we are quoting somebody else, 
namely Marshall and associates4 who 
stated that mortality and morbidity are 
probably not significantly modified by 
efforts to reduce transportation time in 
patients with head injuries alone. Prob­
ably, the key word here is “ significantly” .
We tried to find out how many patients 
with head injuries alone died before 
reaching the Health Sciences Centre in 
Winnipeg and could get statistics only on 
the total number of deaths associated with 
head injuries for the province of 
Manitoba. There was no way of deter­
mining which of these were cases of head 
injury alone or of knowing which of these 
patients would have been taken to the 
Health Sciences Centre; hence, we had to 
let it go at that. We certainly agree with 
Dr. Schwartz that many patients with 
acute subdural hematoma can be saved 
with very early admission and, even more 
importantly, with very early recognition 
and transport to the operating room. 
During the period of our study, there was 
no recorded instance of a patient with a 
head injury alone and a lucid interval 
dying in transport. With only this infor­
mation we did not feel justified in trying 
to make further assumptions in this area.
Dwight Parkinson, md, facs, frcsc
Professor,
Section of Neurosurgery,
University of Manitoba,
750 Bannatyne Ave.,
Winnipeg, Man.
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Mediastinal Packing 
for Refractory Bleeding 
After Open-Heart Surgery
To the editors.—I read with interest Dr. 
Del Campo’s article on mediastinal pack­
ing for refractory nonsurgical bleeding 
after open-heart surgery (Can J  Surg 
1985; 28: 55-6).
I used this technique 7 years ago on a 
child who underwent insertion of a right 
ventricular pulmonary artery valved con-
FIG. 1—Postoperative roentgenogram 
showing radiopaque markers in mediastinal 
pack used to control bleeding.
FIG. 2—Appearance following removal of 
mediastinal pack.
duit. At the end of the operation, bleed­
ing from the pulmonary artery suture line 
could not be controlled by conventional 
means, but tight packing with several 
pieces of 4 X 4-inch gauze successfully 
stopped the bleeding. The postoperative 
chest film (Fig. 1) shows the radiopaque 
markers in the gauze pack. The gauze 
pack was removed under direct vision the 
following day by reopening the ster­
notomy (Fig. 2). There was no more 
bleeding and the child was discharged 
from the hospital without further com­
plications.
Del Campo’s technique of bringing the 
end of the mediastinal pack through a 
skin incision for later removal without 
sternotomy is certainly an attractive alter­
native technique.
Ricardo J. Moreno-Cabral, md, frcsc 
Ste. 710,
1380 Lusitana St.,
Honolulu, HI 96813 
USA
Military Surgery and the Medical 
Profession’s Responsibilities
To the editors.— Ox. A.C. Derby’s paper 
on military surgery (Can J  Surg 1985; 28: 
183-6) and Professor Cruse’s editorial 
comment (Can J  Surg 1985; 28: 102) say 
two things: first, that for centuries the 
medical profession has tried to treat 
lesions resulting from war and, second, 
some new procedures developed in war­
time are useful in peacetime, if they are 
not forgotten. Neither writer points out 
that the medical profession has not, so 
far, seriously addressed the etiology and 
pathology of war itself.
Down the centuries, military strategy 
has evolved from combat between profes­
sional soldiers to the involvement of large 
numbers of conscripts to the mass killing 
of civilians. Machines of increasing com­
plexity from the longbow to the ther­
monuclear bomb have been invented for 
killing and maiming people. Still, the 
basic sequence has changed little: rulers 
and politicians initiate wars, militarists 
direct them, and populations suffer and 
die. While it is encouraging to know that 
medicine has salvaged a higher propor­
tion of the wounded in successive wars, 
this must not obscure the fact that in each 
successive war there have been larger 
numbers of deaths and injuries.
It is now accepted that a nuclear war 
would destroy most living things on earth. 
This knowledge should make war obso­
lete. But politicians and military 
strategists keep on making the same old 
mistakes; the rhetoric of distrust and hate 
goes unchecked; new and deadlier 
weapons are being invented and
deployed. War should be unthinkable, 
but never in human history has it been 
more imminent.
This is why the medical profession 
world-wide must put all its effort towards 
preventing catastrophe, both by insisting 
on the abolition of weapons of mass des­
truction and by encouraging more ra­
tional ways of preventing or resolving 
conflicts.
D .B . Stewart, mbe, frcsc
PO Box 805,
Killarney, Man.
R0K 1G0
To the editors.—I concur with Dr. D.B. 
Stewart that the medical profession 
should make every effort to prevent war. 
The question is, should this effort be 
made through strength or weakness? 
Many needless lives were lost in two world 
wars as the result of unsuccessful attempts 
at prevention by appeasement and disar­
mament.
To deal with the causes and prevention 
of wars was not appropriate to or within 
the scope of my paper “ The military sur­
geon — not least in the crusade” (Can J  
Surg 1985; 28: 183-6). I certainly did not 
intend to obscure the horrors of war or 
glorify the participants, but, rather, I 
wished to remind Canadian surgeons of 
the importance of a working knowledge 
of the principles of military surgery and 
to review our military surgical heritage to 
which we owe so much.
I saw the first casualty who came 
from Korea, while on posting at an 
army hospital in the United States. In less 
than 6 years the military surgeons had 
forgotten (or never knew), for example, 
that wounds of the colon should be exteri­
orized or that all wounds should be 
debrided. The results were often disas­
trous.
This publication 
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It is 40 years since the last atomic bomb 
was dropped. Since then, there have been 
numerous conventional wars, incidents 
and terrorists attacks and it is likely that 
this type of conflict will continue in spite 
of all efforts and that Canada may well 
be involved.
A. Campbell Derby, md, frcsc 
RR l,
Iroquois, Out.
KOE 1K0
Choledochoduodenal Fistula 
and Gallstone Ileus 
in the Absence of the Gallbladder
To the editors.—I read with interest the 
case reported by Masters and Wellington 
(Can JSurg  1985; 28: 65-6) and I believe 
it merits further comment.
The authors did not mention whether 
cholangiograms were performed at the 
time of the initial cholecystectomy. Rou­
tine use of operative cholangiograms is 
useful in detecting unsuspected stones in 
the common bile duct,1-3 decreasing the 
number of negative duct explorations2’4’5 
and thus the incidence of retained 
stones.1’2,6 The old-fashioned method of 
palpating the duct for stones is unreliable 
and unnecessary.
During the 6 years after the cho­
lecystectomy the patient had recurrent 
bouts of cholangitis. Ultrasonography 
confirmed the presence of a stone within 
the common bile duct. In these circum­
stances, endoscopic papillotomy and 
extraction of the stone should have been 
carried out.7 This procedure is relatively 
safe and is least hazardous to the patient.
Finally, I was not quite sure about the 
indication for performing barium studies 
when the correct clinical diagnosis of gall­
stone ileus had already been made. It did 
not provide any further information and 
probably delayed the operation.
J. Derodra, frcs
Rm. 4W8,
Department of Gastroenterology,
McMaster University,
1200 Main St. W,
Hamilton, Ont.
L8N 3Z5
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To the editors.—In response to Dr. 
Derodra, it was not our intent to publish 
a treatise on the diagnosis and treatment 
of common-duct stones but to report 
what we perceived as an unusual and 
interesting case. I do not know the opin­
ions of patient’s attending physicians on 
operative cholangiography or endoscopic 
sphincterotomy before August 1983, 
when we first saw this patient. Neverthe­
less, the indications and value of opera­
tive cholangiography are well recognized 
by most medical students and the tech­
nique has routinely been practised at our 
hospital for at least 10 years.
As to the use of endoscopic papil­
lotomy before the development of the
choledochoduodenal fistula, a stone 
measuring 3.0 X 2.5 cm would not be 
expected to pass through an endoscopi- 
cally incised sphincter nor would a stone 
of this size and consistency be likely to 
yield to attempts at crushing.
Finally, a barium study was done in this 
woman because we had not before seen 
gallstone ileus in the absence of the gall­
bladder. Perhaps this is excusable since 
only one reported case could be found in 
the surgical literature. As to the opera­
tive delay resulting from performance of 
the barium study, the patient was in fact 
in better condition after the development 
of her choledochoduodenal fistula, be­
cause the long-standing common-duct 
obstruction was relieved.
J.L. Wellington, md, frcsc
Department of Surgery,
Ottawa General Hospital,
501 Smyth Rd.,
Ottawa, Ont.
K1H 8L6
SESAP IV Question
12. Which of the following statements about Barrett’s esophagus is NOT true?
(A) A stricture is usually present above the arch of the aorta
(B) A stricture usually forms at the junction of squamous and 
columnar epithelium
(C) Barrett’s ulcer is in columnar-lined esophagus
(D) Sliding esophageal hiatus hernia is usually present
(E) The risk of esophageal carcinoma is significant
For the question above select one of the five answers given.
(Reproduced by permission from SESAP IVSyllabus; Surgical Education and 
Self-Assessment Program No. 4. For enrolment in the Surgical Education and 
Self-Assessment Program No. 4, please apply to the American College of Sur­
geons, 55 East Erie St., Chicago, IL 60611.)
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What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and. as 
its practitioners, you must be the source as well as the readers of this column.
Ethics in Research on Surgical Techniques: 
a Conversation
Without a word, Baby Fae reminded 
everyone that surgeons, in consultation 
with their patients (parents or guardians), 
can carry out research on human beings 
using techniques that haven’t necessarily 
been thoroughly tested in animal models 
and laboratories.
However, according to Jean G. Cou­
ture, President of the Royal College of 
Physicians and Surgeons of Canada, the 
operation to introduce a baboon’s heart 
into a baby who was fatally ill produced 
concerns among the public more because 
of the unconventionality of the transplant 
than because of the ethical questions 
involved. Among scientists, the work was 
criticized because the backcloth of 
research was thin at best. Said Couture 
in a conversation with CJS about ethics 
in surgery and surgical research, “ The 
procedure was strongly criticized because 
the research was insufficient to show a 
human could tolerate a baboon’s heart.” 
The operation was experimental, not a 
logical link in systematic research.
Despite the criticisms, the Baby Fae 
operation was seen by many as a last 
resort, said Couture. The child was going 
to die, so the ethical consideration was 
“ whether you should apply preliminary 
experimental surgery to human beings” . 
Other ethical questions that were asked 
last month at a meeting on transplanta­
tion at the University of Kentucky, said 
Couture, were: What happens to a per­
son’s “ soul” or behaviour when he or she 
receives a transplant from a baboon? 
Would the hormones intrinsic in the heart 
produce anomalous characteristics?
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, PO 
Box 8650, Ottawa, Ont. K1G 0G8.
Quite different are the ethical questions 
in research on a technique that works but 
could be improved — for example, ask­
ing a patient to test a cement to repair a 
fracture of the femur when one knows 
that screws will do the trick and that in 
10 years the cement may give way.
Different again are the questions in 
randomized clinical trials. Said Couture, 
“ If a clinical trial is properly put together 
and supervised, you have two good treat­
ments, and you want to find out which 
treatment is better. The ethical problem 
comes in the middle of the trial when you 
find that one treatment is better than the 
other. Even then, you’re not sure until the 
trial is complete. You have to have a cer­
tain number of cases or the answer is not 
scientifically sound. You should stop the 
trial if you find that one treatment is 
bad.”
In 1978, the Medical Research Coun­
cil of Canada drew up guidelines for ethi­
cal research on human subjects and has 
since maintained a standing committee on 
ethics and experimentation as well as a 
working group that meets regularly. At 
the urging of the MRC, medical schools 
that did not have their own ethics review 
committees established them. The com­
mittees carefully examine the protocols 
and methods for human experiments pro­
posed by investigators. They ensure that 
there are provisions for obtaining 
informed consent from the subjects; that 
the proposed question and research pro­
tocol are scientifically valid; that the use 
of human subjects is necessary; that the 
risks and benefits to the subjects and to 
society are identified; and that the group 
of proposed subjects has the ability to 
give informed consent.
In effect, the committees provide pro­
tection for those involved in formal
Couture: Clinical trials protect the public.
research projects. Said Couture, “ Ethics 
review committees are strictly organized 
so the protection of the subjects is 
ensured. Problems would be in research 
funded outside recognized agencies where 
the guidelines for ethics review might not 
be as strict.” How much research falls 
into this category is uncertain but, accord­
ing to the MRC, patients in hospital are 
an at-risk group. To safeguard this group, 
or at least ensure that the ethical questions 
are asked for any treatment given, some 
hospital are hiring experts in ethics — the 
Montreal Children’s Hospital recently 
became the second in Canada to employ 
an “ ethicist” , Dawson Schultz.
“ Chemical trials protect the public” , 
and the ideal, according to Couture, is a 
clinical trial of two good treatments — 
well-organized, randomized trials that 
show one of the treatments is better. The 
best recent example is part of an ongo­
ing study by the National Surgical Adju­
vant Breast Project. “ It proved without 
any doubt that conservative surgery is as 
good as more radical surgery for women 
who have tumours smaller than 4 cm and 
disease confined to the breast and 
regional lymph nodes.”
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Couture, who is involved in surgical 
research at Laval University, said, essen­
tially, that all surgery is experimental until 
supported by properly controlled trials. 
The focus of the work that Couture is 
doing is biomaterial prostheses: “ 50% of 
what we are doing is for vascular 
prostheses, but in the last couple of years 
we have been working on cardiac valves 
and mammary prostheses.” The work is 
being funded by the MRC and the minis­
try of health; thus, the protocols for any 
human experiments would be carefully 
screened.
The information obtained from their 
trials is passed to the Bureau of Medical 
Devices within the Health Protection 
Branch and provides an objective meas­
ure of clinical trials by manufacturers. 
Couture noted that the seller’s vested 
interest makes many clinicians suspicious 
about the quality of the manufacturers’ 
tests despite the efforts of the bureau. He 
would like to see the bureau take on an 
advisory role as well as its current func­
tions as a controlling agency. “ I think the 
bureau should be able to advise surgeons 
on what is a good graft and what is not, 
by drawing on objective research. We 
need to have as much assistance as is 
available for drugs; for example, we 
should have a com pendium  of 
prostheses.”
Devices Approved for Clinical 
Trials Mainly Surgical
The annual list of devices approved by 
the Bureau of Medical Devices for clini­
cal trials was published recently, and all 
but 1 of the 50 items were designed for 
use by a surgical specialty.
Dr. A.K. DasGupta, Director of the 
Bureau of Medical Devices, spoke to CJS 
about the process: “ From our point ot 
view, the prime responsibility for testing 
belongs to the guy who sells the device. 
A regulation agency like ours has to check 
that the man has done the testing needed 
and that the results assure that the device 
does what it claims to do.” The level of 
testing depends on the claims for the 
device. “Laboratory testing is enough for a 
device that measures blood sugar whereas 
some implants need years of testing in 
humans. The tests are done at the 
manufacturer’s expense by appropriate 
specialists.” If the results of the trials are 
satisfactory, then the bureau relies on 
reports from clinicians to monitor the 
quality of the products on the market.
Medical Devices Adverse 
Experiences Registry Under Way 
but Under Used
Since February this year, the Canadian
Medical Association, with a grant from 
the Department of National Health and 
Welfare, has been housing the Medical 
Devices Adverse Experiences Registry. To 
date, the registry has had only two credible 
calls. Lynn Cohen, who is the CMA staff 
member taking the calls, told CJS that the 
response is expected to pick up now that 
information kits have gone out to 38 000 
physicians, 1500 hospitals and 250 medi­
cal writers.
Proposed Data Collection Registry 
for Surgery of Morbid Obesity 
Losing Impetus
The Canadian Consensus Group for the 
Surgery of Morbid Obesity has been 
stymied in its attempts to obtain funds for 
a central registry to collect information 
on the operations currently being used to 
treat morbid obesity. According to Dr. 
Joel Freeman, the secretary for the group, 
there are at least two dozen varieties of 
operations and currently no long-term 
data showing what works. The operations 
are being modified continuously, and vir­
tually no data span more than 24 months.
The consensus group, which was 
formed just a year ago, drew up a form 
for follow-up of patients who are mor­
bidly obese, whether or not they undergo 
surgical treatment, and submitted a 
proposal for funding from the National 
Health Research Development Program. 
The group was hoping for enough money 
to cover the costs of collecting and analys­
ing the information. The proposal was 
refused, so the group began urging 
interested surgeons to contribute $1000 to 
$1500 towards a registry and recom­
mended that only two operations be used: 
vertical-banded gastroplasty and gastric 
bypass.
Currently, the proposal is in limbo, but 
the group is still committed to informa­
tion-gathering. The experience with hori­
zontal gastroplasty as treatment for mor­
bid obesity clearly indicates why. Initially 
the procedure was promising. Although 
associated with many complications, 
including stenosis of the stoma, leakage 
with or without subphrenic abscess, and 
pneumonia, it seemed to work: most 
patients who underwent this form of gas­
tric partitioning lost weight. Unfor­
tunately, after about 12 months, they 
either regained it or reached a plateau. A 
few surgeons, however, still perform the 
procedure.
All provincial health plans currently 
cover the costs of surgical intervention for 
morbid obesity and more than 5000 oper­
ations are performed annually in Ontario
alone, according to data Freeman ob­
tained from Statistics Canada. Patients 
who are referred for surgery have virtu­
ally no alternatives, although jaw wiring 
has been proposed as an intermediate 
measure for people who are too obese to 
undergo an operation safely.
Surgical intervention is a last resort, 
reserved for patients who have tried 
repeatedly to diet under medical supervi­
sion, have had subclinical hypothyroidism 
ruled out, and have been suffering clini­
cally recognizable disease because of their 
obesity.
The goup is committed to finding 
which treatment is best for their patients; 
ironically, the health insurance system is 
willing to pay regardless of the efficacy 
of the treatment, yet no one is anxious to 
invest in finding out what works.
New Head of Neurosurgery 
at Toronto Western
Charles H. Tator, Professor of Neu­
rosurgery at the University of Toronto, 
recently accepted positions at Toronto 
Western Hospital as head of neurosurgery 
and codirector of the Playfair Neuros­
cience Unit.
A scientist of international standing in 
both the clinical and basic scientific 
aspects of neurosurgery, Tator’s current 
work is being supported by the MRC as 
well as various other agencies. He is 
exploring the use of hormones and elec­
trical currents to stimulate regeneration 
of nervous tissue.
Amy Chouinard
Charles H. Tator, MD, FACS, FRCSC
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Endoscopic Control of Upper Gastrointestinal Bleeding
One important objective in managing 
patients with upper gastrointestinal 
hemorrhage is to control the bleeding 
until the patient's condition is stable and 
definitive therapy can be carried out. 
Endoscopic techniques are now available 
to attain this goal. Endoscopic sclerosis 
has become an accepted treatment for 
bleeding esophageal varices, especially in 
patients with Child's class B or C cirrho­
sis. Control of nonvariceal bleeding by 
endoscopic techniques is now feasible 
and involves laser photocoagulation and 
electrocoagulation. Clinical experience 
with endoscopic laser photocoagulation 
has demonstrated that it can success­
fully arrest bleeding in gastric and duo­
denal ulcers. Endoscopic electrocoagula­
tion has been successful in stopping 
bleeding from Mallory-Weiss tears, acute 
gastric erosions, and gastric, duodenal 
and stomal ulcers. Use of an endoscopic 
heater probe, now in the development 
stage, to control bleeding gastric and 
duodenal ulcers will be an important 
addition.
Chez les patients souffrant d'hemorragie 
des voies gastro-intestinales superieures, 
un des objectifs importants du traitement 
consiste a maitriser les saignements 
jusqu'a ce que I'etat du patient soit 
stabilise et qu'on puisse appliquer un 
traitement definitif. Des techniques 
endoscopiques existent maintenant qui 
permettent d'atteindre ce but. La 
sclerose endoscopique est maintenant 
acceptee comme traitement des varices 
oesophagiennes, specialement chez les 
cirrhotiques de classe B ou C dans la 
classification de Child. L'arret des hemor- 
ragies non variqueuses par methodes
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endoscopiques est maintenant possible 
grace d la photocoagulation au laser et 
I'electrocoagulation. L'experimentation 
clinique de la photocoagulation endosco­
pique au laser revelle que celle-ci peut 
venir a bout des saignements dans les 
cas d'ulcdres gastriques et duodenaux. 
L'electrocoagulation endoscopique per- 
met d'arreter I'hemorragie dans les cas 
de dechirures de Mallory-Weiss, d'ero- 
sions gastriques aigues et d'ulceres gast­
riques, duodenaux ou du stoma. 
Pr6sentement en developpement, les 
sondes endoscopiques chauffantes con- 
stitueront une addition importante aux 
moyens deja connus de juguler les 
saignements des ulceres gastriques et 
duodenaux.
Upper gastrointestinal hemorrhage is one 
of the most common causes of emergency 
hospital admission in North America. 
Mortality varies between 5% and 30%, 
depending on the cause and severity o f the 
bleeding.1'3 In spite of greater emphasis 
on early diagnosis and improvements in 
medical, surgical and critical care, mor­
tality is still around 10% and has not 
changed significantly in the last 25 
years.4'6
Various reports710 have documented a 
substantial decrease in operative mortal­
ity when conservative therapy controlled 
the hemorrhage so that surgery could be 
carried out on a semielective basis (Table 
I). Thus, one of the main objectives in 
managing patients with profuse upper
gastrointestinal bleeding should be to con­
trol the bleeding until the patient’s con­
dition has stabilized, when definitive 
therapy can be performed. Endoscopic 
techniques (Table II) are available to stop 
upper gastrointestinal hemorrhage and 
will be discussed in this report.
Sclerosis o f Esophageal Varices
Crafoord and Frenckner11 in 1939 
were the first to report the use of 
sclerotherapy for bleeding esophageal 
varices. A 19-year-old patient presented 
with hematemesis and melena. Esopha- 
goscopy demonstrated large esophageal 
varices. Repeated injection of the varices 
was carried out until they had all disap­
peared. There was no further bleeding in 
the 3-year follow-up period. This report 
did not create much enthusiasm because 
at that time portasystemic shunting was 
considered the most effective method of  
managing esophageal varices. In spite of 
the widespread use of portasystemic 
shunts, the occasional report appeared, 
describing variceal sclerotherapy.12'13 In
Table II—Endoscopic Techniques Available to 
Control Upper Gastrointestinal Hemorrhage
Sclerosis of esophageal varices 
Laser photocoagulation 
Electrocoagulation 
Thermal probe 
Tissue adhesives
Table l-Surgical Mortality in Patients With Upper Gastrointestinal Hemorrhage: 
Emergency Versus Semielective Surgery
Authors, yr
Emergency surgery Semielective surgery
No. of 
patients
Operative 
mortality, %
No. of 
patients
Operative 
mortality, %
Kelley and associates, 19637 151 19 99 3
Schiller and associates, 19708 412 20 168 7
Halmagyi, 19709 34 21 84 7
Crook and associates, 197210 111 31 102 11
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the 1960s, because of dissatisfaction with 
shunt surgery, many surgeons began to 
look for alternative methods of controll­
ing bleeding esophageal varices. In 1973, 
Johnston and Rodgers14 reported their 
15-year experience with injection 
sclerotherapy. They did 217 endoscopic 
injections in 116 patients; hemorrhage 
was controlled in 93 % of the bleeding epi­
sodes.
This report was the first of many from 
around the world, describing the effec­
tiveness of endoscopic injection 
sclerotherapy in controlling variceal 
bleeding. In 1979, Terblanche and 
associates15 reported a controlled trial of 
24 patients; 13 control patients and 11 
who had endoscopic injection sclerother­
apy. Recurrent variceal hemorrhage 
occurred in 9 (69%) patients in the con­
trol group, while variceal bleeding 
occurred in only 4 (36%) patients in the 
injection sclerotherapy group. The total 
follow-up was 25 months. MacDougall 
and associates16 reported a controlled 
trial of 107 patients with bleeding 
esophageal varices. Twenty-two (43%) of 
the 51 patients in their sclerotherapy 
group had further bleeding compared 
with 42 (75%) of the 56 control patients.
Recent studies17’18 have also confirmed 
that endoscopic sclerotherapy effectively 
controls acute variceal bleeding and, also, 
compares favourably to portacaval shunt­
ing. Larson and colleagues17 reported a 
controlled trial of 82 patients who were 
randomized to either medical therapy (39 
patients) or injection sclerotherapy (43 
patients) within 48 hours after an acute 
variceal hemorrhage. The incidence of 
rebleeding and the number of units of 
blood transfused was significantly 
(p < 0.01) lower in the sclerotherapy 
group. Cello and associates18 carried out 
a randomized trial, comparing endoscopic 
sclerotherapy with portacaval shunting in 
Child’s class C patients with alcoholic cir­
rhosis and profuse variceal bleeding. The 
number of units of blood received was 
significantly (p < 0.01) less but the num­
ber of rebleeding episodes was signifi­
cantly (p < 0.05) higher in the sclerother­
apy group. The overall survival was 
similar in both groups. The authors con­
cluded that the effectiveness of portacaval 
shunting was similar to that of sclerother­
apy in managing variceal bleeding in these 
patients and suggested that endoscopic 
sclerotherapy should be the procedure of 
choice.
Many different techniques of endo­
scopic sclerosis of esophageal varices have 
been described in the literature. Some 
advocate rigid endoscopy under general 
anesthesia,19'20 fiberoptic endoscopy with 
premedication alone,21’22 intravariceal or 
paravariceal injection,19’20 the addition 
of a flexible esophageal sheath23 or the 
incorporation of a balloon at the end of
the fiberoptic endoscope to compress the 
varix after injection.24 Various sclerosing 
solutions have been used: ethanolamine 
oleate, sodium m orrhuate, sodium 
tetradecyl sulfate and ethanol. In an 
animal model, Jensen and associates25 
found that ethanol 95%, tetradecyl 1.5% 
and ethanolamine 5% each gave greater 
than 60% sclerosis of esophageal varices.
The complications reported have 
included hemorrhage, esophageal ulcers, 
esophageal strictures and perfora­
tions.15'21 The use of flexible endoscopy 
has decreased the incidence of perfora­
tions and with increased experience the 
incidence of esophageal ulcers and stric­
tures has also been lowered.
Sclerotherapy Protocol
The following protocol has proven 
effective in managing patients with bleed­
ing esophageal varices. The patient is 
admitted to hospital, preferably to an 
intensive care unit. Endoscopy should be 
carried out immediately to ensure that the 
bleeding is not from a lesion other than 
varices. Endoscopy will also indicate 
whether the varices are actively bleeding 
or whether variceal bleeding has stopped. 
If there is active bleeding, a Sengstaken- 
Blakemore tube is passed down the 
esophagus and balloon tamponade 
applied for 24 hours. In most patients this 
controls the bleeding. Endoscopic sclero­
sis is then carried out. The patient is 
sedated with meperidine (50 mg intra­
venously) and diazepam (10 to 20 mg 
intravenously). The varices are visualized 
with the flexible endoscope and sclerosis 
is carried out. An injection needle is 
passed down the biopsy channel and 2 to 
3 mL of ethanolamine oleate 5% is 
injected intraluminally into the varix. A 
maximum of three varices, beginning at 
the esophagogastric junction , are 
sclerosed at one time. The procedure is 
repeated weekly until most or all the 
varices are sclerosed. If the sclerosis is 
successful, the patient is readmitted to 
hospital in 3 months for repeat endoscopy 
and if esophageal varices are still present 
or have recurred, endoscopic sclerosis is 
carried out again.
Conclusions
It seems clear that endoscopic injection 
sclerotherapy is now playing an important 
role in the treatment of bleeding 
esophageal varices. Accumulating evi­
dence suggests that this should be the ini­
tial approach and there is a strong possi­
bility that sclerotherapy will replace 
shunting procedures in the management 
of most patients with bleeding esophageal 
varices. However, it must be emphasized 
that endoscopic sclerosis will not always 
stop bleeding from esophageal varices. If
the bleeding is not controlled, then oper­
ative procedures such as the Sugiura 
procedure26 should be considered.
Endoscopic Control of Nonvariceal 
Bleeding
Endoscopic control of nonvariceal 
bleeding of the upper gastrointestinal 
tract has become an important therapeu­
tic modality. The first report in 197027 
involved the use, in two patients, of a cys- 
toscope passed through a gastrostomy. 
One patient had a gastrostomy for an 
inoperable squamous cell carcinoma of 
the esophagus. After radiotherapy, pro­
fuse gastrointestinal bleeding occurred 
due to a large gastric ulcer. Conservative 
therapy did not stop the hemorrhage. A 
cystoscope was passed through the gas­
trostomy into the stomach and a panen­
doscope was then used to identify and 
successfully cauterize a bleeding vessel at 
the edge of the ulcer. The second patient 
was a 47-year-old woman who had under­
gone cholecystectomy and choledocho- 
tomy for cholelithiasis and choledocho- 
lithiasis. Postoperatively, serious upper 
gastrointestinal bleeding occurred. Con­
servative therapy was unsuccessful in con­
trolling the bleeding, so vagotomy, sub­
total gastrectomy and gastrostomy for 
multiple bleeding gastric erosions were 
carried out. Four days later, bleeding 
recurred. Through a cystoscope passed 
through the gastrostomy opening, a 
panendoscope visualized multiple bleed­
ing gastric ulcers in the gastric remnant. 
These were successfully cauterized.
Since 1970 many groups have inves­
tigated and applied various endoscopic 
methods to control nonvariceal upper 
gastrointestinal bleeding. These have 
involved laser coagulation, electrocoagu­
lation, thermal probes and tissue adhe­
sives.
Laser Photocoagulation
Laser photocoagulation has been used 
for a long time to manage retinal detach­
ment and skin lesions. In 1967, Ketcham 
and associates28 reported on the effec­
tiveness of this technique in producing 
small-vessel thrombosis. In 1970, Good- 
ale and colleagues29 successfully used a 
carbon dioxide continuous-wave laser 
applied to a gastroscope to control bleed­
ing gastric ulcers in dogs. Nath and 
colleagues30 in 1973 reported an 
experimental study with a fiberoptic laser 
endoscopy system. Two years later, 
Dwyer and associates31 successfully con­
trolled arterial bleeding from gastric 
ulcers in dogs using an argon laser cou­
pled to a fiberoptic endoscope. Other 
reports appeared describing endoscopic 
laser photocoagulation of bleeding gas­
tric lesions in animals.32'34
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Initial clinical experience with this tech­
nique was described by Kiefhaber and his 
group.35 Of 140 bleeding episodes in 110 
patients, 131 were effectively controlled 
by endoscopic laser photocoagulation. 
The lesions included esophageal varices, 
Mallory-Weiss tears, gastric and duo­
denal ulcers and acute gastric erosions. 
Dwyer and associates36 documented two 
cases of upper gastrointestinal bleeding: 
one was a 50-year-old woman with bleed­
ing gastric erosions, successfully con­
trolled by argon laser photocoagulation. 
In the other case, a 42-year-old man with 
a malignant bleeding gastric carcinoma, 
laser photocoagulation was unsuccessful 
and operation was needed to control the 
hemorrhage. Friihmorgen and col­
leagues37 reported a success rate of over 
90% when they used laser photocoagu­
lation to control bleeding gastric lesions.
In 1981, Ihre and associates38 reported 
a controlled trial comparing endoscopic 
laser treatment (66 patients) with conser­
vative management (69 patients) for 
upper gastrointestinal bleeding. They did 
not find any difference between the two 
groups with respect to the number of 
units of blood received, mortality and 
rebleeding rate. There were several 
problems with this trial: the power level 
of the laser was too low to obtain effec­
tive hematemesis. Technical difficulty 
with the equipment prevented laser pho­
tocoagulation in 8 of 66 patients. Ten 
patients in the laser group had bleeding 
esophageal varices, and experience has 
shown that laser photocoagulation is fre­
quently unsuccessful in controlling bleed­
ing esophageal varices.
In a controlled trial, Vallon and 
associates39 investigated the role of argon 
laser photocoagulation in bleeding pep­
tic ulcers. Sixty-eight patients were in each 
of the laser and control groups. Laser 
photocoagulation was no more effective 
than standard therapy in stopping bleed­
ing and preventing rebleeding from pep­
tic ulcers. Swain and colleagues40 also 
studied the efficacy of argon laser pho­
tocoagulation in controlling hemorrhage 
from peptic ulcers. Thirty-six patients 
were in the laser group and 40 patients 
were in the control group in which 
endoscopy was carried out, aiming the 
laser beam on the bleeding point but not 
applying full power. There was significant 
(p < 0.05) reduction in the rebleeding rate 
and in mortality (p < 0.02) in the laser 
photocoagulation group.
To analyse the role of laser photo­
coagulation in arresting bleeding lesions 
of the upper gastrointestinal tract, Rut- 
geerts and associates41 carried out a con­
trolled trial. All 23 patients with spurt­
ing arterial bleeding (13 gastric and 10 
duodenal ulcers) underwent laser therapy. 
Bleeding stopped in 20 patients but 
recurred in 11. Fourteen of the 23 patients
required surgery. The overall mortality 
was 30% (7 of 23). Eighty-six patients 
with active, nonspurting bleeding and 43 
patients with inactive bleeding lesions 
were randomized to YAG (yttrium- 
aluminum-garnet) laser phototherapy or 
conservative therapy. In the patients with 
active, nonspurting bleeding, there was an 
increase in the number of bleeding lesions 
controlled by laser treatment and a reduc­
tion in the rebleeding rate. The overall 
mortality was similar in the laser and con­
servative groups. In patients with inactive 
bleeding, laser therapy reduced the 
rebleeding rate and overall mortality. The 
authors concluded that laser therapy was 
successful in all groups except those with 
arterial spurting lesions.
Swain and colleagues,42 in an update 
report in 1984, analysed the role of 
neodymium-YAG laser photocoagulation 
in 123 patients with bleeding peptic ulcers 
(visible vessel or blood clot). In the 
visible-vessel group, laser therapy reduced 
the rebleeding rate and need for emer­
gency surgery.
The results of the above studies are 
encouraging but further trials are 
required, especially those involving cer­
tain subgroups such as patients with gas­
tric or duodenal ulcers with either acute 
bleeding or visible vessels. Further infor­
mation is urgently required before we can 
conclude that laser photocoagulation has 
an important role in the management of 
patients with upper gastrointestinal 
hemorrhage. Laser equipment is costly, 
special requirements are necessary for 
installation and service and it can’t be 
moved around the hospital. There are 
also hazards to endoscopists using laser 
phototherapy. Therefore, although its 
potential is evident, widespread use of this 
technique is unwarranted at present.
Electrocoagulation
Endoscopic electrocoagulation has 
been widely accepted in the treatment of 
colonoscopic polypectomy; morbidity is 
minimal and mortality almost nil. In 
1971, Blackwood and Silvis43 reported 
on the use of endoscopic electrocoagula­
tion in upper gastrointestinal hemor­
rhage. Papp44 described seven patients 
with upper gastrointestinal hemorrhage 
who underwent endoscopic electrocoagu­
lation; three had gastric ulcers, one a duo­
denal ulcer, one patient had acute gastric 
erosions, one a stomal ulcer and one a 
bleeding gastric varix. Electrocoagulation 
successfully stopped the bleeding gastric 
ulcers, duodenal ulcer, gastric erosions 
and stomal ulcer. Electrocoagulation of 
the gastric varix temporarily controlled 
the bleeding, but several hours later the 
patient died of exsanguination from 
esophageal varices. In 1975, Sugawa and 
colleagues45 carried out electrocoagula­
tion in six seriously ill patients. Three had 
acute gastric erosions, one a gastric ulcer, 
one a Mallory-Weiss tear and another a 
bleeding gastric polyp. Electrocoagulation 
controlled the bleeding in all patients 
except the one with a bleeding gastric 
ulcer and one patient with bleeding acute 
gastric erosions. Papp46 updated his 
experience and analysed the efficacy of 
electrocoagulation in 38 patients with 
upper gastrointestinal bleeding. Bleeding 
was controlled in 15 patients with gastric 
ulcers, 14 with duodenal ulcers, 6 with 
Mallory-Weiss tears, 1 patient with acute 
gastric erosions, 1 with a gastric varix and 
1 with an esophageal ulcer. Electrocoagu­
lation was unsuccessful in one patient 
with a Mallory-Weiss tear and one with 
a bleeding duodenal ulcer. Three gastric 
and three duodenal ulcers rebled. One 
gastric and one duodenal ulcer were suc­
cessfully controlled by repeat elec­
trocoagulation. In total, bleeding was 
controlled in 95% of the cases.
Gaisford47 reported his experience 
with 71 patients who underw ent 
endoscopic electrohemostasis. Twenty- 
nine had gastric ulcers, 16 pyloroduo- 
denal ulcers, 8 jejunal ulcers and 6 
Mallory-Weiss tears. Other lesions 
included esophageal ulcers, gastric 
varices, acute gastric erosions, gastric 
polyps and leiomyomas. Initial hemosta­
sis was obtained in all patients and per­
manent cessation of bleeding in 65.
Volpicelli and colleagues48 carried out 
endoscopic electrocoagulation in 12 
patients with bleeding upper gastrointes­
tinal lesions; 6 with duodenal ulcers, 5 
with gastric ulcers and 1 with an 
esophageal ulcer. Hemostasis was initially 
obtained in all 12 patients. One patient 
rebled and then underwent surgery.
The results of endoscopic electrocoagu­
lation to date are very promising. Bleed­
ing can be controlled permanently. This 
technique can also temporarily control the 
bleeding lesion so that the patient can be 
prepared for semielective surgery. Any 
hospital that manages patients with upper 
gastrointestinal bleeding should assign 
one endoscopist to become experienced in 
the use of endoscopic electrocoagulation.
Thermal Probes
Based on the principle of enhanced 
coagulation of a bleeding area by thermal 
coagulation in association with direct 
pressure, Protell and associates49 deve­
loped a heater probe that could be passed 
through an endoscope. Preliminary 
experiments demonstrated that it was very 
effective in stopping bleeding gastric 
ulcers. In a clinical study, Johnson and 
associates50 reported that the heater 
probe was superior to YAG laser therapy 
in controlling bleeding from gastric and 
duodenal ulcers. The heater probe
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stopped the bleeding in 19 of 20 patients 
while laser therapy was successful in only 
24 of 35 bleeding peptic ulcers.
The thermal probe shows excellent 
promise. It is inexpensive, does not 
require complex instrumentation and is 
portable.
Tissue Adhesives
Several authors have reported on the 
use of tissue adhesives or sprays applied 
through the endoscope. Keller and 
Logan51 reported satisfactory results 
with acrylic polymer sprayed on acute 
ulcers in a patient with hemorrhagic gas­
tritis. Linscheer and Fazio52 endoscopi- 
cally sprayed thrombin and fibrinogen 
directly onto a bleeding gastric ulcer in 
an experimental dog model. Bleeding time 
was greatly decreased both in non- 
heparinized and heparinized dogs. On the 
other hand, Protell and associates53 did 
not find that tissue adhesives stopped 
bleeding from experimental gastric ulcers. 
In a canine model, endoscopic spray 
application of trifluoroisopropyl 2-cyano­
acrylate did not completely stop bleeding 
although there was a reduction in the rate 
o f bleeding. It appears that endoscopic 
spraying or application of tissue adhesives 
or clotting factors to control bleeding 
lesions o f the upper gastrointestinal tract 
is not yet ready for clinical use.
Summary
Endoscopic control o f upper gastroin­
testinal hemorrhage has progressed from 
experimental studies to widespread clini­
cal use. As instrumentation improves, it 
will be possible to control bleeding lesions 
of the upper gastrointestinal tract, at least 
temporarily, so that surgery can be per­
formed under ideal conditions. This will 
reduce overall mortality in patients 
presenting with upper gastrointestinal 
hemorrhage.
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Cancer of the Colon and Rectum: 30-Year Follow-up Study
This study review s the course o f all 
patients registered at the Saskatoon 
Cancer Clinic between 1949  and 1951, 
w ith  h isto logica lly proven cancer o f the 
colon or rectum. The data were 
abstracted, coded and analysed by life- 
table methods. Follow-up was complete 
to  death or to  1982. There were 403  
patients (58 .3%  were men). Cancer of 
the rectum accounted fo r 51%  o f the 
to ta l, the sigmoid colon 22%  and the 
cecum 10% . The prim ary tum our was 
resected by abdominoperineal resection, 
hem icolectom y or segmental colectomy 
in 63%  o f the patients; co lostom y alone 
was performed in 21% .
The overall survival w as 31%  at 5 
years, 24%  at 10 years, 15%  at 20 
years and 7%  at 30 years from  diagno­
sis. Many o f the deaths in th is relatively 
elderly group o f patients were due to 
causes other than the cancer. Consider­
ing cancer-related causes o f death only 
in patients w ith  resectable lesions, the 
cum ulative probability  o f survival at 5,
10, 20 and 30 years was 63%  ±  4% , 
54%  ±  4% , 48 %  ±  4%  and 47%  ± 
6% , respectively (probability ±  1 stand­
ard error), fo r those w ith o u t lymph- 
adenopathy, and 14%  ±  3% , 12%  ± 
2% , 10%  ± 2%  and 9%  ± 3% , respec­
tive ly, fo r those w ith  involved nodes.
Death from  the cancer was rare after 
10 years while deaths from  competing 
causes continued to  occur, a t a near
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constan t rate, fo r 30 years. The data 
suggest th a t the cancer w as eradicated 
in one th ird  o f all patients, and in one 
half o f patients in subgroups w ith  no 
lym phadenopathy or w ith  shallow  
primary lesions.
Cette etude passe en revue revo lu tion  
de tous les patients qui ont ete inscrits a 
la Saskatoon Cancer Clinic sou ffran t 
d 'un  cancer h isto logiquem ent demontre 
du colon ou du rectum . Les donnees ont 
ete resumees, codifiees et analysees au 
moyen de m ethodes actuarielles. La sur­
veillance des suites therapeutiques s'est 
arretee avec la m ort du patient ou a I'an- 
nee 1982. On a com pte 4 0 3  patients 
(dont 5 8 .3%  d'hom m es). Les cancers du 
rectum  repr6sentaient 51%  du to ta l, 
ceux du sigmoTdes 22%  et ceux du 
caecum 10% . La tum eur primaire avait 
et6 soumise a une resection 
abdom inoperin£ale, £ une hemicolec- 
tom ie ou d une colectom ie segmentaire 
dans 63 %  des cas; une colostom ie sim ­
ple avait et6 pratiquee dans 21%  des 
cas.
G lobalement, le taux de survie fu t de 
31%  a 5 ans, de 24%  d 10 ans, de 
15%  & 20 ans e t 7%  a 3 0  ans apres le 
d iagnostic. Parmi ce groupe de patients 
relativem ent ages, plusieurs deces furent 
attribuables a des causes autres que le 
cancer. Si Ton s 'en tien t aux causes de 
nature cancereuse chez les patients qui 
ont eu une lesion resecable, la probabilite 
cum ula tive  de survie d 5, 10, 20 et 30 
ans fu t de 63%  ±  4% , 54%  ±  4% , 
48 %  ±  4 %  et 47 %  ± 6%  respective- 
m ent (probabilite ± I'erreur type) pour 
ceux qui n 'ava ien t pas de lymphad£no- 
pathie, e t de 14%  ±  3 % , 12%  ±  2% , 
10%  ±  2%  e t 9%  ±  3%  respective- 
m ent chez ceux qui avaient une atte inte 
lym phatique.
Apres 10 ans les d£ces dus au cancer 
devinrent rare alors que les d£c£s de 
causes autres continudrent de survenir a
un taux presque constan t pendant 30  
ans. Ces donnees ind iquent que le 
cancer a pu etre eradique chez un tie rs 
de tous les patients ou chez la m oitie  
d 'un  sous-groupe de patients qui 
n 'ava ien t pas de lym phad6nopathie ou 
qui ava ient une tum eur primaire super- 
fic ie lle .
Although numerous reports present 
5-year survival figures for cancer o f the 
colon and rectum,1-7 there is a dearth o f 
information on long-term results. How 
many patients survive cancer o f the colon 
or rectum to die o f other causes? In how 
many patients is the cancer apparently 
eradicated? What is the mortality o f  the 
disease at various times following diag­
nosis? What is the shape o f the life-table 
curve over a prolonged period? The 
records o f  the Saskatchewan cancer 
clinics provide a unique opportunity to 
answer these questions. This study was 
designed to analyse the results in a popu­
lation o f  patients with cancer o f the colon 
or rectum followed up for 30 years.
The Saskatchewan cancer clinics have 
records o f patients in that province from 
1932 to the present with a diagnosis o f 
any type o f  cancer. The accuracy and 
completeness o f  follow-up data are quite 
remarkable, due to the stability o f  the 
population, the prestige enjoyed by the 
clinics and the policies o f the provincial 
health department concerning patients 
with cancer. In 1944, the government 
decided to reimburse patients for all serv­
ices related to a diagnosis o f cancer, 
provided that they were registered with 
one o f  the cancer clinics, a decision that 
ensured 100% registration.
Patients and Methods
A ll 403 patients registered with the 
Saskatoon Cancer Clinic from 1949 to 
1951, who had histologically proven
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adenocarcinoma of the colon or rectum, 
were studied. Each patient’s chart was 
reviewed and the information obtained 
was coded onto a prepared “ OP-SCAN” 
form which could be read directly by the 
computer’s optical scanning input device.
The following information was ob­
tained for each patient: sex, dates of birth 
and diagnosis, presenting complaint, 
location of primary tumour, histologic 
features of the tumour, extent of bowel- 
wall and lymph-node involvement, surgi­
cal treatment, date of termination and 
status at termination. Concerning the 
extent of bowel-wall invasion, stage A 
refers to involvement of the mucosa 
including the muscularis mucosae, stage 
B, includes cancer confined to the bowel 
wall including the muscularis propria and 
stage B2 extension to the serosa. It was 
not possible in every case to correlate the 
stage of bowel-wall invasion with the sta­
tus of mesenteric nodes because lymph 
nodes were not always found in the 
specimen.
The data from the “ OP-SCAN” forms 
were read into the computer and analysed 
using the BMDP8 software for life tables 
and survival functions.
Findings
Patient Data
Of the 403 patients, 235 (58.3%) were 
men. The patients’ ages ranged from 18 
to 88 years (mean 61.3 ± 12.1 years [±
1 SD]). The age distribution is shown in 
Fig. 1. The distribution of the primary 
lesions in the various segments of the 
bowel is shown in Table I.
Primary Surgical Treatment
The operations performed are listed in 
Table II. In many cases it was not possi­
ble to establish from the chart whether the 
operation had been performed for cure. 
This aspect of the procedure was, there­
fore, not coded for analysis.
Extent o f  Tumour at Diagnosis
In those patients who had resection of 
the cancer, the extent of bowel-wall inva­
sion was as follows: stage A, 5%; stage 
B|, 22%; stage B2, 73%. Lymph nodes 
were examined in 247 patients and 73 
(30%) were found to contain tumour. The 
presence of metastatic disease, most com­
monly in the liver, was recorded in 34% 
of patients at the time of primary diag­
nosis or operation.
Follow-up
The follow-up information was com­
plete. Every patient was followed up until 
death or until 1982 to give a complete 
30-year study. Twenty-two patients were
alive and well 30 years from the time of 
diagnosis.
The patient’s status at the time of death 
or termination was determined in all 
except 14 cases. The cause of death was 
recorded in 96.5% of those who died. Of 
the 367 patients who died of known cause 
during the follow-up period, 289 (79%) 
died of bowel cancer, and 78 (21%) of 
other causes. No patient was alive with 
disease or alive with unknown status at 
the conclusion of the study.
Operative Mortality
Death occurred within 1 month of 
operation in 6.5% of patients with resec­
table lesions. These deaths are included 
in all the life tables.
Life Tables and Survival Analysis
The cumulative proportion of patients 
surviving at intervals up to 30 years is 
depicted in Fig. 2, showing the different 
curves for deaths due to cancer and to all 
causes. Ninety-five percent of patients 
who died of the cancer died within 8 years 
of diagnosis. Death from cancer was rare 
after 10 years. Deaths from all other 
causes continued to occur in this relatively 
elderly patient population. The overall 
actual survival was 31% at 5 years, 24% 
at 10 years, 15% at 20 years and 7% at 
30 years from diagnosis.
In Fig. 3, the overall cumulative sur­
vival is shown on a semilogarithmic scale. 
This demonstrates that deaths from all 
other causes occurred at a near-constant 
rate from the 8th to the 30th year, 
whereas the rate of cancer death at that 
time fell close to zero.
There was no difference in the outcome 
related to sex (Fig. 4). The results for 
patients with rectal cancer were slightly 
worse than for those with cancer of the
Table 1—Location of the Primary Tumour
Site No. %
Cecum 39 10
Ascending colon 17 4
Transverse colon
and flexures 35 9
Descending colon 17 4
Sigmoid colon 87 22
Rectum 206 51
Table II—Primary Operation Performed
Procedure No. %
Abdominoperineal resection 123 30
Anterior resection 36 9
Hemicolectomy or
segmental resection 79 20
Colostomy alone 84 21
Other procedures,
e.g., Hartmann, Mikulicz 16 4
No operation, biopsy only 65 16
colon (Fig. 5) but the difference was 
neither significant nor important.
Including only those patients who had 
a procedure to resect the primary tumour, 
Fig. 6 depicts the life-table analysis for 
cancer deaths only in patients with and 
without positive mesenteric lymph nodes. 
With no lymphadenopathy, the probabil­
ity of survival at 5, 10, 20 and 30 years 
was 63% ± 4%, 54% ± 4%, 48% ± 
4% and 47% ± 6% respectively (proba­
bility ± 1 standard error). The equiva­
lent figures in patients with involved 
nodes were 14% ± 3%, 12% ± 2%, 
10% ± 2% and 9% ± 3% respectively.
iso-
Age (years)
FIG. I—Age distribution.
..
o* 0.9-
................ I I i i I i I I i |i  i i t I
10 15 20 25 30
TIME (Years)
FIG. 2—Life-table analysis for 30 years, 
comparing cancer deaths (broken line) with 
deaths from all causes (solid line).
FIG. 3—Life-table analysis for 30 years on 
semilogarithmic scale: cancer deaths (broken 
line) and deaths from all causes (solid line).
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FIG. 4—Life-table analysis for men (broken 
line) and women (solid line). Deaths from 
cancer only.
FIG. 5—Life-table analysis for patients with 
cancer of rectum (broken line) and other sites 
in colon (solid line). Deaths from cancer only.
FIG. 6—Life-table analysis for patients hav­
ing resection of primary lesion, with (broken 
line) and without (solid line) involved lymph 
nodes. Deaths from cancer only.
FIG. 7—Life-table analysis for patients with 
varying extent of involvement of bowel wall: 
stage A (short dashes), stage B, (long dashes) 
and stage B2 (solid line). Deaths from cancer 
only.
The life table for patients with varying 
involvement of the bowel wall is shown 
in Fig 7. Only deaths due to cancer were 
included in this analysis and, again, death 
was rare after 10 years. The probability 
of survival at 30 years was 57% ± 14% 
for stage A, 37% ± 6% for stage B, and 
21% ± 3% for stage B2 (probability ± 
1 standard error).
Discussion
The method of abstracting and coding 
the information from patients’ charts 
used in this study was chosen because it 
involves only one transcription from the 
chart to the stage of final analysis. It may 
seem almost incredible that follow-up was 
complete without loss of a single case, but 
this is consistent with the system for han­
dling patients and their records at the 
Saskatchewan cancer clinics.
Cancer of the colon and rectum is a 
common disease that is well understood 
in terms of incidence, distribution, clini­
cal and pathological presentation, and 
mode of spread.1,3'4'6 In this study, the 
slight preponderance of men was noted 
for cancer at every location, whereas it 
is commonly accepted that for cancer of 
the colon, as opposed to the rectum, there 
is a slight preponderance of women. The 
distribution of lesions throughout the 
bowel was similar to that reported in 
other series.
The prognosis for patients with 
colorectal cancer is usually stated in 
5-year survival figures,1’5 related to 
different stages of the disease on presen­
tation. The overall 5-year survival is 
reported in the range of 75% for Dukes’ 
stage A, 60% for stage B and 30% for 
stage C, where stage A designates tumour 
confined to mucosa and muscularis 
mucosae, stage B represents full-thickness 
wall involvement and stage C includes 
malignant lymphadenopathy. This kind 
of information is of limited value in that 
form, first because the result at 5 years 
does not represent the final outcome, and 
second because no account is taken of 
deaths from causes other than the cancer. 
It is often appropriate to include all 
deaths in the statistics when dealing with 
a relatively young population, but in 
colorectal cancer the patient population 
is older and the cause of death more likely 
to be unrelated to the cancer as the com­
peting causes of death assume greater 
importance.
In Figs. 2 and 3, the overall results may 
be followed for 30 years. The unbroken 
line traces the actual survival, taking into 
account all causes of death. The broken 
line is derived from deaths caused only 
by the cancer, representing at annual 
intervals the cumulative probability of 
survival if no cause of death other than 
the cancer is included. These figures
demonstrate that in the first 5 years 
almost all of the deaths that occurred 
were due to cancer, whereas after 10 years 
cancer is rarely the cause of death, while 
deaths from other causes continue to 
occur regularly as would be expected in 
a group of patients in this age range. 
Using the semilogarithmic scale in Fig. 3, 
the rate of dying of all causes is quite 
different in years 0 to 5 from that in years 
5 to 30. In the early period the annual 
mortality is about 20% compound, while 
in the later period it is about 5% because 
of the relative absence of cancer deaths 
after 10 years. These results contrast 
markedly with those of long-term follow­
up in patients with breast cancer. Mueller 
and his colleagues9'10 showed that the 
rate of dying of breast cancer remained 
quite constant at 8% per year compound 
for 20 years, although competing causes 
of death also became more frequent with 
increasing age.
This study shows that about one third 
of the patients have no further problem 
with the colorectal cancer after the 
primary management (Figs. 2 and 3) and 
that sex (Fig. 4) and primary cancer site 
(Fig. 5) do not influence the outcome. 
The results for rectal cancer are margi­
nally but insignificantly worse than for 
the other sites.
In this retrospective study it was not 
possible to stage the patients accurately 
according to Dukes’ classification because 
of those who had limited resections or 
inadequate sampling of lymph nodes. It 
would be unreasonable, for example, to 
assign a patient to Dukes’ stage B with 
negative lymph-node status if only three 
nodes were examined. The results accord­
ing to nodal status (Fig. 6) and depth of 
bowel-wall involvement (Fig. 7) had to be 
assessed independently. It is noted that 
the cumulative probability of survival at 
30 years for patients with no lymph­
adenopathy was 47%, and for patients 
with stage A lesions, 57%. This suggests 
that the disease has been eradicated in 
these patients by whatever primary oper­
ative procedure was performed, or that 
removal of the primary tumour has 
allowed the patient to regain control of 
the disease process.
From what is known about the growth 
rate of colorectal cancers, the tumour 
doubling time may range from 30 to 400 
days, with a mean of around 100 
days.11,12 This suggests that the cancer 
has been present from 5 to 15 years before 
diagnosis and helps to explain the shape 
of the life-table curves in the figures. 
There appears to be a group of patients 
in whom the disease is widespread at the 
time of diagnosis and it appears that the 
presence of malignant mesenteric lym­
phadenopathy is simply a manifestation 
of this. Fig. 6 suggests that 90% of node­
positive patients must have had dissemi­
nated disease at the time of primary sur-
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gery because they died within such a short 
time. It also suggests that attempts to 
achieve better results by more radical sur­
gery will not succeed. The small group of 
patients with involved lymph nodes who 
survived longer than 10 years may 
represent disease confined to the bowel 
and lymph nodes without widespread dis­
semination, but there are other possible 
explanations involving the unexplained 
but paramount factors in the balance of 
power between tumour and host. Figs. 6 
and 7 suggest that in 50% of patients who 
are node-negative, or who have shallow 
tumours, removal of the primary has 
arrested the disease. Once again, it may 
be suggested that this has occurred 
because the cancer was already confined, 
by whatever mechanism, to the bowel 
wall. In addition to the obvious advan­
tages of preventing death from hemor­
rhage and intestinal obstruction, remov­
ing the primary tumour may also change 
the balance of power in favour of the 
host.
The data available for this study do not 
permit comparison of different proce­
dures, or extents of resection performed, 
but the results encourage the continued 
application of most current surgical prin­
ciples in the management of cancer of the 
colon and rectum. The data, however, do 
not support an aggressive policy in the 
management of the regional lymph nodes.
I thank Mr. Sanjay Dhingra who was 
involved in the data collection and the statisti­
cal analyses, and the staff of the Saskatoon 
Cancer Clinic who gave their enthusiastic 
support.
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Management of Chronic Perineal Sinuses by Wide Excision 
and Split-Thickness Skin Grafting
Nine patients who had chronic perineal 
sinuses following proctectomy for inflam­
matory bowel disease underwent wide 
excision of the sinus and split-thickness 
skin grafting. All patients had persistent 
pain and discharge. All but one had 
undergone multiple surgical procedures 
previously. Fibrous tissue was excised 
from the sinus tract and the wound was 
grafted either immediately (six patients) 
or at a later date (three patients). Five 
patients had complete healing of the 
wound initially while four required further 
procedures. Eight patients have been fol­
lowed up for an average of 4.6 years 
(range from 5 months to 12 years). 
Complete healing was achieved in seven 
patients; all are free of pain and can 
work or are unrestricted in their daily ac­
tivities. One patient is improved but still 
requires analgesia and is disabled by the 
persistent pelvic pain.
Neuf patients porteurs de sinus 
perineaux chroniques consecutivement a 
une proctectomie pour maladie intes- 
tinale inflammatoire ont subi une exci­
sion large du sinus avec greffe de peau 
d'epaisseur partielle. Tous souffraient de 
douleur chronique et prdsentaient un 
ecoulement suppure. Tous sauf un 
avaient eu des interventions chirurgicales 
multiples au preaiable. Le tissu fibreux 
fut excise du sinus et la plale fut greffee 
soit tout de suite aprfes (six patients), 
soit a une date ulterieure (trois patients). 
Une guerison complete de la plaie fut
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obtenue chez cinq patients alors que les 
quatre autres devaient subir de nouvelles 
operations. Huit patients ont fait I'objet 
d’examens de contrdle sur une periode 
moyenne de 4.6 annees (allant de 5 
mois h 12 ans). Une guerison complete a 
ete obtenue chez sept patients; tous 
sont exempts de douleur et peuvent 
travailler ou n'ont aucune entrave & leurs 
activites quotidiennes. L'etat d’un 
patient est ameliore mais il a encore 
besoin d'analgesiques et est handicappe 
par une douleur pelvienne persistante.
A major complication of proctectomy is 
failure of perineal wound healing. By 
definition, a chronic perineal sinus is one 
that remains unhealed 6 months after sur­
gery. Unfortunately, it is a frequent com­
plication in patients with inflammatory 
bowel disease and is associated with high 
morbidity. Usually, the patient suffers 
from persistent perineal drainage and pel­
vic pain. The drainage may be so profuse 
and malodorous that a pad or dressing 
must be worn constantly. Analgesia 
requirements may be great and narcotic 
addiction is not infrequent. The chronic 
perineal sinus tract is usually long and 
narrow, lined by unyielding fibrous tis­
sue and covered by granulation tissue. At 
this stage, conservative measures such as 
irrigation or curettage are of little benefit. 
Healing is unlikely unless the fibrotic tis­
sue is widely excised.
We review the experience at the 
Toronto General Hospital with wide exci­
sion followed by split-thickness skin 
grafting in the treatment of chronic 
perineal sinuses.
Patients
Nine patients (six male, three female) 
were treated by this method between 1974 
and 1984 at the Toronto General Hospi­
tal. Their average age was 31 years (range 
from 16 to 48 years). Five patients had 
ulcerative colitis and four Crohn’s dis­
ease. The average time from proctectomy 
to treatment was 2.7 years (range from 
2 months to 7 years).
All patients complained of persistent 
perineal drainage and pelvic pain. Three 
were addicted to narcotics. One patient 
was bedridden by pain from the perineal 
wound. With one exception, all patients 
had previously undergone multiple surgi­
cal procedures (between 3 and 25) in 
attempts to achieve healing. These 
included curettage of the sinus in seven, 
drainage of abscesses in four, use of 
gracilis muscle flaps in two, and coccygec- 
tomy, skin grafting and use of a silicone 
mould in one patient each.
Procedure
Patients are placed in the lithotomy 
position. A Foley catheter is inserted into 
the bladder. Broad-spectrum antibiotics 
are administered prophylactically before 
operation and continued postoperatively. 
The perineum and both thighs are pre­
pared with antiseptic cleaning solution. 
The skin graft is taken from the pre­
selected donor site on the thigh and 
preserved while the perineal sinus is 
excised.
Typically, the sinus has a small exter­
nal opening (Fig. 1) and a long tract (Fig.
FIG. 1—Appearance of typical chronic 
perineal sinus. External opening is small, but 
tract is long and narrow.
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2), which may extend to the midsacral 
area. A probe is inserted into the tract. 
A wide elliptical incision is made around 
the opening using electrocutting to 
minimize bleeding. The tract is excised, 
removing all of the thick fibrous tissue 
until normal healthy tissue is encountered 
(usually subcutaneous tissue of the 
ischiorectal fossa). Almost always the 
tract extends further than anticipated 
preoperatively. At the apex of the sinus, 
the fibrous tissue may be adherent to the 
sacrum and impossible to excise, in which 
case it is curetted and left. Bleeding may 
be profuse and transfusion of several 
units of blood is not uncommon. While 
performing the dissection, care must be 
taken to prevent inadvertent damage to 
vital structures, particularly if there is a 
long sinus tract whose apex is close to 
loops of small bowel lying low in the 
pelvis. By inserting a Foley catheter into 
the bladder and inserting a finger into the 
vagina in females, the risk of damage to 
these structures can be minimized.
When the dissection is complete, the 
defect is usually cone shaped (Fig. 3). The 
wound is irrigated liberally and hemosta­
sis is achieved before applying the graft 
which is sutured with absorbable suture 
material. If the apex of the defect is inac­
cessible, it may be left ungrafted or the 
graft may be held in place with a pack. 
The wound is packed snugly with fluffed 
gauze, held in place with silk skin sutures 
tied over it. Excess skin may be stored and 
used later to graft the wound if there is 
incomplete “ take” .
Postoperatively, the patient is placed 
on bed rest for 5 to 7 days, when the 
dressings are removed (Fig. 4). If graft 
healing is incomplete, the wound may be 
regrafted or left to granulate depending 
on the size of the area involved.
Results
Using this method, six patients under­
went excision and primary split-thickness 
skin grafting while in three the skin graft­
ing was delayed — from 1 to 2 weeks in 
two and 8 weeks in the third.
The wound healed completely in five 
patients. Four patients required further 
procedures. One of them underwent 
curettage of the wound on three subse­
quent occasions. The second patient 
required grafting again after 2 months 
and this was followed by debridement 10 
months later. There was virtually no heal­
ing of the initial skin graft in the third 
patient. This probably was due to a delay 
in grafting that resulted in the presence 
of overgrown granulation tissue when the 
graft was applied. A second skin graft 
was applied but became infected with 
Pseudomonas sp, resulting in a “ take” 
of approximately 25%. However, over 
the next several weeks, the remainder of 
the wound healed completely by secon­
dary intention. The fourth patient under­
went several subsequent procedures 
including repeated excisions and split­
thickness skin grafting, rotational flap 
and curettage of the wound. These were 
only partially successful.
At present, the perineal wounds in 
seven patients are completely healed. 
These patients have been followed up for 
an average 4.6 years (5 months to 12 
years). No one uses analgesia. In most 
patients there is some mucus discharge 
from the wound but it is not malodorous 
and can be controlled using a 4 x 4-inch 
gauze and changing it once daily. All 
seven patients are fully employed or are 
unrestricted in their normal daily activi­
ties. One patient, who was bedridden 
preoperatively and who required multiple 
surgical procedures, has had incomplete 
healing of the wound although it is 
improved. Unfortunately, he is still 
addicted to analgesics and is completely 
debilitated due to the perineal wound. 
One patient was lost to follow-up.
Discussion
The pelvic anatomy is of paramount 
importance in the failure of perineal 
wound healing.1 Following proctectomy, 
a large cavity remains, bounded by the 
fixed bony structures and relatively 
immobile soft tissues of the pelvis. Thus, 
little tissue can migrate to obliterate this 
space. Instead, fluid accumulates in a 
manner analogous to that seen in the 
chest following pneumonectomy. In time, 
the fluid and blood organizes, there is 
some migration of tissue, the space is 
obliterated and healing occurs. However, 
if the fluid becomes infected, the abscess 
cavity may become surrounded by thick
FIG. 2—Sinogram illustrates long, narrow 
sinus tract that extends from perineum (arrow) 
to midsacral region.
fibrotic tissue, preventing healing of the 
wound. Patients with inflammatory 
bowel disease are at high risk of having 
perineal abscesses and thus chronic 
perineal sinuses, probably because they 
often have perianal sepsis or residual 
inflammation in the pararectal tissues, or 
both, at the time of proctectomy. The 
reported frequency of unhealed perineal 
wounds in these patients has varied from 
7% to 33%.2’3 In a consecutive series of 
44 patients with inflammatory bowel dis­
ease who underwent proctectomy at our 
institution, the perineal wound failed to 
heal in 2 (4.5%).4 However, none of 
these patients have significant symptoms 
and have not required further surgery.
FIG. 3—All fibrous and granulation tissue 
is excised right to apex of tract. Split-thickness 
skin graft is applied immediately or at later 
stage as in this patient.
FIG. 4—Dressings are removed 5 to 7 days 
after skin grafting. There is further contrac­
tion of wound with time.
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The chronic, unhealed perineal wound 
may be a large shallow defect, but more 
commonly there is a small external open­
ing and a long narrow tract. There is per­
sistent low-grade sepsis that results in a 
continuous malodorous discharge and 
chronic pain. At times, the external open­
ing may close and pus accumulate, requir­
ing drainage. However, conservative 
measures such as drainage, irrigation or 
curettage of the wound are of temporary 
benefit only when a chronic tract forms. 
To achieve permanent healing, it is essen­
tial that all the thick fibrous tissue be 
excised until only normal tissue remains. 
Once this has been accomplished, the 
wound may be handled by several meth­
ods, including primary closure, secondary 
healing, skin grafting or by rotation of 
a myocutaneous flap using the gracilis 
or gluteus maximus muscle to fill the 
defect. Our preference has been to skin 
graft the wound. It has several advan­
tages. Healing time is shorter than leav­
ing the wound open to heal by secondary 
intention. Prolonged dressing changes are 
unnecessary and patients can return to 
work more quickly. Furthermore, pa­
tients with Crohn’s disease tend to form 
exuberant granulation tissue so complete 
healing may not occur. Primary wound 
closure and healing are usually not suc­
cessful because there is a large defect and 
continuing sepsis.
Several authors5,6 have reported good 
results using myocutaneous flaps. Woods 
and Beart5 achieved complete healing in 
13 of 14 patients, using either unilateral 
or bilateral gracilis muscle flaps. In five 
of these patients, a second procedure was 
necessary. It is our preference, however, 
to use a split-thickness skin graft if pos­
sible, since excellent results can be 
achieved with this relatively simple tech­
nique which is associated with less mor­
bidity. In particular, if the initial graft 
fails, grafting can be repeated with little 
added morbidity. This is not true for a 
myocutaneous flap.
The dissection may be difficult because 
of dense fibrous tissue. In most situa­
tions, the tract extends further than antic­
ipated preoperatively, but it can be iden­
tified and followed quite easily if a probe 
is inserted into it. It may be impossible 
to remove the most proximal part of the 
tract because of the dense fibrous tissue 
adherent to the sacrum and, indeed, one 
must be careful at this level to avoid 
injury to the small bowel lying in the 
pelvis. It appears that complete excision 
of the tract is unnecessary as long as only 
a short tract remains and the remainder 
of the wound is saucerized. Coccygec- 
tomy was not performed in any of our 
patients and is not advocated because it 
may increase pain postoperatively. When 
the dissection is completed, one may be 
surprised by the size of the resulting 
cavity. However, over several months, it
contracts dramatically and the residual 
defect has been acceptable to all our 
patients. In our experience, the skin graft 
does not prevent the wound from con­
tracting as was suggested by Silen and 
Glotzer.1
Antibiotics were given prophylactically 
to only four of our patients, but after one 
graft became infected and sloughed, we 
began to administer antibiotics preoper­
atively and postoperatively for several 
days. No patient received adrenocor- 
ticotropin as advocated by Anderson and 
Turnbull.7.
The unhealed perineal wound was a 
major disability for all patients in this ser­
ies. As mentioned previously, many 
patients with persistent perineal sinuses do 
not have significant symptoms and do not 
require surgical treatment. In this series, 
however, three patients were unable to 
work and required large amounts of nar­
cotics to control the pain. The rest of the 
patients had less severe symptoms. All but 
one patient had undergone multiple sur­
gical procedures previously. Thus, it is 
gratifying that the procedure was success­
ful in seven of eight patients even though 
four required a second procedure. Ander­
son and Turnbull7 used a similar tech­
nique and reported that 40 of their 44 
patients had a good result although only 
7 of these had complete healing of the 
wound.
In summary, nine patients with chronic 
perineal sinuses following proctectomy 
for inflammatory bowel disease under­
went wide excision of the sinus and split­
thickness skin grafting. Five patients had 
initial, complete healing of the wound 
whereas further surgery was required in 
the others. After an average follow-up of 
4.6 years, the wound is completely healed 
in seven patients (one was lost to follow­
up). All of these patients are free of pain 
and are not restricted by their perineal 
wounds.
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Changing Patterns in the Management of Locally Advanced 
Breast Cancer: a Preliminary Report
Over the 8 years from 1976 to 1983, 28 
patients with stage IIIB (T4a,b,c, IMX-2, 
MO) and inflammatory breast cancers 
without evidence of disseminated dis­
ease at the time of diagnosis were 
treated at Ellis Fischel State Cancer 
Center in Columbia, Mo. This group com­
prised 4% of all cases of primary breast 
cancer seen during that period. Radio­
therapy was the primary treatment in 
one half of the group during the first 4 
years of the study (group A). Since 
1981, locally advanced breast cancer 
has been treated by multidrug 
chemotherapy followed primarily by 
mastectomy (group B). The rate of local 
control was the same for both groups 
(78%). However, the median survival for 
group A was 11 months, only one 
patient being alive 5 years after diagno­
sis, whereas in group B, 12 of 14 
patients were alive and clinically free of 
disease 9 to 31 months after diagnosis 
with a median follow-up of 16.5 months. 
This preliminary report confirms recent 
findings, supporting the use of poly­
chemotherapy followed by mastectomy 
in the management of patients with 
locally advanced breast cancer.
En 8 ans, de 1976 a 1983, 28 patientes 
ayant un cancer du sein au stade IIIB 
(T4a,b,c, NX-2, MO) ou un cancer inflam- 
matoire du sein sans signes de dissemi­
nation au moment du diagnostic ont ete 
traitees au Ellis Fischel State Cancer 
Center de Columbia, Mo. Ce groupe
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comptait pour 4% de tous les cas de 
cancer primaire du sein vus au cours de 
cette periode. Au cours des 4 premieres 
annees de I'etude, la radiotherapie fut le 
traitement primaire pour la moitie du 
groupe (ce qui constitue le groupe A). 
Depuis 1981, les cancers localement 
avances du sein ont ete tra ils  par poly- 
chimiotherapie suivie d'une mastectomie 
(gioupe B). Le taux de controle local a 
ete le meme pour les deux groupes 
(78%). Toutefois, la survie mediane du 
groupe A fut de 11 mois alors que seule- 
ment une patiente a survecu 5 ans apres 
le diagnostic. En comparaison, dans le 
groupe B, 12 des 14 patientes sont 
vivantes sans manifestations cliniques de 
maladie de 9 a 31 mois apres le diagnos­
tic; la surveillance mediane est de 16.5  
mois. Ces resultats preliminaires confir­
m ed des observations recentes soute- 
nant I'emploi de la polychimiotherapie 
preparative a la mastectomie dans le trai­
tement des patientes atteintes d'un can­
cer localement avance du sein.
By the turn of the 20th century, Halsted’s 
radical mastectomy had become the stan­
dard management for primary breast 
cancer regardless of the local extent of the 
disease. Inflammatory cancer of the 
breast, the most aggressive form of this 
neoplasm, was recognized as early as 1807 
by Bell,1 the clinical characteristics were 
described by Bryant2 in 1887 and the 
term  was coined by Lee and 
Tannenbaum3 in 1924. Early experience 
in the surgical treatment of locally 
advanced breast cancer was uniformly 
dismal. Data from our institution pub­
lished by Donegan4 revealed a local 
recurrence rate of 45.8% and only one 
5-year survivor following surgery alone. 
These poor results of surgery alone in the 
management of inflammatory cancer of 
the breast or of the noninflammatory type 
that had either ulcerated, was fixed to the 
chest wall, developed satellite nodules or 
produced edema of the breast prompted 
Haagensen and Stout5 in 1943 to develop 
criteria for inoperability. Their contribu­
tion to our understanding of the limita­
tions of primary surgical management in 
these patients has become a classic.
As early as 1949, Baclesse6 advocated 
radiotherapy as the sole method of treat­
ment for cancer of the breast. During the 
following 35 years, radiotherapy domi­
nated as the primary and often the only 
form of management. The results of 
treatment improved somewhat as radio- 
therapeutic technology and dosimetry 
advanced. Data published between 1924 
and 1964 revealed that radiotherapy alone 
resulted in a mean survival between 4 and 
20 months but practically no 5-year sur­
vival. One of the first reports of super­
voltage radiation in the management of 
locally advanced breast cancer was that 
of Wang and Griscom7 who, in 1964, 
reported a mean survival o f 30 months 
among 10 patients with inflammatory 
breast cancer. More recently, results of 
radiotherapy alone for inoperable breast 
cancer have shown local control rates 
ranging from 10% to 46%.8,9 Local con­
trol was further enhanced by twice-daily 
fractionated irradiation9’10 and, in 
another study, with the application of 
interstitial implants.11 Doses greater than 
6000 rad have given improved local con­
trol and have been advocated by several 
investigators.8,1013 Despite a progressive 
improvement in local control rate, sur­
vival in locally advanced carcinoma of the 
breast remained poor. Zucali and 
associates8 reported that the median sur­
vival in a retrospective study of 454 
patients was 2.1 years. Bruckman and 
colleagues13 studied 116 patients with 
stage III disease treated by primary radio­
therapy and obtained a 5-year survival of 
25%. In their opinion, the addition of 
mastectomy to effective radiotherapy was 
unnecessary. However, in one recent 
study, the addition of mastectomy to 
radiotherapy increased the survival from 
2.5 to 3.9 years.8 A multimodal ap­
proach to the management of locally 
advanced carcinoma of the breast that 
includes multiagent chemotherapy as the 
first line of therapy has gained popular­
ity in the last decade.14-24 Encouraging 
data showing better local control and sur­
vival rates have changed the patterns of 
care in the management of locally 
advanced breast cancer.
The purpose of this paper is to share
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our results obtained during two recent 
periods in which comparable groups of 
14 patients with locally advanced and 
inflammatory cancer of the breast were 
treated by different methods.
Methods and Results
From 1976 to 1983, approximately 700 
new cases of primary breast cancer were 
treated at Ellis Fischel State Cancer 
Center in Columbia, Mo. The most 
locally advanced tumours without evi­
dence of disseminated disease are those 
that fall into the stage Illb category 
(T4a,b,c, NX-2, MO) and inflammatory 
breast cancer. This group accounted for 
8% of all cases of cancer seen during the 
same period. One half of the patients with 
locally advanced disease were found to 
have clinical evidence of dissemination at 
the time of initial visit and are not 
included in this report. The remaining 4% 
(28 cases) were analysed and form the 
basis of this report. Histologic documen­
tation and complete follow-up was 
obtained for all patients. The stage was 
defined in accordance with the 1983 
manual for cancer staging of the Ameri­
can Joint Committee on Cancer. The 
TNM classification and the Columbia 
clinical classification are compared for 
clarity in Table I. The therapeutic 
approach to the care of these women is 
shown in Table II.
Group A
From 1976 to 1979, 14 women were 
treated. Their ages ranged from 32 to 89 
years (mean 61 years). Twelve of these 
patients were treated primarily by radio­
therapy consisting of 6000 rad of cobalt 
60 delivered in 6 weeks. A simple mastec­
tomy was performed as primary treat­
ment in two patients. Chemotherapy, 
consisting o f cyclophosphamide, 
methotrexate and 5-fluorouracil (5-FU), 
was given to six patients following radio­
therapy while radiation followed surgery 
for the two patients who refused 
chemotherapy. Ten of the 14 women were 
estrogen receptor-negative and 8 had 
inflammatory cancers defined as such by 
a combination of rapid onset of classic 
signs and symptoms and histologic con­
firmation of lymphatic cutaneous involve­
ment. Overall, the local control of chest- 
wall disease was 78%. In three women, 
the chest-wall disease progressed rapidly 
following completion of radiotherapy. 
With one exception, clinical manifesta­
tions of disseminated disease developed 
in all and the mean survival was 11 
months. The only survivor, a patient with 
inflammatory cancer, is alive and clini­
cally free of disease 62 months after diag­
nosis.
Group B
between 1980 and 1983. The mean age 
was also 61 years (ranging from 40 to 76 
years). All patients in this group were ini­
tially given an average of 4.6 cycles (rang­
ing from 3 to 9) of chemotherapy consist­
ing of the following: cyclophosphamide, 
100 mg/m2 orally, on days 1 to 14; Adri- 
amycin, 25 mg/m2 intravenously, on 
days 1 and 8; and 5-FU, 500 mg/m2 
intravenously on days 1 and 8 (CAF). 
Two patients also received vincristine, 
two received methotrexate and two pred­
nisone. Mastectomy was then performed 
in 10 patients. Simple mastectomy was 
performed in six, modified radical 
mastectomy in two and radical mastec­
tomy in two patients. Surgery was aimed 
at resecting all gross disease; cancer-free 
margins were obtained histologically in all 
patients. In this group, 11 women were 
estrogen receptor-negative and 7 had 
inflammatory cancers. Radiotherapy was 
administered to two patients who refused 
mastectomy. Two others who refused 
both surgery and radiotherapy were 
managed by chemotherapy. The overall 
local control rate, defined as total clini­
cal absence of chest-wall disease, was 
78%, the same rate as in group A. 
However, the three patients in whom the 
primary tumour was not controlled have 
had a stable course in contrast to the rapid 
progression of disease in group A women. 
Tumour size was reduced by more than 
50% in eight (57%) patients following 
preoperative chemotherapy. The tumour 
regressed, but by less than 50% from the 
original tumour size, in five patients who 
received chemotherapy preoperatively, 
and in one patient local disease progressed 
during the initial chemotherapeutic regi­
men. The three failures of local control 
occurred in one of two patients who 
received radiotherapy after chemotherapy 
and in two patients who had refused local 
control measures. There were no local 
recurrences in 10 patients who underwent 
mastectomy following chemotherapy.
After a mean follow-up of 16.5 
months, two group B women had died; 
one had inflammatory cancer and 
progressive disease and had refused local 
control measures, and one died of sepsis 
24 months after diagnosis without evi­
dence of metastatic breast cancer. At the 
time of writing, 10 of the remaining 12
Group B consisted of 14 women treated
Table 1—Comparison of the Columbia Clinical Classification and 
TNM Staging of the American Joint Committee on Cancer (1983)
TNM Staging Haagensen's criteria of inoperability (1943)
Stage Illb Stage C -  grave signs of advanced breast carcinoma
T4b Edema of skin involving less than one third of the breast
T4b Skin ulceration
T4a Solid fixation of tumour to chest wall
N2 Massive involvement of axillary lymph nodes
N2 Fixation of axillary nodes
Stage Illb Stage D -  signs of more advanced breast carcinoma
T4c Combination of any two of the grave signs
T4b Edema of skin involving over one third of the breast
T4b Satellite skin nodules
T4d The inflammatory type of carcinoma
N3 Supraclavicular nodal involvement
N3 Internal mammary metastases
N3 Edema of the arm
Stage IV
M l Distant metastases
Table 11-Management of Locally Advanced Breast Cancer. Ellis Fischel State Cancer Center -  Preliminary Report
Group
No. of 
patients
Mean age, 
yr (range)
Primary
treatment
No. of 
patients
Subsequent
treatment
No. of 
patients
Local
control, %
Group A 14 61 (32-89) Radiotherapy 12 Chemotherapy 6 78*
(1976-1979) Surgery 2 Radiotherapy 2
Group B 14 61 (40-76) Chemotherapy 14 Mastectomy 10 78t
(1980-1983) (3 to 9 cycles) Radiotherapy 2
Chemotherapy 12
*3 uncontrolled tumours were progressive.
t3  uncontrolled tumours are stable.
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patients were alive and free of clinical dis­
ease from 10 to 31 months after diagno­
sis and 2 were alive with stable chest-wall 
disease. All had continued multidrug 
chemotherapy. Among the six surviving 
women with inflammatory cancer, five 
were clinically disease-free; all of them 
underwent mastectomy after chemother­
apy. The sixth woman had stable disease 
following chemotherapy alone.
Discussion
Unfortunately, the majority of patients 
with locally advanced breast cancer will 
die of their disease. Nevertheless, in recent 
years it has been recognized that anti- 
neoplastic chemotherapy not only can 
produce a remarkable initial response but 
also allows other modalities of local con­
trol to be more effectively applied. The 
rationale in favour of multidrug 
chemotherapy initially is also to control 
micrometastases, since locally advanced 
breast cancer is clearly a systemic disease.
Data published during the last 5 years 
have generated considerable optimism for 
the primary use of chemotherapy. In an 
initial report, Morris and colleagues14 
studied three patients with untreated, 
advanced, local and distant disease. There 
was marked regression of the primary 
lesions, and all patients underwent 
mastectomy with good results. In 1982, 
the same group19 reported on 27 
patients, 13 of whom had inflammatory 
cancer. After four cycles of CAF 
chemotherapy, the tumour had become 
operable in 24 women and 22 of them 
underwent mastectomy. These workers 
claimed 70% partial response and good 
surgical results. Further follow-up of this 
group of patients was recently pre­
sented23 and the encouraging results con­
tinue, including those women with 
inflammatory cancer. P erlo ff and 
Lesnick20 have recently reported their 
experience with 17 patients with stage III 
disease treated with two to four cycles of 
combination chemotherapy followed by 
modified radical mastectomy. All patients 
were considered to have operable disease 
following chemotherapy even though 
tumour size was reduced by more than 
50% in only 10 patients. The median sur­
vival in this group was longer than 40 
months.
Radiotherapy in conjunction with or 
preceded by chemotherapy has also been 
studied recently. Sponzo and col­
leagues15 treated 13 patients with high- 
dose radiotherapy (7000 to 9000 rad) fol­
lowed by combination chemotherapy and 
obtained complete remission in 85% with 
a median duration of response of 38 
months. More recently22 they have pre­
sented results of a randomized trial sug­
gesting that a lower radiotherapeutic dose 
(5000 rad) given during the third and 
fourth cycles of induction chemotherapy
appeared to be as effective. Barker and 
associates12 reported on 31 women with 
inflammatory breast cancer treated with 
preirradiation CAF chemotherapy. They 
failed to show improvement in local con­
trol; however, Buzdar and associates17 
from the same group later reported that 
on further follow-up the combined moda­
lity of treatment improved the disease- 
free interval in all patients. The lack of 
improvement in survival in patients youn­
ger than 50 years was attributed to the 
high incidence of central nervous system 
recurrence.
Although multidrug chemotherapy as 
the initial therapy is to be credited for the 
recent improvements in control and sur­
vival, mastectomy has regained a definite 
place in the management of this disease. 
The randomized prospective study by De 
Lena and the Milan group18 showed that 
although the total response rate was the 
same (75%), 100% of the women ran­
domized to the mastectomy arm obtained 
complete remission compared with 60% 
for the radiotherapy arm. In our 
experience to date, no local regional 
recurrences have occurred in the 10 
patients who underwent mastectomy. 
Although the literature suggests that well- 
planned and executed radiotherapy can 
achieve similar local control rates, in our 
opinion radiotherapy should be reserved 
for patients who refuse surgery, are poor 
candidates for operation, have residual 
tumour following surgery and dissemi­
nated disease with short life expectancy 
or whose tumour remains inoperable fol­
lowing chemotherapy.
Recently, Fastenberg and colleagues24 
have used surgery and radiotherapy 
postoperatively following initial chemo­
therapy. No local relapses were observed 
in this group and the overall survival com­
pared favourably to that after radiother­
apy alone. The combination of all modal­
ities of treatment may yield a modest 
increase in local control rates but is also 
likely to result in higher morbidity par­
ticularly if radiotherapy is used before 
surgery.
Multidrug chemotherapy that includes 
doxorubicin (Adriamycin) should be used 
as the primary modality of management, 
but further chemotherapy alone does not 
maintain local control. After four cycles 
of induction chemotherapy, mastectomy 
should be done if tumour-free margins 
can be obtained without extensive recon­
struction. It is essential to achieve local 
control so that chemotherapy can be 
resumed within 2 to 3 weeks of operation. 
Chemotherapy should then be continued 
indefinitely to a maximum dose, unless 
severe toxicity occurs. Our data also sup­
port the current literature which suggests 
that in this group of patients, menopausal 
or estrogen receptor status does not 
influence therapy or survival.
Recent progress in the management of 
locally advanced breast cancer has 
resulted in a substantial improvement in 
local control and meaningful survival for 
a disease once considered to be uniformly 
and rapidly fatal.
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Is Age Alone a Contraindication to Major Cancer Surgery?
The question of w hether major cancer 
operations are w orth w h ile  in elderly 
patients is becoming more im portant, as 
we are faced w ith  a progressively aging 
population.
From Jan. 1, 1978 to  Dec. 31, 1983, 
268  elderly patients underw ent major 
operations for esophageal, gastric, intes­
tinal, pancreatic and retroperitoneal 
cancer. The patients were divided into 
three age groups: group A , 65 to  74 
years (163 patients), group B, 75 to  84 
years (81 patients) and group C, 85  to 
92  years (24 patients). The overall oper­
ative m orta lity  was 1 1 .2% , 8 .6 %  in 
group A, 13.6%  in group B and 20 .8%  
in group C. The higher rates in groups B 
and C resulted from  tw o  major factors: 
(a) the presence o f serious cardiopulm o­
nary disease preoperatively and (b) the 
developm ent of one or more serious 
com plications postoperatively. When 
these tw o  factors were compensated 
for, the rates became comparable at 
6 .1 % , 6 .6%  and 8 .3 % , respectively.
The e ffect o f preexisting cardiorespira­
to ry  compromise was approxim ately 
equal in each group. The e ffec t o f 
postoperative surgical com plications 
became more pronounced w ith  advanc­
ing age.
M ost patients enjoyed substantia l palli­
ation o f sym ptom s. The average length 
o f hospital stay was not unduly 
prolonged. Major cancer surgery can be 
safe and beneficial fo r elderly patients, 
but concerted attem pts m ust be made to
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im prove their status preoperatively. The 
m inim um  e ffec tive  operation should be 
perform ed and postoperative care should 
be intensified.
Avec le vie illissem ent progressif de la 
population, il devient im portant de se 
demander s 'il vaut la peine de soum ettre  
les patients geriatriques cancereux a des 
operations majeures.
Du 1er janvier 1978  au 31 decembre 
1 983, 2 6 8  patients ag6s ont subi des 
operations majeures pour des cancers 
oesophagiens, gastriques, in testinaux, 
pancreatiques et retroperitoneaux. Ces 
patients ont ete repartis selon I'age: le 
groupe A  age de 65  a 7 4  ans (163  
patients), le groupe B, de 75 & 8 4  ans 
(81 patients) e t le groupe C, de 8 5  a 92 
ans (24 patients). La m ortalite operatoire 
a ete de 1 1 .2% ; 8 .6 %  dans le groupe A, 
1 3 .6%  dans le groupe B et 2 0 .8 %  dans 
le groupe C. Les taux plus eleves 
observes dans les groupes B et C resul- 
ta ien t de deux facteurs im portants: a) la 
presence preop6ratoire de maladies 
cardiopulm onaires serieuses et b) le 
developpem ent d 'une ou de plus d 'une  
com plication postoperatoire. Quand ces 
deux facteurs sont pris en com pte, les 
taux deviennent comparables so it 6 .1 % , 
6 .6 %  et 8 .3%  respectivem ent. L 'e ffe t 
des affections cardiorespiratoires preex- 
istantes a ete a peu pres egal dans 
chaque groupe. L 'e ffe t des com plications 
chirurgicales postop^rato ires s 'est tou te- 
fo is  accentue avec I'age.
La plupart des patients on t benefici£ 
d 'un  e ffe t pa llia tif marque sur les sym p- 
tom es. La duree m oyenne d'hospita lisa- 
tion  n 'a  pas ete prolongee outre mesure. 
La chirurgie anticancereuse majeure peut 
etre sure pour les patients ag6s e t leur 
etre  profitab le mais tous doivent ten ter 
d 'am eliorer leur e ta t preoperatoire. On 
devrait s'en tenir a I'operation m inim um  
efficace et in tensifier les soins postoper- 
atoires.
Elderly patients are frequently denied 
major cancer operations because they are
considered too old. Reasons cited include 
an unacceptably high operative risk, 
unnecessary pain and suffering, long 
hospital stay and little benefit in view of 
their relatively short life expectancy. In 
the light of recent advances in anesthesia 
and perioperative care, this view may be 
outdated. Certainly, in the anecdotal 
experience of most general surgeons, 
elderly patients have survived their proce­
dures and enjoyed a better quality of life 
afterwards. Even if life expectancy is not 
increased, substantial palliation has been 
achieved. This study was undertaken to 
determine if these impressions are correct 
or if, indeed, age should be considered a 
contraindication to major cancer surgery.
Patients and Method
Two-hundred and sixty-eight patients 
(137 women, 131 men), 65 years of age 
and older (mean 73.8 years), were studied 
retrospectively. All had undergone major 
operations for cancer of the esophagus 
and cardia, stomach, colon, rectum, pan­
creas and retroperitoneum, between Jan. 
1, 1978 and Dec. 31, 1983. The patients 
were chosen consecutively without regard 
to the stage of the disease, to whether dis­
tant metastases were present or whether 
the procedure was considered palliative or 
curative. They were divided into three 
groups on the basis of age. Group A com­
prised 163 patients aged 65 to 74 years, 
group B, 81 patients from 75 to 84 years 
of age and group C, 24 patients 85 to 92 
years old.
Serious preoperative cardiac or respira­
tory disease was judged to be present or 
serious surgical complications to have 
developed from information in the chart. 
Criteria for serious cardiorespiratory dis­
ease were modified from the risk index 
of Goldman and associates.1 The criteria 
included frequent angina, recent myocar­
dial infarction, shortness of breath on 
climbing less than one flight of stairs, 
obvious clinical evidence of cardiac fail­
ure or arrhythmia and the need for regu­
lar medication for cardiac or respiratory
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symptoms. Serious surgical complications 
included anastomotic leakage and seque­
lae, intraperitoneal infection, wound 
dehiscence, postoperative hemorrhage 
and pulmonary embolism. Operative 
deaths were those occurring during the 
hospital stay following operation.
Results
Of the 268 patients, 33 were considered 
to have serious cardiac or respiratory dis­
ease preoperatively, serious surgical com­
plications developed postoperatively in 
22; 8 of these patients had both cardiac 
or respiratory disease and serious surgi­
cal complications.
Operative Mortality
In all there were 30 operative deaths 
(11.2%) (Fig. 1). The mortality for group 
A was 8.6%, for group B 13.6% and for 
group C 20.8%. The rate increased 
markedly in those who had preexisting 
serious cardiorespiratory disease or seri­
ous surgical complications. If these 
patients were eliminated, the mortality in 
each group became approximately equal 
and comparable to that of patients under 
65 years of age subjected to similar proce­
dures. Closer study of these patients 
(Table I) showed that 59% of those with 
serious surgical complications subse­
quently died. This effect became more 
pronounced with advancing age. The 
patients with cardiac or respiratory dis­
ease preoperatively were also at risk, with 
30% dying postoperatively. This factor 
affected each group approximately 
equally and was not apparently affected 
by advancing age. Of the eight patients 
who had both preexisting cardiorespira­
tory disease and a serious surgical com­
plication, only one survived.
Fig. 2 shows the mortality by anatomic 
site of the cancer. This ranges from no 
deaths for the five patients with 
retroperitoneal tumours to a high opera­
tive mortality of 37% for bile duct and 
pancreatic cancers.
Palliation o f  Symptoms
Of the 268 patients, 238 survived oper­
ation. The substantial relief of major 
symptoms is evident in Table II. Ninety- 
four percent noted relief of dysphagia, 
vomiting, bleeding and tenesmus. In addi­
tion, the effects of gastrointestinal and 
biliary obstruction were overcome in the 
majority of patients. Relief of pain and 
anorexia, and the sense of well being were 
not considered since they are less easy to 
define.
Hospital Stay
The average length of stay was longer 
than for younger patients (Table III). This
was especially evident in group C patients, 
over 85 years of age. Some of this time 
was due to complications and prolonged 
convalescence. There was also a problem 
in transferring these people to a chronic- 
care facility or nursing home since beds 
are not readily available. There was no 
important difference in duration of hospi­
tal stay with respect to the various tumour 
sites.
Discussion
The need to treat elderly cancer patients 
is a problem of increasing importance. 
First, there are more older people because
FIG. 1—Operative mortality by age group. CR = cardiorespiratory disease.
T a b le  1— M o r t a l i ty in  4 7  P a t ie n ts  W ith  S e r io u s  C a rd io re s p ira to ry
D is e a s e  o r S u r g ic a l C o m p lic a t io n s
S u rg ic a l C a r d io r e s p ir a to r y O v e ra ll ,
c o m p lic a t io n s , d is e a s e , e ith e r  o r  b o t h , *
G ro u p n o . / t o t a l  n o . (% ) n o . / t o t a l  n o . (% ) n o . / t o t a l  n o . (% )
A 5 / 1 2  (4 2 ) 2 / 6  ( 3 3 ) 5 / 1 5  ( 3 3 )
B 5 / 7  (7 1 ) 5 / 1 6  ( 3 1 ) 7 / 2 0  ( 3 5 )
C 3 / 3  ( 1 0 0 ) 3 /1 1  ( 2 7 ) 4 / 1 2  ( 3 3 )
T o ta ls 1 3 / 2 2  ( 5 9 ) 1 0 / 3 3  (3 0 ) 1 6 / 4 7  ( 3 4 )
* 0 f  th e  8  p a t ie n ts  w h o  h a d  b o th  p ro b le m s , 7  d ie d .
T a b le  I I — P a llia t io n  o f  S y m p to m s  in  2 3 8  S u rv iv o rs
S ite  o f  tu m o u r
P a l lia t io n ,  
n o . / t o t a l  n o . (% ) S y m p to m s
E s o p h a g u s  a n d  c a r d ia 1 0 / 1 0  ( 1 0 0 ) D y s p h a g ia
S to m a c h 3 1 / 3 4  ( 9 1 ) V o m itin g , a n e m ia
C o lo n 1 2 3 / 1 3 1  ( 9 4 ) O b s tru c t io n , b le e d in g ,
R e c tu m 3 3 / 3 5  ( 9 4 )
a n e m ia
O b s tru c t io n , d ia r r h e a ,
P a n c re a s  a n d 2 7 / 2 8  ( 9 6 )
te n e s m u s , b le e d in g  
J a u n d ic e , in te s t in a l
re t r o p e r i to n e u m o b s tru c t io n
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of population trends and longer life 
expectancy.2 Second, this group is 
statistically more likely to have malignant 
lesions. Current population estimates and 
projections clearly indicate that the fre­
quency of geriatric procedures in general, 
and cancer operations in particular, will 
increase rapidly for the rest of this 
century.3’4
Although more elderly patients are 
being operated upon, many physicians 
remain reluctant to refer patients, even 
those with potentially curable tumours, 
preferring a more conservative approach. 
The impression is that operation repre­
sents a high risk with little potential 
benefit. This view is based on the pre­
sumed frailty of these patients and their 
relatively short life expectancy. These 
concepts are based on historical facts or 
simple bias. They fail to take into account 
recent advances in preoperative prepara­
tion, techniques of surgery and anesthe­
sia and postoperative care and monitor­
ing, which have all combined to make 
major surgery common and safe. In fact, 
recent data show that the operative mor­
tality for elective general surgical proce­
dures of all kinds is not appreciably 
different in the elderly.5 It is also impor­
tant to note that at age 80 full life expec­
tancy has not necessarily been reached. 
Fifty percent of octogenarians will live 
another 5 years.6
The results of the present study show 
that in this group of elderly patients who 
undergo operations of major magnitude 
for various types of cancer, the mortal­
ity is within acceptable limits. Only 14 of 
221 patients who did not have either seri­
ous cardiorespiratory disease preopera- 
tively or surgical complications postoper- 
atively died following operation. This rate 
(6.3%) is comparable to that of younger 
patients who undergo similar procedures. 
As would be expected, those with serious 
cardiac or respiratory problems had a 
markedly increased operative mortality. 
Each age group was affected approxi­
mately equally, indicating that it was 
probably the intercurrent disease, rather 
than the age of the patient, that was the 
deciding factor. Similarly, the develop­
ment of surgical complications was poorly
tolerated by all groups. However, this 
effect seemed to increase with advancing 
age, demonstrating that there is a lesser 
margin of safety as one gets older. Even 
though the primary operative trauma is 
well handled, a second insult resulting 
from a serious complication can alter the 
precarious balance and put into motion 
a chain of events that cannot be reversed.
The results also indicate that the aver­
age length of hospital stay, although 
longer than would be expected for youn­
ger patients, is not unreasonable consider­
ing the disease processes and the magni­
tude of the procedures performed. The 
differences are certainly not great enough 
to justify withholding surgery on an eco­
nomic basis. Although the study did not 
examine specific complications, there is 
ample evidence that the higher rate of 
morbidity seen postoperatively in older 
patients is due to the associated disease 
rather than age.7"9
The strikingly effective palliation of 
symptoms in the patients who survived 
operation is perhaps the most important 
aspect. Operation is often the only good 
method of palliation. If these patients had 
been denied this, they would likely have 
remained symptomatic and uncomforta­
ble for the rest of their lives. This benefit 
alone represents a strong argument for 
subjecting the elderly individual to the 
pain and risk of operation.
On the evidence from this study, it 
appears that denial of major cancer sur­
gery on the basis of age alone is not justi­
fied. However, it is equally apparent that 
the status of these patients preoperatively 
must be improved. Cole10 emphasized 
the necessity of getting elderly people into 
good nutritional condition preoperatively, 
in order to minimize morbidity and mor­
tality. This is strikingly illustrated by the 
disproportionate number of deaths from 
bile duct, pancreatic and esophageal 
cancers in our study. Patients with these 
tumours are traditionally malnourished 
when they are admitted for operation. 
Elderly cancer patients are also more 
prone to infections and handle them 
poorly.11 They should be given antibi­
otics prophylactically. The use of sub­
cutaneously administered heparin12
Table Ill-M ean Length of Hospital Stay (Days) by Tumour Site
Group
Site of tumour Overall A B C
Esophagus 
and cardia 22.2 23.4 16.0 26.0
Stomach 18.0 18.9 17,1 17.0
Colon 22.3 14.8 21.0 27.4
Rectum 26.5 19.8 29.2 94.0
Pancreas 20.6 20.1 19.1 29.3
Retroperitoneum 26.4 18.5 20.0 55.0
Means 22.2 17.4 21.4 32.1
prophylactically to reduce thromboem­
bolic events is more controversial, but is 
recommended in these patients for simi­
lar reasons. It is obvious that patients 
with serious cardiorespiratory disease are 
at high risk. This should be reduced 
preoperatively by intensive treatment of 
congestive heart failure, arrhythmias, 
bronchoconstriction and other reversible 
conditions. If the condition cannot be 
adequately controlled, then these patients 
should not undergo major cancer opera­
tions. Each case must be considered 
individually. Meticulous attention to 
detail in the diagnosis and physiologic 
management of all primary and intercur­
rent diseases, as well as their interactions, 
is the cornerstone of success in the surgi­
cal treatment of the aged.13
Intraoperatively, a basic rule should be 
to do as little operating as possible in an 
attempt to shorten the procedure and 
decrease complications. The minimum 
effective operation should be performed. 
Radical resections should rarely be under­
taken. The object should be to clear 
enough gross tumour to prevent local 
recurrence. If an obstructing lesion is 
unresectable, it should be bypassed or 
decompressed by the simplest means 
available.
Postoperatively, the patient should be 
kept in an intensive care setting and ven­
tilation and invasive monitoring liberally 
utilized. These measures should be used 
for prophylaxis against cardiac arrhyth­
mias, myocardial infarction and other 
problems before they arise. There should 
be no hesitation in continuing ventilation 
until the pain and distension caused by 
the operation have subsided. Physiother­
apy and early mobilization should be 
instituted to prevent the complications of 
prolonged bed rest which are more com­
mon in the elderly.
Is there an age limit beyond which 
operation is contraindicated? The answer 
is probably no, since the physiologic age 
is a more important determinant than the 
chronologic age. There are many spec­
tacular examples of surgical success in 
patients 85 years of age and older who 
have gone on to live useful lives, free of 
symptoms and able to enjoy their remain­
ing years. In essence, one should make the 
decision to operate on the same basis as 
in the younger patient, that is, whether 
the potential benefits justify the risks. 
One must also ensure that the operation 
does not prolong dying rather than liv­
ing. Substantial palliation must be the 
goal, and it can be realistically achieved. 
Finally, mental status is also an impor­
tant factor to be considered in deciding 
whether a patient will be capable of 
enjoying a productive, happy life. If these 
principles are effectively used, the results 
can be gratifying for both patient and 
surgeon.
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Conclusions
Well nourished and otherwise healthy 
elderly patients tolerate major cancer sur­
gery well if no serious complications 
develop. Denial o f the benefits o f major 
cancer surgery on the basis o f age alone 
is not justified. If there are serious preex­
isting cardiorespiratory problems or seri­
ous surgical complications, the mortality 
markedly increases. The development of 
serious surgical complications was poorly 
tolerated by all groups in this study and 
the effect was greater with advancing age. 
Preoperative cardiorespiratory disease 
affected each age group approximately 
equally. Substantial relief o f symptoms 
was achieved in most patients. The aver­
age length of hospital stay was longer
than would be expected with younger 
patients, but was not unreasonable for 
procedures o f such magnitude.
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Manipulation of Tissue Forces in Treating the Adult 
Respiratory Distress Syndrome
In 16 anesthetized dogs, low-pressure 
pulm onary edema w as induced by the 
intravenous infusion of oleic acid (0.02 
mL/kg). One group of four animals 
served a s controls. In the remaining 12 
animals, the pulmonary capillary wedge 
pressure (Pcwp) w as lowered in an effort 
to decrease the accumulation of 
extravascular lung water (EVLW). In 
eight dogs, the E V L W  value decreased 
a s measured by the thermal green dye.
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double-indicator method. The low Pcwp 
w as maintained until the EVLW  reached 
a minimum. In four dogs, reduction of 
the Pcwp did not decrease the accumula­
tion of E V L W  but did reduce the rate of 
accumulation. In animals in which the 
EVLW  reached a minimum, restoration of 
Pcw p to baseline values did not increase 
edema, while the control animals con­
tinued to deteriorate. Presumably, 
changes in tissue and lymphatic 
dynam ics compensated for the increased 
capillary permeability.
On a provoque chez 16 chiens anesthe­
sias un oedeme de basse pression pul- 
monaire par perfusion intraveineuse 
d 'acide oleique (0.02 mL/kg). Quatre 
chiens ont servi de groupe temoin. Chez 
les 12 autres animaux. la pression capil- 
laire pulmonaire (PCP) a ete abaissee 
dans une tentative pour diminuer ('ac­
cumulation de liquide extravasculaire 
dans les poum ons (LEVP). Chez huit 
chiens, la mesure du LEVP  par la 
methode du double indicateur au 
colorant vert thermique a ete abaissee.
La PCP a ete gard£e basse jusqu 'a  ce 
que le LEV P  atteigne un minimum. Chez 
quatre chiens la reduction du PCP n 'a  pu 
diminuer I'accumulation de LEVP mais
reduisit la vitesse d'accumulation. Chez 
les animaux chez qui le LEVP  atteignit un 
minimum, le retablissement, du PCP aux 
valeurs de depart n 'a  pas entra?n£ d 'aug- 
mentation de I'oedeme alors que les 
animaux temoins continuerent de se 
deteriorer. Presum6ment, des change- 
ments dans la dynamique des tissus et 
du system e lymphatique ont compense 
pour ('augmentation de la permeabilite 
capillaire.
Adult respiratory distress syndrome is 
associated with a number of clinical con­
ditions in which the common denomina­
tor is the development of hemorrhagic 
pulmonary edema secondary to damage 
of the pulmonary capillary endothelium. 
Important causes of adult respiratory dis­
tress syndrome include trauma, shock, 
sepsis and pulmonary fat embolism. Con­
sequently, the treatment of this disease is 
very important to staff working in surgi­
cal intensive care units. It is now generally 
accepted that pharmacologic treatment 
directed against the pulmonary endothe­
lial damage is usually unsuccessful once 
the lesion is established, so alternative 
approaches are necessary.
At the root of pulmonary edema
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associated with adult respiratory distress 
syndrome is the inability of the pulmo­
nary capillaries to maintain the colloid 
osmotic gradient across the membrane. 
Normally, the colloid osmotic gradient 
represents a safety factor, keeping the 
lungs dry,1 opposing filtration of edema 
fluid. When this safety factor is interfered 
with, hydrostatic forces prevail and 
edema forms. Several authors2,3 have 
proposed lowering the pulmonary capil­
lary wedge pressure (Pcwp) in an effort 
to combat edema. This approach is gener­
ally successful. However, the questions as 
to how much and for how long the Pcwp 
should be lowered remain unanswered. In 
the present study, I have taken this 
approach further. It is known from previ­
ous studies1,4 that the relation between 
Pcwp and edema is biphasic. In normal 
lungs, the Pcwp can be increased up to 
25 mm Hg without appreciable edema. 
Further elevations result in precipitous 
accumulation of pulmonary fluid. In 
other words, over a given range of Pcwp,
FIG. 1—Extravascular lung water (EVLW) 
in three groups is plotted against time in base­
line (1), steady state after adult respiratory dis­
tress syndrome is induced (2), after decreases 
in pulmonary capillary wedge pressure (Pcwp) 
(3) and after Pcwp is normalized (4) in group 
III. Arrow at 100 minutes represents lowering 
of Pcwp from 10 mm Hg to near zero and 
arrow at 300 minutes represents return of Pcwp 
to baseline value of 10 mm Hg.
the lung tissues are “ refractory” to edema 
formation.1 It has been shown5 that this 
refractory state is related to lung hydra­
tion. In this study, I tested the possibil­
ity that lungs afflicted by adult respira­
tory distress syndrome can be rendered 
refractory to edema.
M ethod
Sixteen mongrel dogs were anesthetized 
with sodium pentobarbital (30 mg/kg), 
intubated and ventilated at a tidal volume 
of 15 mL/kg with 60% oxygen, using a 
Harvard ventilator (Harvard Apparatus 
Co. Inc., S. Natick, Mass.) and a Ben­
nett air-oxygen mixer (Puritan-Bennett 
Corp., Los Angeles, Calif.). Additional 
sodium pentobarbital was administered as 
required. The left jugular vein was 
exposed and a thermistor-tipped Swan- 
Ganz catheter was flow directed into the 
pulmonary artery to measure pulmonary 
artery pressure and Pcwp. A second 
catheter was flow directed into the right 
atrium for the injection of indicators.
Extravascular lung water (EVLW) was 
measured in vivo by means of the ther­
mal green dye, double-indicator, dilution 
technique. A thermistor tipped catheter 
(femoral artery lung water catheter, 
model 96-020-5F; Edwards Laboratories, 
Santa Ana, Calif.) was directed into the 
abdominal aorta through the left femoral 
artery. This catheter was also used to 
measure arterial pressure. It was con­
nected to a dye densitometer cuvette 
(model DC401, Waters Instruments Inc., 
Rochester, Minn.), which in turn was 
coupled to a densitometer (model D402A, 
Waters Instruments Inc.). Blood was 
withdrawn through the cuvette by a pump 
and immediately reinfused after the meas­
urements were made. Both the femoral 
catheter and the densitometer were con­
nected to a model 9310 Edwards lung 
water computer for processing the ther­
mal and dye signals. To obtain the meas­
urements, 10-mL boluses of ice-cold 5% 
dextrose containing 2 mg of indocyanine
green were administered into the right 
atrium. The computer obtained the ther­
mal and green-dye mean transit times, as 
well as cardiac outputs. The volume of 
extravascular lung water was calculated, 
multiplying the indicator mean transit 
time difference by the cardiac output as 
described by Chinard.6
Plasma colloid osmotic pressure was 
measured with a membrane oncometer 
(PM30, Amicon Corp., Danvers, Mass.). 
Arterial and mixed venous blood samples 
were obtained for partial pressure of oxy­
gen and carbon dioxide and pH mea­
surements.
Experimental Protocol
After the instrumentation was com­
pleted, the animals were volume loaded 
with Ringer’s lactate solution to obtain 
an initial Pcwp of about 10 mm Hg. A 
set of baseline hemodynamic, EVLW and 
gas-exchange measurements was obtained. 
Oleic acid (0.02 mL/kg) was then given 
intravenously and the EVLW value moni­
tored during the development of the capil­
lary leak syndrome until a new steady 
state was achieved at about 2 hours, when 
all measurements were repeated. One 
group of four animals (group I) was 
observed until the end of the experiment 
and served as a control. In all other 
animals the Pcwp was lowered by phle­
botomy to about 2 mm Hg and the 
EVLW value monitored. Group II com­
prised four dogs in which the accumula­
tion of EVLW did not decrease. In the 
eight animals in which the EVLW 
decreased (Group III), all measurements 
were repeated at about 300 minutes, the 
shed blood and crystalloid solution were 
reinfused to restore Pcwp to baseline 
values, and the EVLW value was moni­
tored for 2.5 hours. Thereafter, a new set 
of values was obtained. Group II dogs 
were observed for comparable times.
At the end of the experiments, the 
animals were killed with an overdose of 
potassium chloride, their chests quickly 
split and their lungs excised and weighed.
T a b le  1 - M e a s u r e m e n t s  (M e a n  ± S t a n d a r d  E r r o r )  in  1 6  D o g s  D u rin g  E x p e r im e n t
C o n d itio n E x t r a v a s c u la r M e a n  blo od M e a n  p u lm o n a r y P u lm o n a r y P a r t ia l
a s  in d ic a te d lu ng  w a t e r , C a r d ia c  o u tp u t, p re s s u re , a r t e r y  p r e s s u re , c a p i l la r y  w e d g e p r e s s u r e  o f
in F ig . 1 G ro u p T i m e ,  m in m U k g L/m in m m  H g m m  H g p r e s s u r e ,  m m  H g o x y g e n ,  m m  H g
1 1 _ 3 .6  ± 3 .3 6 .4  ± 1 .6 16 1 ± 20 1 4 .5  ± 5 .9 1 1 .3  ± 2 .3 3 0 2  ±  4 7
II _ 2 .4  ± 2 .8 6 .9  ± 2 .2 1 6 5  ± 50 1 6 .8  ± 1 .7 9 .3  ±  1 .8 3 0 6  ± 3 5
III — 2 .9  ±  2 .7 8.1 ± 3 .2 1 7 7  ±  35 1 4 .9  ± 0 .9 1 0 .4  ±  2 .0 3 2 6  ±  4 4
2 1 1 2 9  + 2 0 2 0 .4  ±  1 0 .7 5 .9  ± 1.0 1 5 4  ±  12 1 8 .7  ± 6 .5 9 .7  ±  0 .6 1 9 5  ±  8 0
II 121 ± 3 4 2 0 .4  ± 1 1 . 0 4 .9  ± 1.8 1 4 3  ± 16 1 6 .2  ±  3 .0 8 .6  ±  3.1 1 9 6  ±  5 5
III 1 3 4  ± 2 8 1 8 .6  ± 1 1 .4 6 .2  ±  1.7 1 5 6  ±  41 1 5 .9  ± 2 .0 9.1 ± 3 .0 2 1 2  ±  1 1 7
3 1 3 2 1  ± 2 5 29.1 + 1 6 .9 5.1 ± 2 .5 14 1 ± 4 1 9 .0  ± 1 .7 9 .0  ±  0 .5 61 ±  2 4
II 3 1 7  ± 5 6 2 6 .8  +  7 .9 3 .7  ± 1 .2 1 3 8  ± 8 1 2 .2  ± 1 .3 1 .3  ± 0 .8 1 1 3  ±  5 4
III 3 1 1  ± 4 7 1 5 .8  ±  1 7 .4 4 .1  ±  1.2 13 1 ± 26 1 0 .5  ±  2 .9 2 .4  ±  1 .7 2 1 5  ±  1 0 9
4 1 4 7 2  ±  2 6 3 8 .3  ±  1 9 .5 6 .6  ± 5 .0 14 1 ± 11 2 2 .3  ± 2 .0 1 0 .2  ± 2.1 4 9  ± 17
II 4 8 3  + 3 2 2 9 .4  ± 2 1 .4 5.1 ± 0 .7 1 2 9  ± 25 1 3 .7  ±  2 .0 2 .0  ±  3 .0 7 4  ±  3 5
III 5 0 2  ± 7 6 14 .0 ± 3 .8 5 .0  ± 2 .3 1 2 8  ± 29 1 0 .9  ± 3 .0 1 0 .5  ±  3 .5 1 6 5  ±  4 9
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Results
Fig. 1 represents the time course of 
mean EVLW, normalized for the ani­
mal’s weight, in the three groups. For 
clarity, standard deviations are omitted. 
Note how, following the infusion of oleic 
acid (1 in Fig. 1), the EVLW increased six 
times in all groups by about 2 hours (2 
in Fig. 1). In the control group, EVLW 
continued to accumulate to an average of 
38 mL/kg by 8 hours. After the Pcwp was 
lowered, EVLW decreased substantially 
(p < 0.01, Student’s (-test) in group III 
animals to 16 mL/kg (3 in Fig. 1) and 
remained lower once the Pcwp was 
returned to baseline values (4 in Fig. 1). 
There were no further increases until the 
end of the experiment. In group II, 
EVLW continued to accumulate after the 
Pcwp was lowered. However, it did so at 
a lower rate (p < 0.05). At the end of the 
experiment, the EVLW value in this 
group was no different from that in group 
I.
All results are summarized in Table I. 
The hemodynamic parameters remained 
stable throughout the experiment, unless 
they were changed as part of the 
experimental design. Oleic acid induced 
comparable amounts of edema in all 
groups. Only in group III, where the 
EVLW value decreased, was there an 
improvement in the gas exchange. There 
were no changes in colloid osmotic pres­
sures after the baseline determinations.
To validate the in-vivo measurements 
of EVLW, values obtained in all groups 
before the termination of the experiments 
were plotted against the excised lung 
weights (Fig. 2). There was a good corre­
lation (thermal [mL/kg] = 1.74 x 
excised [mL/kg] -  12.1 mL/kg, r = 0.9, 
p < 0.001).
Discussion
In this study, lowering the Pcwp as a 
therapeutic approach to adult respiratory 
distress syndrome was explored. This 
approach has previously been advocated 
by Prewitt and associates2 in an attempt 
to decrease the forces driving edema fluid 
across the damaged capillary membrane. 
They demonstrated significant reductions 
in EVLW values as well as improvement 
in the gas exchange. However, there were 
several drawbacks: in one group of 
animals, in which the Pcwp was lowered 
by giving diuretics, there were significant 
reductions in cardiac output. Because 
such reductions are to be expected when 
the Pcwp is drastically lowered, these 
authors and others have tried hemo­
dynamic manipulations to maintain car­
diac output at a lower Pcwp. Among 
other combinations, reduction of after­
load and inotropism, with or without diu­
resis, plasmapheresis and ultrafiltra­
tion have been tried.2'3 In many cases, 
when vasoactive drugs are used to 
manipulate afterload or support cardiac 
output, paradoxical deteriorations in gas 
exchange occurred, presumably because 
these drugs interfered with the redistribu­
tion of local pulmonary flow. In addition, 
these studies failed to consider: (a) the 
magnitude of the reduction in Pcwp, (b) 
how long this reduction should be main­
tained, particularly in the light of poten­
tially serious side effects, and (c) whether 
edema would reaccumulate once the inter­
ventions were discontinued, unless heal­
ing of the endothelial membrane had 
occurred.
In the present study, this approach is 
taken one step further. Previous work in 
our laboratory suggests that the suscep­
tibility of lung tissue to accept edema is 
directly related to its state of hydration. 
The drier the lung tissue, the more refrac­
tory it is to edema formation.4 A num­
ber of osmotic and mechanical hypo­
theses have been advocated to explain this 
phenomenon, but they are beyond the 
scope of this discussion. It has been 
shown by Gee and Spath7 and by 
Adcock and colleagues8 that the ability 
of the pulmonary lymphatics to remove 
edema fluid increases about 10 times as 
edema forms. Presumably, edema in­
creases interstitial hydrostatic pressure, 
lymphatic channels are opened and dis­
tended (primed) by the edema flow. These 
authors have demonstrated that the 
increased draining capacity of the pulmo­
nary lymphatics persists even when the 
Pcwp is lowered. It is conceivable that the 
combination of pulmonary tissues more 
refractory to edema and an increased lym­
phatic draining capacity could keep lung 
tissue dry despite the presence of adult 
respiratory distress syndrome. Conse­
quently, in this study, the Pcwp was 
lowered as much as possible and kept low 
as long as further reductions in EVLW 
occurred. Once a minimum EVLW value
GRAVIMETRIC EVLW, g/kg
FIG. 2—In-vivo estimates of EVLW (ther­
mal) are plotted against autopsy determinations 
(gravimetric). Dotted line represents identity, 
solid line represents best-fit equation.
was achieved, the Pcwp was returned to 
normal levels without reaccumulation of 
edema for an additional observation 
period of 2.5 hours. This is equivalent to 
the initial time needed for edema to accu­
mulate. In all dogs in which the EVLW 
value was reduced, gas exchange im­
proved substantially. This outcome was 
probably a direct result of the therapeu­
tic intervention, since the control dogs 
deteriorated progressively. In group II, 
the EVLW value was not reduced when 
the Pcwp was lowered. No firm conclu­
sions can be drawn from the present data 
to explain this phenomenon. It is known, 
however, that the lesion produced by oleic 
acid administration is variable. Perhaps 
in these animals the lesion was so severe 
that the reductions in the Pcwp were not 
sufficient to reverse the balance of forces 
in the direction of edema reabsorption. 
Given the good correlation between ther­
mal and autopsy EVLW determinations,
I am confident that the in-vivo technique 
is adequate to follow changes in EVLW 
during the course of the experiments.
Based on these results, it seems 
appropriate to attempt reductions in 
Pcwp in the clinical situation by whatever 
means necessary, with the goal of reduc­
ing the EVLW value to a minimum. Once 
this condition is achieved, therapy could 
be withdrawn, and the EVLW value 
monitored as the Pcwp returns to levels 
compatible with a normal cardiac output 
without pharmacologic support. If 
EVLW reaccumulates or fails to decrease 
in the first place, the lesion would seem 
beyond pulmonary compensatory me­
chanisms. In that case, perhaps the treat­
ment of choice is the support of gas 
exchange by mechanical ventilation, 
rather than complicated and potentially 
dangerous hemodynamic manipulations, 
until the lesion improves.
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Intraoperative Localization of Occult Breast Tumours
Mammographic examination of the clini­
cally normal breast can identify some 
breast masses before they become palp­
able. In order to remove them success­
fully, a surgeon requires the help of 
some localization procedure. The only 
method recommended to date has been 
preoperative needle localization under 
radiologic control by a radiologist. A 
technique of intraoperative needle locali­
zation by the surgeon without radiologic 
control has been developed at St. 
Michael's Hospital, Toronto. The method 
saves time, avoids complications and is 
very accurate. Because of the possibility 
that the mass is malignant, the exci- 
sional biopsy is performed as a definitive 
lumpectomy. Of 112 consecutive occult 
tumours so localized, only 3 required remo­
val at a second operation. Twenty-six (23%) 
of the lesions proved to be cancer (16% 
invasive, 7%  noninvasive).
La mammographie du sein cliniquement 
normal peut identifier certaines masses 
mammaires avant meme qu'elles ne 
deviennent palpabies. Pour pouvoir en 
reussir la resection, le chirurgien doit 
s'en remettre a une operation localisee.
A ce jour, la seule methode recomman- 
dee a ete la localisation preoperatoire a 
I'aiguille sous surveillance radiographique 
par un radiologiste. Une technique de 
localisation peroperatoire a I'aiguille par 
le chirurgien sans controle radiologique a 
ete mise au point au St. Michael's 
Hospital de Toronto. Cette methode tres 
precise permet d'epargner du temps et 
d'eviter des complications. A cause de la
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possibility d'avoir affaire a une tumeur 
maligne, I’excision biopsie prend la forme 
d'une "tumorectomie" definitive. Sur 
112 tumeurs occultes consecutives ainsi 
localisees, seulement 3 ont ndcessite 
une seconde operation. Des 112 lesions, 
26 (23% ) se sont averees cancereuses 
(16%  d'invasives contre 7 %  de loca­
lisees).
Mammography can detect some cancers 
of the breast before they become clinically 
palpable. Most recommended techniques 
for localization of these tumours require 
that a needle or wire be inserted into the 
breast preoperatively in the radiology 
department and the patient then be trans­
ferred to the operating room with the nee­
dle secured in position. We have deve­
loped a simple, accurate technique for 
inserting the needle in the operating room 
without any need for radiologic control.
Method
The mammogram must first be 
reviewed with the radiologist preopera-
FIG. 1—Craniocaudad view of right breast.
tively and the following tneasurements 
recorded: the distance of the lesion (either 
medial or lateral) from the centre of the 
nipple in the craniocaudad view (Fig. 1), 
the distance of the lesion (either superior 
or inferior) from the centre of the nipple 
in the mediolateral view (Fig. 2), the 
diameter of the lesion, the distance of the 
lesion to the closest skin in either view and 
the distance of the lesion from the 
posterior margin of the breast in the 
craniocaudad view (Fig. 3).
The first three measurements can be 
transposed to the skin of the breast with 
the patient sitting up on the operating 
table before anesthesia (Fig. 4). Although 
the measurements from the nipple will 
change in the supine anesthetized patient, 
the relation of the lesion to the skin mark­
ing will remain constant and a needle 
passed perpendicular to the table top (Fig.
FIG. 3—Craniocaudad view of right breast 
to measure distance of lesion from chest wall 
and to nearest skin.
FIG. 4—Measurements from Figs. X and 2 
are transposed to skin of breast with patient 
sitting upright on operating table in same posi­
tion as when mammography was performed.
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5) will track very close to the lesion. An 
estimate of the depth of the lesion in the 
breast tissue can be made from the last 
two measurements in Fig. 3 and a needle 
of suitable length selected (usually a plas­
tic disposable 2.5 cm no. 22 needle). The 
tip should be a bit deeper than the calcu­
lated depth of the lesion and usually fairly 
close to the posterior edge of the breast.
My policy has been to treat any occult 
cancers discovered with this technique by 
lumpectomy and axillary dissection. 
Usually the lack of a palpable lesion in 
the specimen renders frozen section 
examination impossible. Consequently, 
all the lesions are removed with a cylinder 
of tissue around the localizing needle 
which will provide a margin of normal 
breast tissue around the lesion if it should 
prove to be cancerous on subsequent 
examination by paraffin sections. This 
entails the removal of a relatively large 
specimen but the cosmetic results are 
excellent as long as the defect in the breast 
tissue is not repaired and no drains are 
used.
The greatest problem is to keep the 
needle in position during the entire proce­
dure. This can be done only by suturing 
the needle securely to the skin or to the 
subcutaneous tissue. We do the latter by 
passing a second needle parallel to the
FIG. 5— Needle o f suitable length is passed 
perpendicular to table top to sufficient depth 
to reach posterior edge of breast.
FIG. 6—Incision into skin and subcutane­
ous tissue centering on entry point of needle 
marked on skin. Second blunted needle is 
introduced into exposed subcutaneous tissue 
parallel to first and secured in position with 
silk suture.
first into the exposed subcutaneous tissue 
after the skin incision has been made (Fig. 
6). A hole is made in the plastic hub of 
the needle with a towel clip (Fig. 7) and 
a 0 braided silk suture is passed through 
the hole and anchored in the subcutane­
ous tissue around it (Fig. 6). The origi­
nal needle can then be withdrawn and dis­
carded.
To remove the required cylinder of tis­
sue, the needle must be palpable at all 
times during the operative procedure. The 
sharp point of the needle inevitably leads 
to puncture of at least the surgeon’s glove 
if not the finger, so it should be blunted 
before insertion by cutting off the tip with 
a wire cutter (Fig. 8). Plastic needles 
(Angiocath) and hooked wires (Frank 
wire) cannot be palpated and are unsatis­
factory.
A mammogram is taken of the speci­
men to make sure it contains the lesion. 
The needle is left sutured in position and 
an extra film is taken for the pathologist 
to serve as a reference point in identify­
ing the location of the lesion. (If the lesion 
contains no microcalcifications, it may be 
very difficult to detect on the roent­
genogram.)
The technique of excision of the breast
FIG. 7—Hole is made in plastic hub of 
needle with towel clip to facilitate passage of 
retaining silk suture.
FIG. 8—Sharp point of needle is cut off with 
wire-cutter.
FIG. 9—Specimen ready for transfer to 
pathologist. Needle is still sutured in position 
to serve as reference mark for comparison with 
specimen mammogram if necessary. Edges are 
clearly and precisely marked by suturing plas­
tic labels to them before specimen is removed 
from breast.
tissue is simple. The upper edge is defined 
first by an incision down to the pectoral 
fascia. A finger passed along the posterior 
aspect of the breast can then feel the 
blunted tip of the needle and the remain­
ing edges of the cylinder can be incised 
and defined. The edges of the specimen 
are identified by suturing labels before the 
specimen is completely removed from the 
breast (Fig. 9). A tantalum clip is placed 
in each of the four walls and in the base 
of the excision cavity for localization pur­
poses in case adjuvant radiotherapy is 
given subsequently. Meticulous hemosta­
sis is essential. The incision is closed with 
interrupted sutures in the subcutaneous 
layer and a continuous subcuticular 
suture and Steristrips in the skin. The 
defect in the breast tissue must not be 
repaired nor drains used if a good cos­
metic result is to be assured.
Results
From July 1, 1972 to Feb. 29, 1984 at 
St. Michael’s Flospital in Toronto, 112 
consecutive occult tumours were localized 
and excised by the techniques described. 
In three cases the occult tumour was not 
removed with the specimen and a second 
operation was required. Of the lesions, 26 
(23%) proved to be cancer, 18 (16%) were 
invasive and 8 (7%) noninvasive cancers.
Discussion
To date, the recommended methods of 
needle localization of nonpalpable breast 
tumours have required that the needle be 
placed under radiologic control in the 
radiology department and the patient then 
be transferred to the operating room with 
the needle in place.1'3 As the benefits of 
mammographic screening become more 
widely appreciated, more and more non­
palpable lesions will be detected and 
referred to general surgeons for biopsy in 
surgical units separate from the mammo­
graphic facility.
Our method requires close cooperation 
between the mammographer and the sur­
geon to make the necessary measurements 
but this can be done at a mutually con­
venient time before the biopsy is per­
formed. The needle is placed by the sur­
geon in the operating room with no need 
for any imaging procedure preoperatively 
and the operating room schedule is not 
subject to change because of scheduling 
in other departments and transfer of the 
patient.
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CANADIAN CARDIOVASCULAR SOCIETY
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Should Obese Patients Not Undergo Coronary
Artery Surgery?
To assess the effect of obesity on the 
patient's recovery from coronary artery 
bypass surgery, a prospective study was 
performed on 200 patients. Group 1 
comprised 101 nonobese patients and 
group 2, 99 obese patients. The mean 
percentage over the ideal weight was 
8.2% in group 1 and 33.4%  in group 2 
(p < 0.001). Preoperative assessment 
revealed no difference in age, sex, 
height, incidence of diabetes, family his­
tory or smoking habits between the two 
groups. Group 2 had a higher incidence 
of hypertension (p < 0.01) and hyper­
lipidemia (p <  0.02). The average num­
ber of grafts placed per patient was 3.4 
± 0.8 in group 1 and 3.5 ± 0.08 in 
group 2. Operative mortality was 2.9% 
and 2.0% in groups 1 and 2 respec­
tively. Obesity was a predictive factor in 
postoperative hypertension (p <  0.025), 
in the development of wound infection (p 
< 0.01) and in an increased requirement 
of bronchodilators Ip <  0.01). The 
postoperative progression of physical 
activity and length of hospital stay was 
similar, being 10.9 ± 5.8 days and 9.7 
± 9.5 days in groups 1 and 2 respec­
tively. The authors conclude that bypass 
grafting is an acceptable therapeutic 
option for obese patients with coronary 
artery disease.
Pour evaluer I'obesite comme facteur de 
risque lors de chirurgie coronarienne, une 
etude prospective a ete entreprise sur 
200 patients. Le groupe 1 incluait 101 
patients normaux, et le groupe 2, 99
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patients obeses. Le pourcentage moyen 
d'embonpoint etait de 8.2%  dans le 
groupe 1 et de 33.4%  dans le groupe 2 
(p <  0.001). II n'y avait pas de diffe­
rence significative pour les paramfetres 
suivants: age, sexe, taille, incidence de 
diabete, d'histoire familiale et de taba- 
gisme. L'incidence d'hypertension 
(p <  0.01) et d'hyperlipidemie 
(p <  0.02) etait plus elevee dans le 
groupe 2. Une moyenne de 3.4 ±  0.8 
greffons furent implantes chez les 
patients du groupe 1 et de 3.5 ± 0.08 
chez ceux du groupe 2. La mortalite ope- 
ratoire fut respectivement de 2.9%  et 
2.0%. L'obesite preoperatoire fut un fac­
teur de prediction d'hypertension posto- 
peratoire (p <  0.025), d'infections de 
plaies (p < 0.01) et d'une utilisation 
accrue de bronchodilatateurs (p <  0.01). 
La progression de I'activite postopera- 
toire et la duree du sejour a I'hopital 
furent semblables, etant de 10.9 ± 5.8 
jours pour les patients du groupe 1 et de 
9.7 ± 9.5 jours pour ceux du groupe 2. 
Les auteurs concluent que la chirurgie 
coronarienne est une option therapeuti- 
que acceptable pour le patient obese.
Obesity is a major health problem in the 
West, affecting approximately one fifth 
of the North American population.1'5 
The association between obesity and 
increased incidence of coronary artery 
disease is well known.2'6'13 Some physi­
cians have doubts about subjecting obese 
patients to cardiac catheterization and 
coronary artery surgery despite little or 
no support from objective study. Obese 
patients are often counselled to lose 
weight before undergoing complete inves­
tigation and surgical treatment for coro­
nary artery disease. Weight loss is often 
not successful and is especially impracti­
cal in patients with limiting angina. With 
the establishment of coronary artery 
bypass grafting as an effective procedure 
for the management of coronary artery 
disease, one questions the ethics of deny­
ing a potentially beneficial treatment to
these patients. It is important, therefore, 
to determine if obese patients have higher 
morbidity or mortality, or both, than 
nonobese patients after bypass grafting.
Our purpose was to study the peri- and 
postoperative courses of obese and non­
obese patients to determine if there is any 
difference in the two groups in terms of 
early mortality, morbidity and length of 
hospital stay.
Method
A prospective study of 200 patients 
aged 40 to 65 years who underwent elec­
tive coronary artery bypass grafting was 
carried out at the University of Ottawa 
Heart Institute, Ottawa Civic Hospital, 
between October 1982 and February 
1983. There were 101 nonobese (group 1) 
and 99 obese (group 2) patients. The 
study was blinded in that the health-care 
professionals involved in the management 
of these patients postoperatively were not 
aware of the study. Patients who under­
went postoperative care at other facilities 
were excluded.
Obesity was defined as weight more 
than 20% over the ideal (based on 
Metropolitan Life ideal weight standards, 
1959, corrected to nude weight), con­
firmed by a body mass index (BMI = 
weight/height2, kg /m 2) greater than 
27_i-io.i4.i5 p reoperatively, the major risk 
factors — diabetes, hypertension, family 
history and smoking — were docu­
mented. The patient’s height and weight 
were recorded. Serum triglyceride and 
cholesterol levels were measured. Coro­
nary angiography and left ventriculogra­
phy were carried out.
All patients underwent coronary artery 
bypass grafting with or without coronary 
endarterectomy under systemic hypother­
mia and cold potassium cardioplegic 
arrest. Keflin, 1 g, was administered 
intravenously 1 hour before operation 
and subsequently at 6-hour intervals for 
48 hours.
The patients were followed through 
their postoperative recovery to the day of
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discharge. Postoperative data collected 
included length of time on the ventilator 
and the frequency of need for bronchodi- 
lators for respiratory wheeze and as an 
adjunct to effective physiotherapy. Use 
of inotropic agents or the intra-aortic bal­
loon pump, or both, were noted. Peri­
operative myocardial infarction was 
determined by electrocardiographic evi­
dence of new 0.04 Q waves and serum 
creatine phosphokinase levels over 1500 
U/L.
Infections were designated as general­
ized or wound, respiratory and urinary 
tract. All required documentation of clin­
ical findings and growth of organisms on 
culture. “ Iatrogenic infections” were all 
superficial phlebitis secondary to insertion 
of catheters intravenously; they were 
diagnosed as a local cellulitis, without cul­
ture, and treated locally.
The frequency of the following com­
plications was noted: (a) reopening in the 
recovery room because of cardiac arrest, 
tamponade or bleeding; (b) disturbances 
of the central nervous system, including 
psychoses, seizures and encephalopathies; 
(c) renal impairment; and (d) develop­
ment of pressure sores. Postpericardi­
otomy syndrome was defined by clinical 
findings of pleuritic chest pain, fever and 
malaise, as well as an erythrocyte 
sedimentation rate greater than 54 mm/h. 
Serious arrhythmias requiring drug inter­
vention were noted.
The stage of ambulation was a team 
decision of the surgeon, nursing and 
physiotherapy staff based on the overall 
condition of the patient. The time 
postoperatively to the various levels of 
ambulation — walking a full corridor, 
climbing flights of 9 and 18 stairs — was 
recorded. Length of stay was determined 
from day of surgery to day of discharge.
The differences in the results were ana­
lysed according to the unpaired Student’s 
t-test.
Findings
Forty-three of the 99 obese patients 
were 20% over ideal weight, 34 more than 
30%, 8 were 40% and 14 more than 50%
FIG. 1—Distribution of patients by percen­
tage over or under ideal weight (Iw).
over their ideal weight (Fig. 1). All obese 
patients had a body mass index greater 
than 27. There was no significant differ­
ence in age, sex or height between the two 
groups (Table I). Weights and body mass 
indices were significantly different (as 
expected) (p < 0.001). Of obese patients, 
56% were more than 30% over their ideal 
weight and had a body mass index greater 
than 30. The mean percentage over the 
ideal weight in nonobese patients was 
8.2% and in the obese group was 33.4%.
With respect to preoperative risk fac­
tors for coronary artery disease, hyper­
tension and hyperlipidemia were signifi­
cantly more common in the obese group, 
p < 0.01 and p < 0.02 respectively (anal­
ysis of variance). The incidence of dia­
betes, family history, smoking and hyper­
cholesterolem ia did not differ 
substantially between the two groups 
(Table II).
The intraoperative data were similar 
for both groups with the exception of 
mean total perfusion time which was 
elevated in the obese group (84 minutes 
versus 79 minutes, p < 0.05) (Table III).
The body mass index correlated closely 
with percentage over the ideal weight 
(r = 0.98).
Postoperatively, the two groups were 
similar with respect to the time the 
patients were on the ventilator, use of 
bronchodilators, duration of inotropic 
support and the incidence of myocardial 
infarction perioperatively (Table IV).
The infection rate was low in our sam­
ple group and no significant difference 
was found between the two groups. The 
sternal incision was rarely reopened and 
there were few central nervous system or 
renal complications. The incidence of 
postpericardiotomy syndrome and post­
operative arrhythmias was similar in the 
two groups. Hypertension was more com­
mon postoperatively in group 2 
(p < 0.05) (Table IV).
There was no significant difference in 
time taken to mobilize patients in the two 
groups (Fig. 2). A test for sensitivity re­
vealed that our sample size could detect 
a difference of 0.5 days between the two 
groups with a power of 80%. Similarly, 
there was no difference between the
Table 1-Distribution of Characteristics*
Characteristic
Group 1 
(n -  101)
Group 2 
(n -  99)
Age, yr 
Sex
54.0 ± 7.0 54 .2+  6.4
M
F
Height, cm 
Weight, kgt 
Body mass indext 
% overweight!
95
6
170.5 ± 8.4 
72.7 + 9.2 
24.9 ± 1,8 
8.2 ± 7.9
83
16
169.1 ± 7.8
87.5 ± 10.4
30.5 ± 2.9 
33.4 ± 12.1
* Where applicable, figures 
tp <  0.001.
are mean + standard error of the mean.
Table 11-Risk Factors*
Risk factor
Group 1 
(n -  101)
Group 2 
(n -  99)
Diabetes
Family history
Hypertensiont
Smoking
Hyperlipidemia!
Hypercholesterolemia
11
67
31
86
47 (85) 
7(92)
12
67
48
82
66(87)
7(95)
’ Numbers in parentheses indicate number of patients who underwent the test 
tp <  0.01. 
tp <  0.02.
Table Ill-Intraoperative Characteristics*
Characteristic
Group 1 
(n -  101)
Group 2 
(n -  99)
No. of grafts 
No. of endarterectomies 
Total perfusion time, mint 
Anoxic time, min
3.4 + 0.8 
14
79 ± 22.1
38.7 ± 11.7
3.5 ± 0.08 
19
84.4 ± 22.2
40.4 ± 10.1
‘ Where applicable, figures 
tp <  0.05.
are mean + SEM.
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groups in time taken to achieve walking 
up 9 and 18 stairs. The obese group had 
a similar length of stay compared to the 
nonobese group — 10.9 and 9.7 days 
respectively (Fig. 2). Sensitivity testing for 
this variable revealed a power of 80% to 
detect a difference of 1 day between the 
two groups.
The mortality was similar for both 
groups at 2.9% for group 1 and 2.0% for 
group 2. These rates and the sample size 
are too small to detect any statistical sig­
nificance.
Discriminant analysis was performed 
on the data. Obesity was a predictive fac­
tor in postoperative hypertension 
(p < 0.025). Although there was no sig­
nificant difference using analysis of var­
iance, obesity appears to be a factor in 
the development of wound infections by 
discriminant analysis (p < 0.01). Simi­
larly, obesity was a significant variable in 
the use of bronchodilators (p < 0.01).
By discriminant analysis, there was 
direct correlation between ambulation 
and wound infection as well as perioper­
ative myocardial infarction. Chi-square 
contingency table analysis showed no 
difference in total number of infections 
between the two groups.
Discussion
Obesity has long been related to 
decreased longevity, various disease states 
and psychologic problems in adjusting to 
being grossly overweight. Studies on 
insurable people show rising mortality 
with increasing weight.1'2 Obesity has
been associated with coronary artery dis­
ease as well as hypertension, diabetes, 
gallbladder disease and arthritis.2’6,7 
Although mortality secondary to coro­
nary artery disease is declining,16 it is still 
prevalent and the obese are at risk. In 
spite of initial contrary findings,8 recent 
analysis of data from the Framingham 
Study suggests that obesity is an indepen­
dent risk factor for the development of 
coronary artery disease.13 For those 
obese patients with symptomatic disease, 
some physicians are reticent about recom­
mending operation. Some of the reasons 
for this are that the diagnostic or ther­
apeutic procedures are considered tech­
nically difficult, rehabilitation is awkward 
and there is supposedly an increased mor­
bidity and mortality.
Patients are often told that they must 
lose weight before surgery will be per­
formed.17,18 A reducing plan involves 
restricting calories and increasing expen­
diture of energy.4 Exercise may be 
difficult in most, impossible in some and 
potentially lethal in a few. By dieting, a 
substantial catabolic state would have to 
prevail to effect weight loss and this might 
lead to malnutrition despite excess weight. 
Feigal and Blaisdell19 and others20 have 
expressed concern about operating on 
those with a weight loss greater than 10% 
or existing malnutrition, for fear of 
increased mortality. There is, however, 
little in the literature on obesity and its 
effects on morbidity and mortality for 
cardiac surgery. Paiement and colleagues21 
stated that obesity is not usually men­
tioned as a major risk factor in cardiac
surgery. According to Vaughn,22 patients 
with a body mass index greater than 30 
are more likely to die, but supportive data 
are still lacking. Mortality for the general 
population is often considered to be the 
same as surgical mortality.
In assessing cardiac patients for sur­
gery, one should note that a stronger rela­
tion exists among direct indicators of 
coronary artery disease such as abnormal 
findings on the electrocardiogram and 
poor outcome than with indirect indica­
tors such as obesity.23 Mason24 noted 
that obese patients are at much greater 
risk than others for the development of 
wound infections because of the poor 
resistance of fat and increased disruptive 
forces. He found that the morbidly obese 
had a 14% wound infection rate, requir­
ing increased hospital stay. In our study, 
which was not confined to morbidly obese 
patients, we found no significant differ­
ence in infection rates and length of 
hospital stay between obese and nonobese 
patients who underwent cardiac surgery.
Pathophysiologic changes in obesity of 
particular interest to the anesthesiologist 
include an absolute increase in blood 
volume and cardiac output, but when 
adjusted for weight these values are only 
60% of expected.4 There is myocardial 
hypertrophy that is proportional to the 
increase in body weight, systemic hyper­
tension that is more prevalent in the obese 
as well as increased right heart pressure. 
From a respiratory viewpoint, obese 
patients have decreased functional 
residual capacity and chest-wall compli­
ance which may lead to atelectasis and 
shunting. Also, with an increased meta­
bolic rate, obese patients have increased 
oxygen consumption; both of these pre­
dispose to hypoxemia. Intubation and 
insertion of intravenous and arterial lines 
are technically difficult and there is an
FIG. 2—Mobilization and length of hospi­
tal stay among obese (black bars) and nonobese 
(white bars) patients (mean ± standard error 
of mean).
Table IV—Postoperative Characteristics
Group 1 Group 2
Characteristic (n -  1011 In -  99)
Respiratory
Ventilatory support, d* 1.3 ± 2.1 1.54 ± 4.9
Use of bronchodilators 28 42
Reintubation 1 1
Cardiac
Intra aortic balloon pump assistance 5 6
Inotropes 15 11
Digoxin 4 6
Myocardial infarction perioperatively 18 17
Reopening 9 6
Hypertensiont 37 50
Arrhythmias
Premature ventricular contractions 28 32
Supraventricular tachycardia 17 16
Infections
Wound infection 3 6
Sepsis 1 2
Respiratory infection 3 1
Urinary tract infection 2 3
Iatrogenic infection 1 6
Other
Dysfunction of central nervous system 6 2
Acute renal failure 2 1
Postpericardiotomy syndrome 14 8
Pressure sores 8 9
*Mean ± SEM. 
tp <  0.05.
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increased risk of aspiration.18,22’25’26 
Although these are serious concerns, data 
relating these parameters with overall 
morbidity and mortality are minimal. 
Warner and Garrett26 noted many years 
ago that definitive studies assessing risks 
of obesity were lacking and this observa­
tion holds true today.
Modern advancements in techniques of 
anesthesia, surgery and rehabilitation 
compel the team treating the obese patient 
with coronary artery disease to consider 
operation. Our obese population was 
defined in terms of two popular criteria: 
relative body weight and body mass 
index. The ideal weights were taken from 
1959 Metropolitan Life tables, but before 
our study was complete these tables were 
revised upwards so that a healthy person 
weighed more. We have continued to use 
the 1959 tables believing that the revision 
is premature based on other data concern­
ing morbidity and mortality of obese peo­
ple.10 We have also used the more 
trusted body mass index and the correla­
tion between the two criteria was high 
(r =  0.98) in our population. Over 50% 
of our obese patients were more than 30% 
over the ideal weight and had a body mass 
index greater than 30. We think this 
represents an adequate sample of obese 
patients.
Of the risk factors for coronary artery 
disease, hypertension and hyperlipidemia 
were more prevalent in the obese 
patients.27 These findings have been well 
documented in the past and it is not sur­
prising that these patients also had a 
higher incidence of hypertension 
postoperatively. Hypercholesterolemia 
did not differ between the two groups, 
but this may be owing to inaccuracies in 
measuring serum cholesterol levels as 
opposed to levels of low- and very low- 
density lipoproteins.2 The incidence of 
diabetes was comparable in the two 
groups.
Postoperatively, respiratory status was 
assessed by the length of time the patient 
was kept on the ventilator, use of bron- 
chodilators and frequency of respiratory 
infection. Most patients in both groups 
were extubated the day after operation; 
only two (one obese and one nonobese 
patient) required reintubation. Both had 
severe heart failure. Although the groups 
did not differ statistically according to 
analysis of variance, discriminant analy­
sis showed an increasing tendency to use 
bronchodilators with increasing weight. 
There were only four cases of postopera­
tive respiratory infections in our series; 
three were in long-term ventilator-dependent 
patients, in the other the length of stay 
was not affected.
Only one obese patient had a respira­
tory infection. According to the phys­
iotherapists, obese patients require more 
chest physiotherapy and are generally 
harder to work with because of their size.
This problem as well as the increased ten­
dency to use bronchodilators should not 
be a deterrent to operation.
Our rate of myocardial infarction 
postoperatively was similar in both 
groups. The high figures in each group 
may reflect the number of endarterecto­
mies performed at our institution.
Overall, the infection rate postopera­
tively was low in both groups. In obese 
patients, veins were preferentially har­
vested from the lower leg to avoid the 
groin area. There were three wound infec­
tions in the nonobese group and six in the 
obese group, a difference that was not sig­
nificant. Discriminant analysis showed an 
increasing risk of wound infection with 
increasing weight, with a related increase 
in duration of hospital stay. Identifying 
the obese patients with wound infections, 
we found that there were two vein-site 
infections and one sternal wound infec­
tion. All required local treatment and the 
hospital stay (40 days) was not prolonged. 
Therefore, the analysis findings must be 
tempered by these facts.
Patients in both groups were mobilized 
at the same time and had similar lengths 
of hospital stay. The Heart Institute has 
an early discharge program that allows 
patients who meet specific criteria to go 
home early. Both groups of patients met 
these criteria and were discharged at simi­
lar times.
The mortality for both groups was 
within acceptable limits: 2.9% and 2.0% 
for nonobese and obese patients respec­
tively. Of the obese patients, two died of 
perioperative myocardial infarction. 
Similarly, in the nonobese group, two of 
the three patients died after myocardial 
infarction while the third had a brain­
stem infarction. Both of the obese 
patients were less than 30% over ideal 
weight (20% and 24%). Although mor­
tality is stated to be greater among obese 
patients postoperatively, our findings do 
not support this belief.
Summary and Conclusions
Obese patients have a high frequency 
of coronary artery disease but many 
biases exist that make physicians and sur­
geons reluctant to recommend these 
patients for bypass grafting. In our study 
of 200 nonobese and obese patients who 
underwent elective coronary artery bypass 
grafting, we did not find any major, sig­
nificant differences in the perioperative 
courses of the two groups. Infection rate, 
respiratory complications, length of stay 
and mortality were similar for both 
groups. Modern techniques of surgery 
and anesthesia, as well as aggressive phys­
iotherapy postoperatively in a specialized 
cardiac surgical unit, make the procedure 
a therapeutic option with reasonable risks 
for the obese patient with coronary artery 
disease.
The study looked at the perioperative 
courses of obese patients who underwent 
coronary artery bypass grafting up to the 
time of their discharge. Long-term results 
should be the subject of further study.
We acknowledge the assistance of the sur­
geons, nursing and physiotherapy staff o f the 
University of Ottawa Heart Institute involved 
in the care of the patients in this study. Spe­
cial thanks go to Mrs. Evelyn Fry for secretarial 
help in preparing the manuscript, and Dr. J.B. 
Freeman for his suggestions.
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Percutaneous Transluminal Angioplasty of Coronary 
Saphenous Vein Bypass Grafts
Between December 1981 and August 
1983, percutaneous transluminal 
angioplasty of saphenous vein grafts 
was performed in 14 men and 4 women, 
selected because of recurrent anginal 
symptoms and graft stenosis. The inter­
val from bypass to angioplasty was 
41 ± 36 months. Of 24 lesions, 9 were 
at the proximal anastomosis, 13 in the 
distal segment and 2 in the middle seg­
ment of the vein graft. The primary suc­
cess rate was 79% . Failure to cross the 
stenosis occurred in three patients and 
failure to dilate in one. The stenosis was 
reduced from a mean of 8 2 %  ± 13% to 
26%  ± 15% . No patient required emer­
gency coronary artery bypass grafting 
but two underwent elective grafting after 
the angioplasty had failed. No patient 
sustained a Q-wave myocardial infarction 
and all who had a successful angioplasty 
were asymptomatic or much improved 
after the procedure. Angiographic follow­
up was available in 12 of 14 patients 
(86% ). Six patients had significant 
symptoms (Canadian Cardiovascular 
Society class II to III) and five of these 
had evidence of restenosis. Among the 
six patients who were asymptomatic, 
two had angiographic evidence of reste­
nosis. The overall rate of restenosis was 
58%  (7 of 12). Repeat angioplasty was 
successful in three of the five patients in 
whom it was attempted.
The authors conclude that percutane­
ous transluminal angioplasty of a 
saphenous vein graft for a localized area 
of stenosis is effective and safe, but 
there is a high rate of restenosis that 
possibly is due to intimal fibrous prolifer­
ation in saphenous vein grafts.
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Entre decembre 1981 et aout 1983, une 
angioplastie transluminale percutanee de 
greffes de veines saphenes a ete prati- 
quee chez 14 hommes et 4 femmes 
choisis pour cause de recidive des symp- 
tomes angineux et stenose du greffon. II 
s'etait ecoule 41 ± 36 mois entre le 
pontage et I'angioplastie. Sur 24 lesions, 
9 etaient situees a I'anastomose proxi- 
male, 13 au segment distal et 2 au 
milieu du greffon. Le taux de succes pri- 
maire a ete de 7 9 % . Chez trois patients, 
il fut impossible d'aller au-dela de la ste­
nose et, dans un cas, on ne reussit pas a 
dilater le greffon. La stenose fut reduite 
en moyenne de 8 2 %  ± 13%  a 26%  ± 
15% . Aucun patient n'a du subir un pon­
tage aorto-coronarien d’urgence mais 
deux recurent une greffe de facon non 
urgente apres I'echec de I'angioplastie. 
Aucun patient ne subit d’infarctus a 
onde Q et tous ceux chez qui I'angio- 
plastie fut reussie devinrent asymptoma- 
tiques ou virent leur etat s'ameliorer sen- 
siblement. Un controle angiographique 
fut obtenu pour 12 des 14 patients 
(8 6 % ). Six ont presente des symptomes 
importants (classification II ou III de la 
Societe cardiovasculaire canadienne) 
dont cinq qui montrerent des signes 
d'une nouvelle stenose. Parmi les six 
patients asymptomatiques, deux ont pre­
sente des signes angiographiques de re- 
stenose. Globalement, le taux de reste- 
nose fut de 58%  (7 sur 12). Une 
deuxi6me angioplastie reussit chez trois 
des cinq patients chez qui elle fut tentee.
Les auteurs concluent qu'en presence 
d'une region de stenose localis^e, 
I'angioplastie transluminale percutanee 
d'une greffe de veine saphene est effi- 
cace et sure. Toutefois, ils constatent un 
taux eleve de restenose possiblement 
due a une proliferation fibreuse de 
I'intima des greffons de veines saphenes.
Percutaneous transluminal coronary 
angioplasty was first performed as a non- 
surgical treatment for coronary artery dis­
ease by Griintzig and associates1 in 1977. 
The application and efficacy of this tech­
nique in selected patients is well estab­
lished.
Coronary artery bypass grafting is 
widely used in patients with symptoms of 
ischemic heart disease. After successful 
bypass grafting, recurrent symptoms can 
be due to narrowing or occlusion of the 
saphenous vein graft, to progression of 
disease in the grafted artery or to the 
appearance of new disease in ungrafted 
vessels.
The saphenous vein graft may become 
stenosed as a result of thrombosis, early 
intimal fibrous proliferation, medial 
fibrosis or atherosclerotic changes, which 
occur most frequently in older grafts.2,3 
Intimal fibrous proliferation is a common 
change. It is thought to be compressible, 
making it potentially amenable to 
angioplasty. Percutaneous transluminal 
angioplasty of saphenous vein grafts has 
been performed successfully in a small 
number of patients, accounting for 4% 
of cases in the National Heart, Lung, and 
Blood Institute Registry.
This report will describe the initial and 
long-term results of angioplasty of 
saphenous vein grafts at the Toronto 
General Hospital and compare our 
experience to that of other centres.
Patients and Methods
Between December 1981 and August 
1983, 18 patients (14 men, 4 women) who 
suffered angina pectoris after coronary 
artery bypass grafting were found to have 
localized stenosis of the graft or anasto­
mosis that was considered amenable to 
angioplasty; there were 24 lesions. The 
patients ranged in age from 33 to 69 years 
(mean 54.8 ± 9.1 years). The mean inter­
val between the bypass procedure and 
angioplasty was 41 ± 36.6 months (rang­
ing from 3 to 132 months) (Fig. 1). The 
mean duration of symptoms was 10.4 ± 
11 months.
The procedure was performed, accord­
ing to methods previously described,1,4 
before the advent of the steerable catheter 
system at our institution. Griintzig Dilac-
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tica (USCI International, Division, C.R. 
Bard Inc., Burlington, Mass.) 20-30, 
20-37 and 20-47 G dilating catheters were 
used. The inflation pressure and duration 
of the inflation were individualized 
according to vessel size, tolerance of 
ischemia and degree of residual stenosis.
Our protocol included (a) a calcium 
blocking agent given orally before the 
procedure and (b) low-molecular-weight 
dextran, 500 mL, and 10 000 units of 
heparin intravenously given at the onset 
of the procedure. Antiplatelet agents 
(acetylsalicylic acid, with or without 
dipyridamole or Anturan) were given 24 
hours before the procedure and continued 
for 6 months thereafter.
Results
Immediate
Nineteen of the 24 lesions were dilated 
with a primary success rate of 79% (15 
lesions). Fourteen of 18 patients had at 
least one graft dilated. The procedure was 
unsuccessful in four patients (five 
lesions). In three instances, the dilating
10
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FIG. 1—Number of patients and age of their 
grafts at time of angioplasty.
Fig. 3a
catheter could not cross the lesion and in 
two instances, the graft could not be 
dilated after proper positioning of the bal­
loon. Nine lesions were located in the 
graft just beyond the proximal anastomo­
sis, 13 were in the area of the distal 
anastomosis and 2 were in the middle of 
the graft. The primary success rate was 
essentially the same regardless of the loca­
tion of the stenosis. Eight of 9 success­
fully managed lesions were in the prox­
imal segment and 10 of 13 in the distal 
segment. Nor was the age of the graft a 
factor in primary success (Fig. 2). In the 
successful group, the mean stenosis was 
reduced from 82% ± 13% (standard de­
viation) to 26% ± 15%. After angio­
plasty, all patients who had successful 
dilatations were either improved or 
asymptomatic. No patients required 
emergency coronary artery bypass graft­
ing. Of the four patients who had failed 
angioplasty, two underwent repeat elec­
tive bypass surgery, less than 1 week after 
the procedure; the other two patients were 
treated medically.
Complication Rate
There were no deaths or major com-
FIG. 2—Primary success (hatched areas) and 
age of grafts.
Fig. 3b
plications. The complication rate in the 
successful patients was comparable to 
that for native vessel angioplasty. 
Although our group is small, this may 
indicate that the procedure is relatively 
safe. One patient had a dissection and 
occlusion of the bypass graft during 
angioplasty. The area of dissection was 
immediately recrossed and successfully 
redilated. Repeat angiography showed a 
good flow. There was no evidence of a 
myocardial infarction and he was dis­
charged from hospital without any fur­
ther intervention. At the time of dis­
charge, he had Canadian Cardiovascular 
Society class I angina.
Follow-up
Angiographic follow-up after angio­
plasty was available in 12 of 14 patients. 
The mean follow-up was 7.25 ± 2.5 
months (range from 4 to 11 months). 
Continued success of the dilated segment 
was seen in five patients but there was evi­
dence of restenosis in seven (58%). The 
definition we used for restenosis was the 
one previously described by Hollman and 
colleagues.5 Restenosis did not correlate 
with the age of the graft nor with the site 
of stenosis. The rate of restenosis was 
63% (five of eight) for proximal segments 
and 57% (four of seven) for distal anasto­
motic segments. At the time of follow-up, 
six patients had minimal or no symptoms 
(Canadian Cardiovascular Society class 0 
to I); four of these patients had no evi­
dence of restenosis on angiography. Six 
patients had moderate symptoms (Cana­
dian Cardiovascular Society class II to 
III); five of these patients had angio­
graphic evidence of restenosis. Percutane­
ous transluminal angioplasty was re-
Fig. 3c
FIG. 3—Angiographic demonstration of primary and long-term successful balloon dilatation, (a) Left anterior oblique view of right coronary 
saphenous vein graft showing 85% stenosis at site of distal anastomosis, (b) Left anterior oblique view of same graft taken immediately after 
angioplasty, with 3.7-mm diameter balloon. Lesion has been successfully dilated and there is no residual stenosis, (c) Follow-up angiogram 
(left anterior oblique view) obtained 6 months after angioplasty showing continued success with minor irregularity at site of previous lesion.
336 VOLUME 28, NO. 4, JU LY 1985 /  THE CANADIAN JOURNAL OF SURGERY
peated in five of seven patients with a 
success rate of 60%. The other two 
patients who showed evidence of resteno­
sis had class I and II angina; therefore, 
angioplasty was not repeated.
Fig. 3 depicts angiographically the 
excellent primary and long-term results in 
a patient who had distal anastomotic ste­
nosis of a vein graft in the right coronary 
artery. This patient began to suffer angina 
5 months after bypass surgery and the 
angioplasty was performed 1 month later.
Discussion
Our primary success rate of 79% is 
comparable to that recently reported by 
Block and associates6 but is higher than 
the 62% quoted by the National Heart, 
Lung, and Blood Institute Registry.7 The 
primary success rate was not altered by 
the site, degree of stenosis or the age of 
the graft. There were no deaths and no 
patient required emergency coronary 
artery bypass grafting.
Spray and Roberts2 have described the 
occurrence of fibrous intimal prolifera­
tion in all layers of the vein wall. Fibrous 
intimal proliferation is presumed to be a 
major cause of stenosis of the saphenous 
vein graft within the first few years after 
surgery. Mural ischemia, arterial intralu­
minal pressure and wall shear stress may 
lead to chronic injury of the vein intima, 
resulting in this process. The process 
appears to have no predilection for prox­
imal or distal anastomotic sites. Our 
primary success rate suggests that these 
intimal changes are compressible.
By 5 years after bypass grafting, 
atherosclerosis becomes a common cause 
of graft stenosis. These lesions, if local­
ized, may also be dilatable. Four of our 
patients who had successful angioplasty 
had grafts longer than 5 years and two of 
these patients have continued to do well. 
A higher incidence of intimal layer ulcer­
ation and thrombosis has been reported 
in older grafts,8 suggesting a risk of 
embolization on passing a dilatation 
catheter down the graft. We encountered 
no such complication in our patients, pos­
sibly because no patient selected for per­
cutaneous transluminal angioplasty had 
an angiographic appearance consistent 
with ulceration or thrombus; such an 
appearance is a contraindication to 
angioplasty at our institution.
Restenosis of the saphenous vein graft 
after percutaneous transluminal angio­
plasty is a major problem. Of our 12 
patients who had follow-up angiography, 
7 (58%) exhibited restenosis. Considering 
individual lesions, restenosis was present 
in 9 of 15 (60%). This is higher than the 
30% restenosis rate of current native ves­
sel angioplasty. Since the initial process 
causing the stenosis in the vein graft may 
be related to trauma (i.e., tension of vein
graft or overdistension with saline), then 
perhaps it is not surprising that there is 
a high frequency of recurrence after the 
trauma produced by balloon inflation. 
Other groups have found high restenosis 
rates as well. In Block’s series,6 12 of 22 
patients (54%), who underwent repeat 
angiography, had restenosis and in 
Douglas’s series9 of 62 graft dilatations, 
38% of lesions were found to have 
restenosed at follow-up angiography after 
angioplasty.
Regarding the location of the lesion, 
Block and colleagues6 found the resteno­
sis rate in the proximal and middle seg­
ments to be 56% versus 15% in the dis­
tal segments. We did not note such a 
difference.
Repeat angioplasty was carried out in 
some of our patients who had restenosis, 
but the small number prevents us from 
drawing any conclusions. In two of five 
cases, dilatation could not be accom­
plished despite a high balloon pressure 
and an appropriately sized catheter, 
indicating a hard plaque.
Conclusions
Percutaneous transluminal angioplasty 
can be used successfully in patients with 
stenosis of saphenous vein grafts 
associated with symptoms. The primary 
outcome is similar to native-vessel 
angioplasty. Further studies are necessary 
to elucidate the mechanism of restenosis 
in these patients and how it might be 
prevented.
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Readaptation post-pontage aorto-coronarien 
et retour au travail
Au Quebec, a peine plus de la moitie des 
patients qui ont subi un pontage aorto- 
coronarien retournent sur le marche du 
travail. Le retour au travail est encore 
plus faible si les sujets sont ages de 55 
a 64 ans, travailleurs manuels ou ont ete 
absents du travail pour 13 semaines ou 
plus.
Depuis le 1er janvier 1983, tous les 
patients de 64 ans et moins, qui ont subi 
avec succes un pontage aorto- 
coronarien, sont invites a un programme 
de readaptation de 6 semaines, debutant 
6 semaines apres leur chirurgie. Le but 
du programme est d'ameliorer le retour 
au travail par une activite physique en 
groupe de faible intensite (60% a 70%  
de la capacite maximale et gymnastique).
Du 1er janvier 1983 au 31 mars 1984, 
68 patients ont participe au programme 
apres pontage aorto-coronarien. La pro­
portion de patients retournant au travail 
a ete amelioree statistiquement (p <  
0.01). La meme tendance a ete observee 
quel que soit le groupe d'age, le type 
d'emploi et ou la duree d'absence du tra­
vail avant la chirurgie.
In Quebec, deceptively few patients who 
have successfully undergone coronary 
artery bypass have been returning to 
work. Those aged 55 to 64 years, blue 
collar workers or those who were off 
work for 13 weeks or more were likely 
not to return to work after surgery.
Du departement de chirurgie cardio- 
vasculaire et Pavilion de Prevention des 
Maladies Cardiaques, Hopital Laval, 
Quebec, PQ
Presente au 37ieme congres de la Societe 
canadienne de cardiologie, Quebec, PQ, le 
19 octobre, 1984
*Fonds de recherche en sante du Quebec
jStagiaire ete 1983, Universite Laval
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Les demandes de tires a part doivent etre 
adressees au docteur N. Michelle Robitaille, 
Pavilion de Prevention des Maladies Car­
diaques, Hopital Laval, 2725, chemin Ste- 
Foy, Quebec, PQ G1V 4G5
From Jan. 1, 1983, all patients aged 
64 years and younger, who successfully 
underwent coronary artery bypass graft­
ing were invited to attend a 6-week re­
habilitation program, starting 6 weeks af­
ter operation. The aim of the program 
was to improve the rate of return to 
work through a low-intensity physical ac­
tivity course (60% to 70% maximal 
working capacity and calisthenics).
Up to Mar. 31, 1984, 68 patients had 
participated in the program. The propor­
tion of patients returning to work was 
significantly (p <  0.01) improved and 
the trend was observed in all age 
groups, and for all types of employment 
and length of time off work before oper­
ation.
Le retour au travail apres pontage aorto- 
coronarien demeure un aspect generale- 
ment decevant du pronostic post- 
pontage.1-3 La proportion de ceux qui 
retournent au travail varie de 60% a 
95%.4 Dans notre milieu, les resultats 
d’une etude retrospective effectuee aupres 
de 239 patients de moins de 65 ans, ope­
res pour pontage aorto-coronarien entre 
janvier 1982 et mars 1983 (suivi moyen 
de 10.5 mois), a montre un taux de retour 
au travail de 1’ordre de 56%.
Un programme d’activite physique, 
supervise medicalement et administre au 
cours de la phase intermediaire de con­
valescence (i.e, avant la 12eme semaine), 
pourrait influencer favorablement le 
retour au travail.4,5 Ce genre de pro­
gramme, en plus d’assurer une continuity 
logique aux exercices de rehabilitation 
entrepris lors de l’hospitalisation, peut 
aider physiquement et psychologiquement 
a mieux traverser cette periode et conse- 
quemment influencer favorablement le 
retour rapide a une vie active.6-11
Le rapport qui suit rend compte des 
resultats obtenus aupres de 68 patients 
operes pour pontage aorto-coronarien 
entre janvier 1983 et mars 1984 et qui ont 
suivi, trois fois par semaine, de la 6eme 
a la 12eme semaine post-pontage, un pro­
gramme supervise d’exercices physiques 
en gymnase.
Sujets et methode
L’etude portant sur le retour au travail 
des sujets qui ont subi un pontage aorto- 
coronarien, seuls les sujets susceptibles de 
reprendre un travail en postoperatoire ont 
ete retenus pour analyse. Ainsi sont exclus 
les sujets de 65 ans et plus, les deces ope- 
ratoires, les retraites et invalides pour 
cause autre que cardiaque, de meme que 
les patients qui ont subi un remplacement 
valvulaire associe au pontage. Le nombre 
de femmes admissibles etant trop petit 
pour permettre une analyse separee, elles 
ont aussi ete exclues de l’etude.
Groupe temoin
Du ler janvier 1982 au 31 mars 1983, 
Pequipe de chirurgie cardio-vasculaire de 
l’lnstitut de Cardiologie de I’Hopital 
Laval a pratique 497 pontages aorto- 
coronariens. Des facteurs d’exclusion 
etant presents chez 198 sujets, 299 
patients ont ete retenus pour l’etude. De 
ce nombre, 239 ont pu etre rejoints par 
telephone au cours de l’ete 1983. Le 
retour au travail a ete evalue par un ques­
tionnaire simple. Dix-neuf pourcent des 
sujets avaient moins de 45 ans, 39% de 
45 a 54 ans et 42% de 55 a 64 ans. La 
duree d’arret de travail avant la corona- 
rographie avait ete de moins de 12 semai­
nes pour 65% des patients, de 13 semai­
nes et plus pour 21%, tandis que 14% des 
sujets etaient sans emploi. La repartition 
des patients selon le type d’emploi etait 
la suivante: 56% de collets bleus, 29% de 
collets blancs et 14% de professionnels.
La periode moyenne de suivi entre la 
chirurgie et la redaction du questionnaire 
a ete de 10.5 mois. Au cours de cette 
periode, les etapes de convalescence et de 
reintegration au marche du travail se sont 
effectuees de faqon traditionnelle et sans 
intervention particuliere.
Groupe d ’intervention
A compter du ler janvier 1983, les 
sujets ages de moins de 65 ans operes pour 
un pontage aorto-coronarien ont ete invi­
tes a un programme de conditionnement
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physique supervise en gymnase. L’invita- 
tion a participer a ce programme etait 
faite au moment du depart de l’hopital 
aux patients residant dans la region 
metropolitaine de Quebec et qui presen- 
taient tous les signes exterieurs d’une con­
valescence normale. Seize des 84 ponta­
ges inscrits se sont retires du programme 
sans y avoir participe; 7 pour des raisons 
medicales (angine, infarctus, haute ten­
sion arterielle, cholecystectomie, accident 
d’automobile, recommandation du mede- 
cin), 7 pour des raisons diverses et non 
medicales et 2 par manque d’interet. Fina- 
lement, 68 hommes operes pour une chi- 
rurgie coronarienne sans procedure chi- 
rurgicale associee ont constitue le groupe 
d’intervention en gymnase; 24% des 
sujets avaient moins de 45 ans, 42% de 
45 a 54 ans et 34% de 55 a 64 ans. Dans 
ce groupe, la duree d’arret de travail 
avant la coronarographie avait ete de 
moins de 12 semaines pour 80% des 
patients, de 13 semaines et plus pour 
19%, tandis qu’un sujet etait sans emploi. 
La repartition des sujets selon le type 
d’emploi etait 37% de collets bleus, 46% 
de collets blancs et 17% de profes­
sionals.
L’evaluation clinique pre-entrafnement
Pour participer au programme d’en- 
trainement en gymnase, les patients 
devaient obligatoirement obtenir l’auto- 
risation de leur medecin traitant, etre 
exempt d’angine residuelle et subir un test 
d’effort sur tapis roulant a la cinquieme 
semaine post-pontage. Les niveaux 
d’adaptation cardiovasculaire a Peffort et 
de capacite physique ont ete determines 
a l’aide d’un test d’effort progressif, selon
FIG. 1—Retour au travail par strate d’age. 
Colonnes hachurees = groupe temoin, colon- 
nes pleines = groupe intervention.
FIG. 2—Retour au travail selon la duree 
d'arret du travail pre-coronarographie. Colon­
nes hachurees = groupe temoin, colonnes plei­
nes = groupe intervention.
le protocole de Naughton modifie,9 
poursuivi jusqu’a 90% de la frequence 
cardiaque predite selon Page ou, le cas 
echeant, jusqu’au niveau d ’effort sous- 
maximal libre de symptomes limitatifs. Ce 
seuil individuel de tolerance a l’effort a 
servi a la prescription subsequente d’exer- 
cices. Les candidats devaient egalement 
se soumettre a une evaluation sanguine: 
cholesterol, cholesterol de haute densite 
(HDL), triglycerides, glycemie et une for- 
mule sanguine complete. Leur statut de 
fumeur etait evalue par questionnaire 
simple.
Le programme d’intervention 
en gymnase
Une fois le test d’effort realise, les can­
didats au programme de readaptation 
physique devaient se presenter trois fois 
par semaine a une seance d’une heure 
d’entrainement physique, entre la 6eme 
et la 12eme semaine post-chirurgicale. 
Chaque seance d’entramement durait 60 
minutes, etait medicalement supervisee et 
comprenait trois parties, soit:
• 15 minutes d’exercices d’echauffe- 
ment puis d ’exercices a dominante mus- 
culaire, pratiques en groupe. Les mouve- 
ments de flexibilite et de mobilisation des 
muscles thoraciques etaient rendus plus 
vulnerables a cause des manoeuvres chi- 
rurgicales recentes.
• 30 minutes d ’exercices a dominante 
cardiovasculaire. Une intensity moyenne 
de 60% a 70% de la frequence cardiaque 
maximale atteinte au test d ’effort 
d ’admission et libre de tout signe electro- 
cardiographique limitatif a ete choisie. 
Cette periode etait divisee en courtes 
sequences de marche ou de bicyclette 
ergometrique interrompues de periodes de 
repos de 2 minutes pendant lesquelles le 
patient pouvait prendre sa frequence car­
diaque.
• 15 minutes de retour au calme au 
moyen d’exercices de relaxation ou d’un 
jeu de ballon sans competition.
Resuitats
Dans le groupe temoin, le retour au tra­
FIG. 3—Retour au travail selon le type 
d’emploi. Colonnes hachurees = groupe 
temoin, colonnes pleines = groupe inter­
vention.
vail est de 56%. Plus les sujets sont ages 
au moment de 1’intervention, plus la fre­
quence de retour au travail est faible (76% 
chez les moins de 45 ans, 59% chez les 
45 a 54 ans et seulement 46% chez les 55 
a 64 ans). La duree d’arret de travail pre- 
coronarographie constitue de loin le fac- 
teur pronostic le plus fortement lie au 
retour au travail: 76% de retour si le delai 
est de 0 a 12 semaines comparativement 
a 26% si le delai depasse 12 semaines. Le 
type d’emploi est aussi associe a des com- 
portements de retour au travail differents, 
ainsi seulement 58% des collets bleus ont 
repris leur travail comparativement a 75% 
et 79% respectivement pour les collets 
blancs et les professionnels.
Dans le groupe d’intervention en gym­
nase, le taux de retour au travail a atteint 
75%. Ici encore, le retour au travail des 
sujets ages de 55 a 64 ans est moindre que 
chez les sujets plus jeunes (57% pour les 
55 a 64 ans contre 88% pour les moins 
de 45 ans et 86% pour les 45 a 54 ans). 
La duree d’arret de travail demeure de 
loin le meilleur element pronostic du 
retour au travail soit 85% de retour si le 
delai est de 12 semaines ou moins contre 
46% si le delai est de 13 semaines ou plus. 
Enfin, le retour au travail est moins eleve 
chez les collets bleus qui ont participe a 
l’intervention (64%) que chez les collets 
blancs (87%) et les professionnels (75%).
La fig. 1 presente la comparaison du 
retour au travail des deux groupes par 
strate d ’age. L’amelioration de la reprise 
de travail a ete observee dans les trois stra- 
tes d’age, mais cette difference atteint une 
valeur statistiquement significative chez 
les 45 a 54 ans (p <0.01, l’epreuve t de 
Student).
La fig. 2 illustre la comparaison du 
retour au travail selon la duree d’arret de 
travail pre-coronarographie. Les sujets 
qui ont cesse de travailler moins d ’une 
semaine en pre-coronarographie ont 
beneficie de l’intervention en gymnase (p 
< 0.25). A l’autre extreme, chez les sujets 
qui ont cesse de travailler plus de 12 
semaines pre-coronarographie, le retour 
au travail a presque double dans le groupe 
intervention (26% contre 46%), mais 
cette difference n ’atteint pas le niveau de 
signification statistique a cause du nom- 
bre reduit de sujets dans ce groupe 
d’intervention (n = 13).
Enfin, la fig. 3 presente la comparai­
son de retour au travail selon le type 
d’emploi. La proportion de patients qui 
reprennent le travail est plus grande dans 
le groupe intervention que dans le groupe 
controle, chez les collets bleus et les col­
lets blancs, mais cette difference n’est pas 
statistiquement significative.
Discussion
Dans la population temoin, le retour au 
travail est inferieur aux taux rapportes par 
les etudes recentes 56% contre 60% a
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90%.4 Toutefois, les facteurs determi­
nant le retour au travail sont les memes 
que ceux cites dans les autres milieux soit 
Page, la duree d ’invalidite “ temporaire” 
pre-coronarographie (ou pre-chirurgie) et 
le type d’emploi.1-3’6 De plus, ces fac­
teurs demeurent d ’importants determi­
nants de la reprise du travail dans le 
groupe intervention.
La comparaison du groupe temoin et 
du groupe intervention demontre que les 
sujets du groupe intervention ont repris 
leur travail dans une plus grande propor­
tion que ceux du groupe temoin. II serait 
bien tentant d’y voir une relation de cause 
a effet. Toutefois, il convient de rappe- 
ler qu’il ne s’agit pas d’une etude rando- 
misee de sujets egalement eligibles et imp­
resses. Lorsque nous avons entrepris 
l’intervention en gymnase, nous voulions 
demontrer qu’une telle intervention est 
faisable, sans risque et peut ameliorer 
l’autonomie des sujets et consequemment 
influencer favorablement le retour rapide 
a une vie active.
Le groupe intervention ne represente 
pas le quart des sujets operes avec succes 
a cette periode. Cette faible proportion 
s’explique par trois facteurs: le pro­
gramme est nouveau, pres de 50% des
patients operes a Laval viennent de l’exte- 
rieur de la region metropolitaine de Que­
bec et enfin, pres de 40% des operes 
avaient plus de 65 ans ou une chirurgie 
valvulaire associee. Malgre la nouveaute 
de l’intervention dans notre milieu, seu- 
lement deux des patients eligibles se sont 
faits recommander de ne pas participer 
par leur cardiologue, sans raison medicale 
apparente.
Enfin, une fois inscrit au programme, 
l’assiduite etait superieure a 90%. De fait, 
seulement quatre patients ont manque 1 
des 18 cours et ce, malgre le climat rigou- 
reux des hivers quebecois.
Les resultats communiques dans ce rap­
port demeurent partiels puisque l’expe- 
rience est encore en cours. Neanmoins, 
ces resultats suggerent l’idee qu’un pro­
gramme de conditionnement physique en 
gymnase peut contribuer a influencer 
favorablement le retour au travail et four- 
nir au patient convalescent une excellente 
occasion de participer plus activement au 
succes de sa readaptation.
Nous remercions de leur collaboration, les 
chirurgiens cardio-vasculaires et les cardiolo- 
gues de la region de Quebec et soulignons l’aide 
technique de l’equipe du laboratoire d’exer- 
cices.
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NOTICES
American Association 
for Hand Surgery
The 15th annual meeting of the Ameri­
can Association for Hand Surgery will be 
held Oct. 24-27, 1985 at the Vista Inter­
national Hotel, Kansas City, Missouri.
For further information contact: Myra 
Josephson, Central Office Manager, 
American Association for Hand Surgery, 
Ste. 218, 2934 Fish Hatchery Rd., Madi­
son, WI 53713; (608) 272-8940.
Thoracic and Cardiovascular 
Surgery
The 17th Asian Congress of Thoracic and 
Cardiovascular Surgery will be held Nov. 
17-21, 1985, in Bangkok, Thailand. The 
meeting is sponsored by the Association 
of Thoracic and Cardiovascular Surgeons 
of Asia, hosted by the Society of Thoracic 
and Cardiovascular Surgeons of Thailand 
and supported by the Royal College of 
Surgeons of Thailand, the Heart Associ­
ation of Thailand and Chulalongkorn 
University. English will be the official lan­
guage for the congress, which will include 
guest speakers, plenary sessions, sympo­
sia, scientific films and exhibits.
Information concerning the congress
and travel arrangements can be obtained 
from Interport, Ltd., PO Box 338, Sun­
set Beach, CA 90742; (213) 592-4446; 
Telex 910-380-5385 (Interport SSBH).
Cleft Palate and 
Related Craniofacial Anomalies
The 5th International Congress on Cleft 
Palate and Related Craniofacial Anoma­
lies will be held Sept. 2-7, 1985 at the 
Congress Center in Monte Carlo.
This congress will be of interest to all 
practitioners concerned with this subject, 
including plastic, dental, pediatric and 
maxillofacial surgeons, orthodontists and 
otorhinolaryngologists.
For further information contact Dr. 
Rene Malek, Chairman, International 
Congress on Cleft Palate and Related 
Craniofacial Anomalies, 6, rue Erlanger, 
75016 Paris France; or write SOCFI, 14, 
rue Mandar, 75002 Paris, France.
Review in Gastroenterology
The University of Rochester Medical Cen­
ter, Rochester, NY, is offering a course 
entitled “ Review in Gastroenterol­
ogy” to be held Oct. 16-18, 1985. It will 
be sponsored by the Gastrointestinal 
Unit, Department of Medicine, of the 
University of Rochester School of Medi­
cine and Dentistry and the course direc­
tor will be Dr. Jagdish C. Mangla. The 
accreditation will be 22 hours of AMA 
Category 1. The registration fee for prac­
tising physicians will be $425, for physi­
cians in training $300 and for endoscopy 
assistants $225.
For further information contact the 
Office of Continuing Professional Edu­
cation, University of Rochester Medical 
Center, 601 Elmwood Ave., Box 677, 
Rochester, NY 14642; (716) 275-4392.
Pan-Pacific Surgical 
Association
The 18th biennial congress of the Pan- 
Pacific Surgical Association will be held 
Jan. 11-17, 1986 in Honolulu, Hawaii. 
The theme of the meeting will be trauma. 
The deadline for registration is Nov. 15, 
1985.
For more information contact: Dr. 
George Bondar, Secretary, Pan-Pacific 
Surgical Association, Rm. 402, 10053- 
111th Street, Edmonton, Alta. T6K 2H8.
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Transforming Skeletal Muscle for Myocardial Assist:
a Feasibility Study
Canine experiments were undertaken to 
determine the feasibility of transforming 
skeletal muscle for myocardial 
assistance. Initially, a rectus-muscle 
pedicle flap was used to power a ven­
tricular assist conduit. A specially 
designed "pulse-train" stimulator 
produced skeletal muscle contractions 
capable of augmenting myocardial func­
tion. Statistically significant increases in 
either systolic or diastolic pressures were 
achieved by appropriate synchronization 
and signal delays of the stimulator.
Then, the left rectus muscle was con­
ditioned by stimulating it at low frequen­
cies (2 to 10 Hz) for 6 to 12 weeks. The 
degree of transformation from type II 
(fast) to type I (slow) fibres was exa­
mined and the resultant tolerance to 
fatigue studied. Preliminary data show 
that a greater proportion of type I fibres 
is associated with increased resistance 
to fatigue. Such transformed skeletal 
muscle should therefore be more suited 
to power the cardiac assist devices.
Des experiences chez le chien ont ete 
realisees afin de verifier la possibility de 
transformer le muscle strie pour assister 
le myocarde. Au debut, un lambeau du 
pedicule du muscle grand-droit fut utilise 
afin d'actionner un conduit d'assistance
From the Division o f  Cardiovascular and 
Thoracic Surgery, Montreal General Hospi­
tal, McGill University, Montreal, PQ
Presented at the 37th annual meeting o f  the 
Canadian Cardiovascular Society, Quebec, 
PQ, Oct. 19, 1984
Supported by a grant from  the Medical 
Research Council o f  Canada
*Research Fellow o f  the Canadian Heart 
Foundation
tDepartment o f  Pathology, Montreal 
General Hospital
Accepted fo r  publication Feb. 6, 1985
Reprint requests to: Dr. Ray C-J. Chiu,
Rm. 947, The Montreal General Hospital, 
1650 Cedar Ave., Montreal, PQ H3G 1A4
ventriculaire. Un stimulateur special 
engendrant un "train d’onde" servit a 
provoquer des contractions du muscle 
strie capables d’ameliorer la fonction 
myocardique. Une augmentation statisti- 
quement significative des tensions systo- 
lique et diastolique fut enregistree grace 
a une synchronisation appropriee du sti­
mulateur.
Par la suite, le grand-droit gauche a 
ete conditionne par stimulation a basse 
frequence (2 a 10 Hz) pendant de 6 a 12 
semaines. On a examine le degre de 
transformation des fibres de type II (rapi- 
des) a des fibres de type I dentes) et on 
a etudie la tolerance a la fatigue qui en a 
resulte. Les donnees preliminaires reve- 
lent qu'un plus grand nombre de fibres 
de type I est associe a une augmentation 
de la resistance a la fatigue. Un muscle 
strie ainsi transforme devrait done §tre 
plus apte a actionner les instruments 
d'assistance cardiaque.
Efforts to provide mechanical assistance 
for a failing heart have been focused prin­
cipally in two areas: cardiac transplanta­
tion and devices for ventricular assistance. 
With the evolution of better immunosup­
pression, cardiac transplantation has 
played a definite therapeutic role but will 
always be limited by cost and availabil­
ity of donors. The majority of left ven­
tricular assist devices and artificial hearts 
have been pneumatically, hydraulically or 
electrically powered, their primary limi­
tation being the power source.1'3 Only a 
few attempts have been made to utilize 
skeletal muscle for the power source.4'5 
The innate advantage of using autologous 
material and energy seems to be out­
weighed by the immediately apparent 
problems of strength and fatigability. 
Kantrowitz, as early as 1955, tried wrap­
ping the aorta with skeletal muscle.6 
Others7 have used diaphragmatic muscle 
flaps to replace portions of the hemody- 
namically less-demanding right ventricle. 
In our laboratory, Dewar and associates8 
used a rectus-muscle pedicle flap to 
replace a portion of the left ventricle. It 
was stimulated in synchrony with the
myocardial contraction by a newly 
devised “ pulse-train” muscle stimulator, 
which generated greater contractile force 
in the skeletal muscle. We were able to 
show a 19.3% increase in left ventricular 
pressure and an increase of 38.3% in left 
ventricular dp /d t (rate of rise of ventric­
ular pressure). However, two primary 
limitations to this approach were identi­
fied. First, in order to obtain an optimal 
relation of length to tension with the 
skeletal muscle graft, a relatively high 
end-diastolic pressure was required. 
Second, when skeletal muscle was sub­
jected to the stimulation required to aug­
ment myocardial function, it rapidly 
fatigued. To address these problems, we 
attempted in this study to use skeletal 
muscle to power a valved balloon conduit 
passing from the left ventricle to the 
thoracic aorta (Fig. 1). In addition, we 
examined the feasibility of transforming 
canine rectus muscle, type II, rapidly
FIG. 1—Diagrammatic representation of 
valved balloon conduit wrapped with skeletal 
muscle passing from left ventricle to aorta.
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fatiguing muscle fibres, to type I fatigue- 
resistant skeletal muscle fibres, and the 
resultant effects on muscle fatigue in 
response to “ pulse-train” stimuli.
Methods and Materials
The capabilities of our pulse-train 
stimulator have been described previ­
ously.8 Briefly: (a) it provides variable 
duration of stimuli lasting from 50 to 320 
ms, (b) the stimulus can be subdivided 
into multiple pulses, (c) it can sense R 
wave, (d) the stimuli can be delayed to 
make the contraction synchronous with 
systole or diastole and (e) it provides a 
variable refractory period allowing 1:1, 
1:2 and 1:3 pacing.
Experiment 1: Skeletal-Muscle-Powered 
Ventricular Assist Conduit
Nine dogs weighing 20 to 35 kg were 
anesthetized with sodium pentobarbital, 
intubated and ventilated. The cardiac and 
hemodynamic status of the dogs was 
monitored continuously by electrocardi­
ography, an aortic arch arterial line and 
arterial blood-gas measurements. A mid­
line abdominal incision was made and the 
left rectus muscle was cleared of sub­
cutaneous tissue, transected at approxi­
mately two thirds of its length and dis­
sected from the posterior sheath. The flap 
was then wrapped in saline-soaked gauze.
A left thoracotomy was done through 
the sixth intercostal space. The aorta was 
cleared for a distance of three intercostal 
arteries, which were ligated and divided. 
The pericardium was opened to expose 
the apex of the left ventricle. The 
diaphragm was incised to pass the con­
duit through from the rectus site to the 
heart and aorta, after the rectus muscle 
had first been sewn around the balloon. 
The proximal end of the conduit (Fig. 1) 
was then inserted into the left ventricu­
lar apex using the partial inflow occlusion 
technique, and the distal end was 
anastomosed to the descending thoracic 
aorta. The sensing electrodes were passed 
from the left atrium to our prototype 
pulse-train stimulator described above. 
Stimulating electrodes were passed from 
the stimulator to the rectus muscle. The 
muscle was then stimulated with varying 
parameters in repeated on-off experi­
ments to see whether appreciable aortic 
pressure could be generated. Only experi­
ments in which there were no technical 
difficulties, such as excessive bleeding, 
were analysed. The on-off experimental 
design allowed for paired Z-test analyses 
of the data. No attempt was made to 
achieve long-term survival of the dogs.
Experiment 2: Skeletal Muscle 
Transformation Study
Four mongrel dogs under Nembutal 
anesthesia had either an internal re­
ceiver or an atrioventricular sequential 
pacemaker implanted. Medtronic epi- 
cardial electrodes (Medtronic Inc., Min­
neapolis, Minn.) were placed in the 
middle portion of the left rectus muscle. 
The dogs that had internal receivers were 
then stimulated with an external transmit­
ter and antenna sewn into closely fitting 
canine jackets, for a period of 6 to 12 
weeks at a frequency of 2 to 10 Hz. The 
pulse width was 0.35 ms and voltage was 
8 V. The dogs were checked daily by pal­
pation to ensure continued functioning of 
the pacemaker.
After 6 to 12 weeks, the dogs were 
anesthetized. Their cardiac and 
hemodynamic status was monitored by 
electrocardiography, Foley catheter and 
femoral arterial line. The stimulating elec­
trode was removed. A biopsy specimen 
was taken from the rectus muscle and 
stained histochemically for myosin 
ATPase.9 These stains at different pH 
can clearly differentiate type II from 
type I fibres. A rectus-muscle pouch was 
then fashioned using the technique previ­
ously described by Dewar and associ­
ates.8 Two temporary pacing electrodes 
stripped for approximately 7.5 cm were 
passed transversely through the muscle 
about 5 cm apart. The latex balloon was 
inflated to a baseline pressure of 75 to 80 
mm Hg. Variable stimulating parameters 
were tried until one was found that 
produced maximal pressures in the 
pouch. The muscle was rested for 15 
minutes, then the fatigue study was 
undertaken. With the parameters estab­
lished earlier, continuous pulse-train 
stimulation was begun. The pressures 
generated were recorded at 30-minute 
intervals. During the experiments, 500 mL 
of dextrose in water were given and the 
muscles were kept moist with saline. 
Rectus muscles from four dogs which had 
received no long-term stimulation were 
used as controls.
Results
Experiment 1: Skeletal-Muscle-Powered 
Ventricular Assist Conduit
With appropriately timed impulses 
(Table I), either the systolic or the 
diastolic aortic pressures can be aug­
mented. A tracing demonstrating systolic 
augmentation with 1:2 pacing is shown in 
Fig. 2. If the delay from R wave to stimu­
lation was less than 160 ms, systolic pres­
sure was augmented. If the delay was 
greater than 160 ms, diastolic pressure 
was augmented. The stimulating para­
meters used to achieve these augmenta­
tions are listed in Table II. One dog was 
assisted while still on cardiopulmonary 
bypass. Fig. 3 shows that the skeletal 
muscle accessory ventricle was able to 
pump at least 25 mm Hg over pump 
pressure.
Experiment 2: Skeletal Muscle 
Transformation Study
The results of the fatigue study on mus­
cle stimulated for 6 to 12 weeks are shown 
in Fig. 4. The increase in proportion of 
type I fibres in a stimulated dog compared
FIG. 2—Synchronous pressure and stimu­
lus tracing, illustrating augmentation of sys­
tolic pressures with appropriately timed stimu­
lation.
FIG. 3—Synchronous pressure and stimu­
lus tracing shows greater augmentation of sys­
temic pressures over pump pressures at low sys­
temic pressures.
Table 11-Range of Stimulating 
Capable of Achieving Systolic o 
Augmentation
Parameters
Diastolic
Stimulation parameters Range
Pulse width, ms 50
Burst frequency, Hz 20
Duration, ms 200-500
Bursts/min 36-60
Voltage, V 2.5-6
Table 1-Augmentation of Systemic Pressure With Stimulation of a 
RectusMusclePowered Ventricular Assist Device
Increase in mean
Phase of No. of aortic arch Range of
augmentation dogs pressure, mm Hg* augmentation, mm Hg
Systole 5 11 ± 1.66 7.2-16.8
Diastole 8 9.5 ± 1.75 2.7-16.5
*SEM, p <  0.05.
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with a control dog is shown in Figs. 5 and 
6. Although a greater magnitude of con­
version of type II to type I fibres appears 
to be associated with increased fatigue 
resistance, more animals must be studied 
before statistical correlations can be 
established.
Discussion
In this study, we demonstrated that a 
valved balloon conduit powered by skele­
tal muscle can improve systemic systolic 
or diastolic pressures. The left ventricu­
lar, apex-to-aorta, valved balloon conduit 
can function as an auxiliary ventricle 
when it is timed to provide systolic 
assistance. The balloon fills during dia­
FIG. 5—Muscle biopsy from control canine rectus muscle (unstimulated), stained for myosin 
ATPase at pH 4.3. Dark fibre bundles are type I, slow-contracting fatigue-resistant fibres and 
pale fibre bundles are type II fibres (reduced by 30% from x 450).
FIG. 4—Relation between degree of fatigue 
in response to stimulation and proportion of 
type I fatigue-resistant fibres.
FIG. 6—Muscle biopsy from canine rectus muscle subjected to long-term, direct muscle 
stimulation at low frequency, stained for myosin ATPase at pH 4.3. Note increased proportion 
of type I muscle fibres compared with Fig. 5 and the appearance of grey staining intermediate 
fibres (reduced by 30% from x 450).
stole and thus reduces the left ventricu­
lar end-diastolic pressure and empties 
during systole to augment aortic pressure. 
In the 1:2 assist mode, the balloon can be 
filled during every other systolic phase, 
thus achieving greater muscular stretch to 
generate greater tension upon stimu­
lation.
The benefits of diastolic counterpulsa­
tion are well established and our conduit 
would be ideally suited to this type of left 
ventricular assist, by timing the muscu­
lar contraction during the diastolic 
period. It would also be useful in a wider 
variety of clinical settings such as diffuse 
cardiomyopathies. In contrast, the 
myocardial patch studied by various 
investigators in the past7,8’10 can be used 
only in the presence of regional, discrete 
areas of myocardial infarction, scars and 
aneurysms, or for hypoplastic right or left 
ventricles. By using the approach reported 
here, we overcome two major problems 
encountered in using skeletal muscle to 
assist a failing heart. Skeletal myograft 
replacing ventricular muscle requires a 
high (greater than 20 mm Hg) diastolic 
pressure to generate maximal contractile 
force. For counterpulsation, however, the 
muscle-wrapped balloon fills during the 
higher systolic pressure phase, thus 
stretching the skeletal muscle and increas­
ing the resting tension required to develop 
efficient contraction. The diastolic aug­
m entation achieved in this study, 
although still less than optimal for effec­
tive cardiac assist, is statistically signifi­
cant (paired t-test, p < 0.05). This aug­
mentation could in the future be increased 
by using a larger muscle pouch. Ours was 
limited by the size of the rectus muscle. 
Other muscles being studied are the latis- 
simus dorsi and pectoralis major. It was 
apparent that with a normal heart and 
systemic pressure, as in our dogs, it would 
be more difficult to show an improvement 
in cardiac function. In general, with heart 
failure and reduced systemic pressures, a 
greater augmentation of pressure could be 
more readily demonstrated. The tracing 
of the dog assisted while on cardiopulmo­
nary bypass clearly shows this.
The optimal stimulating parameters for 
generating the pressures required to aug­
ment myocardial function are still under 
investigation. With a narrower pulse 
width, lower frequency, decreased voltage 
and direct nerve stimulation, muscle 
fatigue may be minimized. Glenn and 
colleagues11 have shown that diaphrag­
matic muscle can be stimulated at slow 
rates for over a year with no fatigue.
In our preliminary study (experiment 
2), only two dogs stimulated for 6 to 12 
weeks showed a clear increase in the 
proportion of type I fatigue-resistant 
muscle fibres when compared with con­
trols. The number is too small for statisti­
cal analysis. Other investigators12 have 
achieved greater success in transforming
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type II to type I muscle fibres with direct 
muscle stimulation, but it appears that 
more complete transformation can be 
obtained by direct nerve stimulation.1315 
Many investigators16,17 have shown that 
the type I fibres are more fatigue resis­
tant than type II fibres. The answer to 
muscle fatigue in this setting most likely 
lies in a concerted approach, making 
optimal use o f aerobic enzymes of 
metabolism and of stimulating parame­
ters, and increasing the percentage of 
fatigue-resistant fibres.
Since skeletal muscle fatigue is highly 
rate-dependent, the capability of deliver­
ing 1:2 or 1:3 mode assists can also delay 
the onset o f fatigue. Recently, Medtronic 
Inc., in conjunction with our group, has 
developed a more advanced, potentially 
implantable pulse-train stimulator. Fur­
ther work is in progress with this new 
stimulator, which has better timing capa­
bility than the prototype stimulator used 
in this study. The goal is to use the 
endogenous energy source of skeletal 
muscle to achieve prolonged cardiac assist 
in patients with heart failure.
Conclusions
Myocardial function can be augmented 
with either a skeletal muscle patch or a
balloon conduit powered by skeletal mus­
cle from left ventricle to aorta.
In preliminary studies, we partially 
transformed rapidly fatiguing type II 
skeletal muscle fibres to type I fatigue- 
resistant fibres in some dogs. The impor­
tance of this transformation when such 
muscle is used to augment ventricular 
function is currently under investigation.
The optimal stimulating parameters to 
achieve adequate pressures and minimum 
fatigue must now be identified.
We appreciate the technical assistance of 
Miss Wynanne Bindon, Miss Celine Lemay, 
Mr. David MacDonald, Mr. Roger Samson, 
Mrs. Maureen Smith and Mrs. Emma Lisi.
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Two-Dim ensional Echocardiography for Diagnosing 
Acute Ascending Aortic Dissection
The diagnosis o f type  A aortic dissection 
(involving the ascending aorta) can be 
made w ith  two-dim ensional echocardio­
graphy, but surgeons usually demand 
angiographic confirm ation. Between 
January 1983  and February 1984, 10 
patients presented at St. M ichael's 
Hospital in Toronto  w ith  type A  aortic 
dissection. Six patients underw ent tw o- 
dimensional echocardiography early in 
the ir evaluation. A positive diagnosis 
w as made in four, based upon visualiza­
tion  o f an intim al flap or a false lumen.
In the other tw o  patients, the findings of 
an enlarged ascending aorta and 
pericardial e ffusion were suggestive but 
not diagnostic. Three patients survived 
operation and are alive and well (fo llow ­
up ranging from  3 to  5 months). One
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patient died w hile  awaiting surgery, one 
died during aortography and one died 
during operation. A ll echocardiographic 
and angiographic find ings w ere con­
firm ed at surgery or at autopsy. It is 
concluded th a t tw o-dim ensional 
echocardiography can diagnose ascend­
ing aortic d issection quickly, accurately, 
easily and w ith o u t risk to  the  patient. In 
selected cases the presence o f a false 
lumen or o f an intim al flap makes it pos­
sible to  proceed w ith  operation w ith o u t 
delay or the  potentia l hazards of aorto­
graphy.
Le d iagnostic des dissections aortiques 
de type  A (im pliquant I'aorte ascendante) 
peut etre fa it  par echocardiographie bi- 
d im ensionnelle, mais les chirurgiens exi­
gent habituellem ent une confirm ation 
angiographique. De janvier 1983  a 
fevrier 1 984 , 10 patients on t ete hospi­
talises au St. M ichael's Hospital de 
Toron to  sou ffran t de dissection aortique 
aigue de type  A. Six patients ont subi 
une echocardiographie bi-dimensionnelle 
au debut de leur evaluation. Un diagnos­
tic  pos itif a ete pose chez quatre apres 
visualisation d 'un  lambeau d 'in tim a ou 
d 'une  fausse lumiere. Chez les deux 
autres patients, les observations d 'un  
renflem ent de I'aorte  ascendante et 
d 'une  effusion pericardique etaient ind i­
catives mas non diagnostiques. Trois 
patients ont survecu a I'operation; ils 
son t m aintenant retablis (les examens de 
contro le  s 'e ta len t sur de 3 a 5 mois). Un
p a tien t est decede en a ttendant la ch irur- 
gie, un durant I'aortographie et un durant 
I'ope ra tion . Tous les resulta ts d 'echocar- 
d iograph ie  et d 'angiographie ont pu etre 
con firm es a la chirurgie ou a I'autopsie. 
On co n c lu t que I'echocardiographie bi- 
dim ensionnelle peut d iagnostiquer une 
d issection  de I'aorte ascendante rapide- 
m ent, facilem ent, avec precision e t sans 
risque pour le malade. Dans des cas 
choisis, la presence d 'une  fausse lum iere 
ou d ’un lambeau d 'in tim a  perm et d 'en- 
treprendre  I'operation sans delai ou sans 
le risque d 'une aortographie.
Type A dissection (involving the ascend­
ing aorta) is among the most common 
catastrophic events involving the thoracic 
aorta. Survival depends upon rapid diag­
nosis and operation. Clinical manifesta­
tions, including severe chest pain radiat­
ing through to the back, neurologic 
sequelae, absent or changing pulses and 
the presence of a new aortic diastolic mur­
mur may suggest type A dissection. Chest 
films may demonstrate a dilated ascend­
ing aorta or a left pleural effusion, fur­
ther supporting the diagnosis. These 
desperately ill patients usually undergo 
retrograde aortography to confirm the 
presence o f a dissection, its location and 
its extent. Noninvasive methods o f  
diagnosis, such as M-mode echocardio­
graphy1 and computerized transaxial 
tomography,2 have been tried but are 
not satisfactory. Two-dimensional echo­
cardiography, another noninvasive mo-
Table I— Patient Characteristics and Results of Treatment*
Patient
no.
Age,
V Sex
Aortic
insufficiencyt
Echo-
cardiogramt Aortogramf Operation Results
1 58 M - + + USCI graft Alive, well
2 61 F - + Not done USCI graft Alive, well
3 63 M + + + - Dead
4 76 M - + - - Dead§
5 62 M + ? Not done USCI graft Dead, operation
6 38 F + ? + USCI graft Alive, well
'Patients 5 and 6 had the aortic valve resuspended at time of surgery. t+ = present, -  = absent, 
t + = positive, -  = negative.
§Autopsy showed type A dissection with intrapericardial rupture.
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dality, can be used at the bedside and can 
definitively establish the diagnosis of aor­
tic dissection.3 We report our experience 
with this technique in a small series of 
patients with type A aortic dissection.
Patients and Results
Between January 1983 and February 
1984, 10 patients were seen at St. 
Michael’s Hospital in Toronto with type 
A aortic dissection. Six underwent two- 
dimensional echocardiography early in 
their evaluation and they form the basis 
of this report. Clinical and two-dimen­
sional echocardiographic data are sum­
marized in Tables I and II.
In four patients a definitive diagnosis 
was made with two-dimensional echocar­
diography ;> based upon visualization of an 
intimal flap (Figs. 1 and 2) with localiza­
tion to the ascending aorta. One other 
patient had a dilated ascending aorta 
associated with a pericardial effusion 
which was highly suggestive, but not diag­
nostic, of aortic dissection since an 
intimal flap could not be seen. The 
remaining patient had a normal ascend­
ing aorta with a markedly dilated aortic 
arch. Catheterization confirmed the 
presence of a dissection localized to the 
aortic arch. All patients had a dilated 
aorta; in four the ascending aorta only 
was involved, in one the ascending aorta, 
aortic arch and descending aorta were all 
involved, and in one the arch only was 
involved. Four of the six patients had 
pericardial effusion and one demon­
strated echocardiographic evidence of 
cardiac tamponade with diastolic collapse 
of both the right ventricle and right 
atrium .4,5 The presence of intraperi- 
cardial thrbmbus was also demonstrated 
in one patient.
One patient who had a definitive 
echocardiographic diagnosis and another 
with an echogram that suggested dissec­
tion were operated on immediately be­
cause of hemodynamic deterioration. One 
of them survived and remains alive and 
well, the other died intraoperatively of 
uncontrollable aortic bleeding. The 
remaining four patients underwent retro­
grade aortography. The aortograms 
showed a dissection in three patients but 
not in the fourth. This patient, who had 
a positive two-dimensional echocardio­
gram, also had a negative computerized 
tomogram; surgery was deferred and he 
died 48 hours later of hemopericardium 
and cardiac tamponade. This patient had 
a pericardial effusion documented on the 
initial two-dimensional echocardiographic 
study. Autopsy confirmed the presence of 
type A dissection with rupture into the 
pericardial space. Of the three remaining 
patients, one died during aortography and 
the other two underwent surgery. Both 
were alive and well, 6 and 8 months
T a b le  l l - S u m m a r y  o f  T w o - D im e n s io n a l  E c h o c a r d io g ra p h ic  F in d in g s  in A ll P a t ie n t s
P a tie n t
n o .
F la p
v is u a liz e d
A o r t a
d ila te d
A o r t ic
in s u f f ic ie n c y
P e ric a rd ia l
e f fu s io n E x t e n t
1 Y e s Y e s Y e s Y e s A s c e n d in g  a o rta
2 Y e s Y e s N o Y e s A s c e n d in g  a o rta
3 Y e s Y e s N o Y e s A s c e n d in g  a o rta  
a n d  a o r t ic  a rc h
4 Y e s Y e s N o Y e s A s c e n d in g  a o rta
5 N o Y e s N o N o A o r t i c  a rc h  o n ly
6 N o Y e s N o Y e s A s c e n d in g  a o rta
FIG. 1—Suprasternal view of ascending aorta and aortic arch. Arrows indicate intimal flaps. 
Ao = aorta, PA = pulmonary artery, LA = left atrium.
FIG. 2—Parasternal long axial view of left ventricle and ascending aorta. Arrows indicate 
intimal flap. LV = left ventricle, RV = right ventricle, LA = left atrium, Ao = aorta, fl = 
false lumen.
FIG. 3—Apical four chamber view of the heart. Large pericardial effusion with thrombus 
is demonstrated. Arrow shows right ventricular diastolic collapse. Th = thrombus, pe = 
pericardial effusion, rv = right ventricle, Iv = left ventricle, ra = right atrium, la = left atrium.
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postoperatively. An intraluminal graft 
(USCI International, Billerica, Mass.) 
was used for repair in all patients. Two 
patients. Two patients required resuspen­
sion of the aortic valve at operation.
All two-dimensional echocardiographic 
findings were confirmed by autopsy or at 
operation. There were no false-positive 
two-dimensional echocardiographic find­
ings during the study period from our 
laboratory.
Discussion
Type A dissection of the aorta is a 
catastrophic event which is rapidly fatal 
if untreated.6 Successful management 
depends on a rapid diagnosis and surgi­
cal intervention.7'8 The diagnostic 
modality selected should not only estab­
lish the presence of the dissection, but 
also pinpoint the area of aorta involved. 
The presence or absence of aortic insuffi­
ciency or a pericardial effusion is also 
important information for the surgeon.
Retrograde aortography is the most 
widely used method of establishing the 
diagnosis of type A dissection. It has the 
advantages of demonstrating the presence 
of true and false lumina as well as localiz­
ing the site of the intimal tear. It also 
visualizes aortic regurgitation secondary 
to annular ectasia. The disadvantages of 
this technique concern its invasive nature 
and the considerable time delay that is 
often unavoidable in performing the 
procedure. This technique, however, is 
not always definitive as evidenced by one 
of our patients in whom the aortogram 
appeared normal. Frequently, the aorto­
gram does not reveal the exact site of 
intimal tear. Moreover, two deaths 
occurred either during or while the patient 
was awaiting angiography.
Dynamic computerized transaxial 
tomography with intravenous contrast 
may demonstrate a double lumen and an 
intimal tear in aortic dissection. This 
method has the advantage of being nonin- 
vasive and has been found by some to be 
as useful as aortography.2 However, this 
technique has several disadvantages. The 
equipment, which is expensive and not 
readily available in all institutions, is not 
portable and is generally located in areas 
where the management of unstable 
patients may be difficult.
Two-dimensional echocardiography 
has added a new diagnostic modality for 
the detection of aortic dissection. Several 
authors1,3’9 have noted its usefulness in 
definitively establishing the diagnosis of 
type A dissections involving the aortic 
root. The two-dimensional echocardio­
graphic diagnosis is based upon visuali­
zation of an intimal flap. This was present 
in four of our six patients (Figs. 1 and 2). 
Associated findings that are also helpful 
but not necessarily diagnostic include a
dilated aorta, aortic insufficiency and the 
presence of a pericardial effusion (Fig. 3). 
In addition, two-dimensional echocardi­
ography also provides information re­
garding left ventricular function which, 
if abnormal, may suggest coexistent 
myocardial infarction resulting from dis­
section into one of the coronary ostia. If 
a pericardial effusion is present, recent 
evidence in the literature suggests that the 
presence of diastolic collapse of the right 
ventricle or right atrium may indicate 
cardiac tamponade (Fig. 3).4'5
Failure to establish definitively the 
diagnosis of dissection occurred in two 
patients. However, both had a dilated 
aorta and one had a coexistent pericardial 
effusion. Importantly, there were no 
false-positive two-dimensional echocar­
diograms in this series. Victor and 
associates3 reported a low incidence 
(2%) of false-positive results using this 
technique.
The advantages of two-dimensional 
echocardiography are several. First, it is 
noninvasive and, therefore, presents no 
risk to the patient. Second, it is com­
pletely portable so that the patient can be 
studied in the emergency room or any 
other area of the hospital without 
difficulty. Third, the technique is rapid, 
there is no need for delay in beginning the 
study which takes only minutes to per­
form. Fourth, not only can the diagnosis 
be confirmed, but associated abnormali­
ties can be visualized, myocardial func­
tion can be assessed and other nonrelated 
cardiac abnormalities documented. The 
disadvantages of this technique are that 
an intimal flap may not always be 
detected and the site of origin of the 
intimal tear may not be reliably seen. This 
is especially true in patients with chronic 
obstructive lung disease in whom ade­
quate images cannot always be obtained. 
Finally, and perhaps most importantly, 
this technique requires an experienced 
echographer to perform and interpret the 
study.
Conclusions
Two-dimensional echocardiography 
can definitively diagnose type A dissec­
tion of the aorta. Because the equipment 
may be brought to the bedside, the diag­
nosis can be made quickly, easily and 
without risk to the patient. In selected 
cases, the hazards and delays involved in 
aortography may be avoided allowing 
definitive treatment.
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1. Organization of the Department of Surgery to Facilitate
Undergraduate Education
The chairman of the department of sur­
gery is responsible for undergraduate 
education and should develop an 
organizational structure involving a direc­
tor of undergraduate education for the 
every-day running of the undergraduate 
program and the determination of poli­
cies. This person should hold a relatively 
senior position and should have under­
gone specialist postgraduate training in 
educational methods and theory. The 
director should be supported by appropri­
ate secretarial services and be compen­
sated for this; the director should also sit 
on the faculty medical curriculum com­
mittee to close the circle of policy made 
at this committee with departmental 
policy.
The departmental undergraduate 
education committee should include 
representatives from all hospitals 
involved in undergraduate education with 
representatives from the various sys­
tems. Some doubling up of representa­
tives can occur. There should be a 
review process of both teaching methods 
and faculty teaching. The former will 
encourage change where appropriate and
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the latter award individuals for their con­
tribution to the teaching process.
Le president d'un service de chirurgie 
responsable de i'enseignement de pre­
mier cycle doit mettre sur pied une struc­
ture organisationnelle comprenant un 
directeur de I'enseignement de premier 
cycle qui sera charge de faire fonctionner 
sur une base quotidienne le programme 
de premier cycle et d'etablir des politi- 
ques. Cette personne devrait detenir un 
poste relativement eleve et avoir acquis 
une formation de deuxieme cycle comme 
specialiste en theorie et en methodes 
d'enseignement. Ce directeur doit rece- 
voir le soutien d’un service de secretariat 
appropri§ et etre remunere en conse­
quence; il doit sieger egalement sur le 
comite du programme scolaire de la 
faculte de medecine afin de pouvoir bou- 
cler la boucle entre les politiques etablies 
par le comite et celles du service de chi­
rurgie.
Le comite d'enseignement de premier 
cycle du service de chirurgie doit com- 
prendre des representants de chaque 
hopital participant & I'enseignement de 
premier cycle ainsi que des representants 
des divers systemes. Certaines doubles 
representations peuvent survenir. II 
devrait exister des processus de revue 
des methodes d'enseignements de meme 
que de I'enseignement dispense par la 
faculte. Le premier visera a encourager le 
changement s'il y a lieu, alors que le 
second r^compensera la contribution de 
certains a I'enseignement.
Three major questions face a department 
o f surgery when undergraduate education 
is considered: first, who is responsible for 
undergraduate education?, second, how 
are the teaching and examination o f med­
ical students organized, assessed and
reviewed?, and finally, how is this whole 
process perceived by the faculty? To 
facilitate the educational process, a 
department directed to undergraduate 
surgical education should be organized to 
deal with these problems. This organiza­
tion will therefore be discussed in the light 
o f these three considerations.
Responsibility for Undergraduate 
Education
There is a clear line o f responsibility for 
undergraduate education. Although it 
ultimately rests with the dean o f  the 
faculty o f medicine, it stops, as far as 
departmental responsibilities are con­
cerned, with the department chairman. 
The chairman needs an executive officer 
and others to deal with the day-to-day 
organization at hospital and system levels. 
The complexity o f  this organization will 
depend upon the size o f the medical 
school.
While the chairman o f the department 
has final responsibility for undergradu­
ate education, he should be able to 
delegate the authority for organizing it to 
a responsible individual, a director o f 
undergraduate education, who has the 
ability and authority to make decisions on 
an ad hoc basis without reference to him. 
The director’ s responsibilities should 
encompass all years o f the medical course 
and the chosen individual must have 
power and authority, adequate support 
services and, preferably, specialist post­
graduate training in educational methods 
and techniques. He should have experi­
ence in the local educational process and 
be a teacher o f recognized excellence. He 
should, therefore, be someone o f relative 
seniority within the department, having 
associate or full professorial status. In 
some schools, there is a tendency to assign 
this responsibility to a junior staff mem-
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ber, the principle apparently being that 
a junior person has little else to do. Not 
only does this devalue undergraduate edu­
cation, but it ensures that when tough 
decisions are called for, neither he nor the 
chairman will be willing to make them.
The director of undergraduate educa­
tion will only be as good as his support 
services. The organization of a depart­
mental office dedicated to undergraduate 
education with a full-time secretary will 
make his job immeasurably easier and 
will raise the level of visibility of educa­
tion within the department. He should 
have a seat on the faculty undergraduate 
curriculum committee, which is the 
decision-making body for the whole 
faculty, because without this he will be 
playing catch-up with those departments 
that are represented. He should also have 
access to a professional educator, some­
one with a doctorate in education. While 
such a person need not be appointed to 
the department of surgery, he should have 
a cross appointment between the depart­
ment and the local professional educa­
tional body. In addition to relieving the 
director of many day-to-day responsibil­
ities, the professional educator will be 
able to cut corners in problem-solving and 
will give professionalism to what other­
wise may tend to be an amateur associ­
ation.
A well-organized instructional media 
service will support the director by 
providing adequate video taping, slide 
taping and slide projection facilities. This 
should make the job easier and enhance 
the ability of director’s teachers to com­
municate.
Curriculum Committee
This is the decision-making body of the 
whole faculty and, as such, is a policy 
determ inant fo r all departm ents. 
Representation on this committee is there­
fore essential, for by so doing the depart­
ment will have input into the decision­
making process in one direction and will 
be able to react easily once policies are 
determined. Moreover, the curriculum 
committee, which is concerned with pro­
gram assessment, curriculum change, and 
teacher and student assessment, will pro­
vide valuable input into departmental 
programs and useful assistance in improv­
ing these programs.
Line of Responsibility
This will be more complex when larger 
numbers of hospitals are involved and 
when teaching is involved in each under­
graduate year. There is, therefore, a ver­
tical matrix where the chain of command 
passes from the dean through the chair­
man of the department to the director of 
undergraduate surgical education to the 
hospitals and, in each hospital, down to
the educational process in each of the 
undergraduate years. The horizontal 
matrix crosses system and division teach­
ing and, in the organization of clinical 
skills such as history-taking and physi­
cal examination, will cross interdivisional 
and also interhospital boundaries. The 
organization of the department should, 
therefore, deal with this criss-cross of ver­
tical and horizontal matrices. These lines 
of communication are enhanced when the 
director of undergraduate education 
chairs an undergraduate education com­
mittee comprising the coordinators of 
undergraduate education for each teach­
ing hospital. Depending on the size of the 
school, the undergraduate education 
committee may include those responsible 
for specific activities, such as clinical 
skills, electives or the clerkship.
The hospital coordinator who is the 
representative on the undergraduate edu­
cation committee should, at his own 
hospital, chair a committee comprising 
surgical representatives from each of the 
undergraduate years, who may represent 
university or department-wide systems or 
divisional committees that cross hospi­
tal boundaries and facilitate communica­
tion in the horizontal matrix. For exam­
ple, the person responsible for Year II in 
an individual medical school may be a 
general surgeon teaching the gastrointes­
tinal system to that year’s students and 
representing a hospital on a gastrointes­
tinal systems committee that ensures coor­
dination of such teaching at all consti­
tuent hospitals. The horizontal matrix will 
also involve communication at hospital or 
university level with members of other 
departments, particularly the department 
of medicine, who share an interest in the 
specific system under consideration, that 
is, gastroenterologists and gastrointesti­
nal surgeons.
With this format, communication from 
the lowest of hospital systems teacher to 
the dean is ensured upwards, while across- 
the-board communication with associated 
departments and hospitals within the 
same system is also facilitated.
Review of Teaching
The educational process is never static 
and the departmental organization should 
reflect this by having a committee struc­
ture that looks at curriculum change, the 
current patterns of teaching and at new 
methods that may be required to respond 
both to curriculum change and to changes 
in teaching methods. The use of com­
puters for problem-solving is an example 
of this and the increasing or decreasing 
involvement of basic science courses in 
the overall curriculum is an example of 
curriculum change that requires continu­
ing investigation.
The assessment of teaching skills is 
important. While it may be difficult to
assess an individual’s teaching ability, it 
is essential that some attempt be made to 
assess his contribution to the overall 
educational process in relation to the 
department’s goals. A method of evalu­
ating teachers must be developed by the 
department and this should be done in 
association with a professional educator. 
Students are the best assessors of teach­
ing and it is recognized that peer assess­
ment has distinct limitations. The recog­
nition of teaching will help to enhance its 
value in the eyes of the department. It 
may take the form of awards, promotion, 
salary increments or tenure where these 
are appropriate.
It is ironic that few of our medical 
schools do anything to enhance the value 
of teaching by the individual members of 
their department. Seldom are new faculty 
members appointed for their teaching 
skills and very few departments have a 
program to initiate new faculty into the 
department. An annual course held in 
association with professional educators in 
the university can direct itself to the 
improvement of teaching skills at bedside, 
in seminars and in the lecture room. It 
may provide a means of upgrading the 
skills of teachers whose performance has 
been shown to be substandard and, at 
worst, will indicate the commitment the 
department has to undergraduate edu­
cation.
In conclusion, it might be worth refer­
ring to some of the results obtained by the 
Association for Surgical Education in its 
survey of undergraduate education in the 
medical schools of the United States and 
Canada.1 Surprisingly, 57% of the direc­
tors of undergraduate education were full 
professors, but only 55% of the 140 
schools surveyed had a director of under­
graduate education. In three quarters of 
these, the directorship was held on a per­
manent basis and the average time of 
holding this appointment was 7 years. 
This certainly indicates that in those 
schools where a director is appointed, 
undergraduate education is taken seri­
ously by those departments. By contrast, 
less than half the schools surveyed had an 
office of undergraduate education or an 
undergraduate education committee and 
only 18% had a professional educator 
appointed to the department of surgery.
The quality of faculty teaching was 
evaluated in nearly 90% of departments, 
the students (97%) being the most com­
mon means of evaluation, although time 
spent teaching by individual teachers was 
also used as the evaluating process in 
about half the schools. There was a 
faculty development program in only one 
quarter of the medical schools in North 
America and in three quarters of these 
medical schools the chairman carried out 
this development himself. In general, the 
programs were poorly attended and only 
about half had a new faculty program.
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It was of interest that less than one faculty 
appointment for teaching had been made 
per department in the previous 5 years.
Conclusions
These findings point out that all is far
from well in undergraduate education. It 
seems that the most major contributions 
a departmental chairman can make are, 
first, to give an unequivocally firm com­
mitment to undergraduate education and, 
second, to organize his department to 
facilitate the whole process of under­
graduate education, in planning, execu­
tion and assessment.
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2. Evaluation of Surgical Faculty and Surgical 
Undergraduate Teaching
Surgical teachers are interested in being 
evaluated. In a survey of 89 such 
teachers at the University of Manitoba, 
most (79% ) preferred having their under­
graduate teaching evaluated by their stu­
dents to other methods of evaluation. 
Eighty-seven percent of North American 
departments of surgery had a mechanism 
for assessing the quality of undergradu­
ate teaching; 97%  used student feed­
back. In order for the evaluation to be 
effective in improving undergraduate 
teaching, there must be serious faculty 
commitment, the teachers must know 
the criteria for evaluation, and feedback 
to the teachers should be early and 
preferably coupled with teacher self- 
assessment. This paper lists criteria for 
the evaluation of surgical undergraduate 
teachers and outlines the evaluation 
instrument currently used in the Depart­
ment of Surgery at the University of 
Manitoba.
Les professeurs de chirurgie desirent 
faire I'objet d'une evaluation. Lors d'une 
enquete menee chez 89 d'entre-eux a 
I'Universite du Manitoba, une majorite 
(79% ) a declare preferer voir son ensei- 
gnement de premier cycle etre evalue par 
ses propres etudiants plutot que de toute 
autre facon. Quatre-vingt sept pourcent 
des services nord-americains de chirurgie 
possedent un mecanisme d'appreciation
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de la qualite de I'enseignement de pre­
mier cycle; 9 7 %  utilisent revaluation des 
etudiants. Pour que cette evaluation 
serve a ameliorer I'enseignement de pre­
mier cycle, il faut I'engagement du corps 
professoral et la pleine connaissance par 
les professeurs des criteres d'evaluation; 
et les rSsultats doivent etre transmis 
rapidement aux professeurs, de prefe­
rence couples & leur propre auto­
evaluation. Get article dresse une liste 
des criteres d'evaluation de I'enseigne­
ment de chirurgie de premier cycle et 
trace les lignes generates de I'instrument 
d'evaluation presentement utilise dans le 
service de chirurgie de I'Universite du 
Manitoba.
Evaluation is an important aspect of med­
ical undergraduate education. Usually it 
is medical students who undergo evalua­
tion. Now there is increasing interest in 
evaluating faculty and their teaching 
standards.
The idea of teacher evaluation will be 
threatening to some of the surgical 
faculty. Others, often the better teachers, 
will welcome being evaluated.
Surgical Faculty Survey
In a recent survey of 89 faculty mem­
bers of the Department of Surgery, 
University of Manitoba (Loewen EN, 
Postuma R: Unpublished data, 1983), 11 
programs of instructional development 
activity were listed (Table I). Members 
were asked to indicate those activities in 
which they would be interested in par­
ticipating as a method of improving their 
teaching. The first choice was a critique 
of their teaching by their students; 79% 
chose this method. Interestingly, critique 
by their peers was favoured by only 56% 
of the respondents.
The Association for Surgical Education 
recently conducted a survey of North 
American departments of surgery.1 It 
found that 87% of the schools had a 
mechanism for evaluating the quality of 
undergraduate teaching. Evaluation by 
students was the most widely used method 
(97%).'
Evaluation Model
Doyle2 suggested the following model 
for evaluating teaching:
• Establish the purpose of evaluation.
T a b l e  1— I n s t r u c t io n a l  D e v e l o p m e n t  A c t i v i t y ,  F a c u l t y  S u r v e y ,  
D e p a r t m e n t  o f  S u r g e r y ,  U n i v e r s i t y  o f  M a n i t o b a ,  1 9 8 3
P r o g r a m  o f  a c t i v i t y
R e s p o n d e n t s  w i t h  
m o d e r a t e - s t r o n g  i n t e r e s t  
in  p a r t i c i p a t i n g ,  %
C r it iq u e  o f  m y  t e a c h in g  b y  m y  s t u d e n t s 7 9
O b s e r v a t i o n  o f  m a s t e r  t e a c h e r s  ( liv e  o r  o n  v i d e o t a p e ) 7 0
S e m i n a r s  o n  in s t r u c t io n a l  s k i l l s  c o n d u c t e d  b y  r e s e a r c h e r  e x p e r t  in 
a r e a  o f  u n i v e r s i t y  i n s t r u c t io n 6 6
O b s e r v a t i o n  a n d  c r i t i q u e  o f  m y  t e a c h i n g  b y  e d u c a t io n a l  c o n s u lt a n t s 6 4
A r t i c l e s  a n d  r e s e a r c h  r e p o r t s  o n  t h e  i m p r o v e m e n t  o f  t e a c h in g 6 2
L e c t u r e s  d e a lin g  w i t h  a s p e c t s  o f  t e a c h i n g  a n d  h o w  t h e y  c a n  
b e  i m p r o v e d 6 1
O b s e r v a t i o n  a n d  c r i t i q u e  o f  m y  t e a c h i n g  b y  f a c u l t y  c o l l e a g u e s 5 6
S e m i n a r s  o n  c l in ic a l  s k ills 5 5
O n e - t o - o n e  c o n f e r e n c e s  w i t h  e d u c a t io n a l  c o n s u l t a n t s  t o  d i s c u s s  
p a r t i c u l a r  i n s t r u c t io n a l  c o n c e r n s 5 2
R e le a s e  t im e  t o  w o r k  a t  i m p r o v i n g  m y  t e a c h in g 4 6
R e s e a r c h  o n  t e a c h in g  a n d  l e a r n in g 4 4
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• Determine the focus of evaluation; 
that is, what is to be evaluated.
• Establish the sources of the evalua­
tive information.
• Determine the methods by which 
information can be gathered.
• Decide upon the technical properties 
or quality of the information.
In proposing this model, three assump­
tions need to be understood: (a) teaching 
does make a difference, (b) teaching 
behaviour is changeable and (c) evalua­
tion of teaching is possible. Studies from 
the literature3 indicate that all three 
assumptions are valid.
Table 11-Rank Order of Importance for 
Promotion and Tenure
Activity
ASE,
1983, %'
AAMC, 
1977, %5
Research 62 67
Clinical service 30 19
Teaching 21 18
Rippey3 has added another dimension 
to this model, namely, the importance of 
ascertaining the goals (written or inferred) 
of the institution. Robins4 pointed out 
that “ Without institutional goals, each 
medical school teacher is free to pursue 
his or her own bent.” He suggested that 
medical schools should inventory the cur­
rent activities of their faculty, that these 
activities should be related to the goals of 
the school, that ambiguities and dis­
crepancies in the goals should be clarified 
and that evaluation of teaching should 
reflect these reconsidered goals.
Shils recommended that the overall 
goal or ethos of the institution should be 
“ a serious commitment to the attainment 
and teaching of important serious 
truths” .3 Thus, research and teaching 
are vital components of the goals of an 
academic medical institution. Unfor­
tunately, in the minds of faculty mem­
bers, teaching is often placed well behind 
other activities. In both the recent Associ­
ation for Surgical Education1 and
Association of American Medical 
Colleges5 surveys, the rank order of 
importance of teaching in determining 
promotion and tenure placed it well 
behind research (Table II). Thus, in the 
institution where research is a major goal, 
it may be difficult to obtain a serious 
commitment to teaching and to its 
improvement.
Purpose of Evaluation
Some of the purposes of faculty evalu­
ation are to: improve instruction, provide 
feedback for the teacher, determine pro­
motion and tenure, evaluate the teaching 
program, carry out research on teaching 
and make decisions on the allocation of 
teaching resources. It is important that 
the purpose of the evaluation be made 
clear at the outset. Also, the greater the 
potential for harm to individual faculty, 
the more rigorous must be the data col­
lected by the evaluation. Evaluations that 
are to be used for administrative decisions
Table Ill-Instructional Evaluation Sheet, Possible Items
I. □rganization/clarity
Explains clearly 
Is well prepared
Gives lectures that are easy to outline
Summarizes major points
States objectives for each session
Identifies important points
Makes good use of examples and illustrations
Covers an amount of material appropriate to the allotted time
Presents material in an organized manner
Gives explanations that are clear and to the point
Is careful and precise in answering questions
Clarifies thinking by identifying reasons for questions
II. Group instructional skill
Answers questions carefully and precisely
Is available for individual help
Welcomes questions from students
Encourages discussion
Invites criticism of his/her ideas
Knows if the students are understanding or not
Is aware when students are having difficulty understanding a topic
Presents or allows various points of view
Exhibits a sense of proportion and humour
Encourages critical thinking and analysis
Encourages relevant student involvement
Welcomes student expression of varying viewpoints
Is concerned with whether students have learned the material
Appears receptive to new ideas and others' viewpoints
Affords opportunities for student questions
Invites students to share their knowledge and experience
Knows when students are bored or confused
Has students apply concepts to demonstrate understanding
Presents a sympathetic attitude towards students
Has a genuine interest in students
Is friendly towards students
Relates to students as individuals
Recognizes and greets students out of class
Is accessible to students out of class
Is valued for advice not directly related to the course
Respects students as persons
Questions students in a non-threatening manner
Establishes a good rapport with students
Demonstrates respect for students
III. Enthusiasm/stimulation
Has interest in and concern for the quality of his/her teaching
Is a dynamic and energetic person
Has an interesting style of presentation
Seems to enjoy teaching
Is enthusiastic about the subject
Seems to have self-confidence
Varies the speed and tone of voice
Has a sense of humour
Seems interested in teaching
Stimulates interest in the subject matter
Attempts to stimulate creative abilities
Is humorous at appropriate time
IV. Knowledge
Is well informed on the material presented 
Relates the material to other areas of knowledge 
Discusses recent developments in the field 
Appears to possess a good mastery of the material 
Discusses points of view other than his/her own 
Contrasts implications of various theories 
Presents origins of ideas and concepts 
Gives references for more interesting and involved points 
Presents facts and concepts from related fields
V. Clinical supervision
Demonstrates clinical procedures 
Provides practice opportunities 
Offers professional support and encouragement 
Observes student performance
Identifies student clinical strengths and weaknesses objectively 
Provides feedback and positive reinforcement 
Corrects students without belittling them
VI. Clinical competence
Objectively defines and synthesizes patient problems 
Demonstrates skill at data gathering, use of consultations and inter­
preting laboratory data 
Manages clinical emergencies 
Works effectively with health-care team members
VII. Modelling professional characteristics
Is self-critical
Takes responsibility
Recognizes own limitations
Shows respect and consideration for others
Does not appear arrogant
Seems to possess self-confidence
Demonstrates sensitivity to others
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affecting a faculty member’s career need 
more discriminating measures than those 
for improving instruction. Defining the 
purpose of the evaluation system is there­
fore a key consideration upon which sub­
sequent decisions depend.
Simply evaluating teaching has little or 
no effect on improving instruction. 
However, studies3 have shown that 
evaluations conducted early in the course, 
when the instructor has time to make 
changes, are more potent than late evalu­
ations; student evaluations are more 
effective when conducted in conjunction 
with a teacher self-evaluation and in order 
for feedback to be effective, faculty mem­
bers must have some knowledge of stan­
dards, otherwise they will not know 
whether the ratings received are good, bad 
or indifferent.
Focus o f  Evaluation
The focus — what is to be evaluated 
— may be on the following three areas:
• Input: for example, what the instruc­
tor says and does, instructional material.
• Process: what the students do inter­
nally with the teaching input.
• Output: the kinds and levels of learn­
ing that the students obtain.
Input is the most common focus of 
evaluation. It concentrates closely on the 
involvement of the instructor in the teach­
ing process. The instructor’s direct con­
tribution can be assessed based upon his 
or her teaching skills, knowledge and abil­
ity to motivate students.
Sources o f  Evaluation
Sources of evaluation are many but 
may be grouped under the following: per­
ceptions, process and product.
Perceptions. —These comprise student
STUDENTS PLEASE COMPLETE AMD RETURN TO THE SUBCERY UNDKNCRADUATE OFF ICC.
THE UNIVERSITY OF MANITOBA 
DEPARTMENT OF SURCERY 
INSTRUCTIONAL EVALUATION SHEET
INSTITUTION ___________________________________
I I MED I Q ]  LECTURE QU PATIENT PRESENTATION
FIG. 1—Evaluation form.
ratings, teacher self-ratings, peer ratings 
and administrative ratings. Student rat­
ings are the most popular sources for 
evaluation since students are the only 
direct daily observers of teaching and 
therefore may constitute a valuable source 
of information. They will be considered 
in more detail later.
Process.—The second source of evalu­
ation is observations made on the process 
of teaching. In this regard, evaluations 
may be made about the teacher’s exper­
tise in the subject matter, his or her teach­
ing skills, charisma, empathy and 
judgement.
Product.—Product outcome is the stu­
dent’s performance. However, if teachers 
are to be evaluated solely on student 
achievement, no teachers may survive. 
Because of the difficulty in determining 
what part of learning is attributable to 
instructor actions, measurements of 
product outcome are rarely used for 
evaluation.
Student Ratings of Instruction
According to Rippey,3 student ratings 
are potentially reliable, valid and useful. 
They are, of course, also unavoidable. 
They work best for improving instruction 
when they are given in conjunction with 
teacher self-evaluation both during and 
at the end of the course.
Advantages
The advantages of student ratings are 
as follows:
• Generally, the data are easy and 
inexpensive to collect.
• They are potentially reliable and 
valid.
• They are often the only source of 
evaluation based on direct ongoing con­
tact with the instructor.
• When assistance with teaching skills 
accompanies student ratings, improve­
ment in instruction does result.
Criticism
Some of the criticisms of student rat­
ings are:
• They are useless if given at the end 
of the course when there is no time for 
improvement. Feedback, therefore, 
should be provided so that the proper 
time is allowed for necessary improve­
ments.
• Some faculty consider students 
immature and hence unable to judge cer­
tain aspects of teaching performance. 
However, the quality of information that 
can be collected from professionally con­
structed rating instruments suggests that 
this criticism may be invalid.
• Faculty may resist a system of stu­
dent ratings of instruction. This is less a 
criticism of the system than it is a tacti­
cal problem that demands faculty com­
mitment and involvement in the rating 
process.
• Data from the student rating instru­
ments may discourage some teachers. In 
this regard, it is important to keep in mind 
the purpose of evaluation.
• The rating instruments are often of 
poor standard. Unfortunately this often 
is the case. Therefore, the rating system 
must be carefully designed.
• Student ratings are merely a popular­
ity contest. Research results suggest that 
this statem ent is incorrect. Seldin6 
reported six studies confirming that the 
teachers who received the highest student 
ratings were more than entertainers. They 
were quality instructors.
Doyle summarized the literature on stu­
dent ratings and came to the conclusion 
that “ provided that the data are gathered 
carefully, reported appropriately and 
interpreted judiciously, student evalua­
tions appear able to make useful contri­
butions to course improvement” .
Methods: the Evaluation Instrument
The criteria for evaluating the surgical 
undergraduate teacher’s performance 
may fall under seven major headings 
(Table III). At the University of 
Manitoba, 21 items were selected from 
this list by surgical faculty and students 
in preparing an instructional evaluation 
sheet (Fig. 1). Students were asked to 
assess the surgical instruction by these 
criteria. Presently, surgical teachers at the 
University of Manitoba are evaluated by 
their students, using this evaluation form.
Implementation o f  Student Ratings
It is suggested that the following 
general principles should be considered in 
implementing a student rating system of 
teaching:
• Establish the purpose of the evalua­
tion system. This is perhaps the most 
important single step in developing the 
system. Because so many strategic deci­
sions are based on the purpose of the 
evaluation, it is obvious that the purpose 
must be established early and defined 
clearly.
• Obtain faculty commitment to the 
evaluation procedure.
• Develop a suitable instrument for 
evaluation. In this respect, criteria for 
evaluation need to be developed (Table 
III). It is recommended that experts in 
evaluation and measurement be consulted 
to develop a suitable instrument.
• Anticipate resistance. Resistance to 
any major change is to be expected. The 
degree of resistance can be anticipated if 
a faculty survey of attitudes towards var­
ious methods of improving instruction, 
including the use of student ratings, is 
conducted. Candid and truthful informa-
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tion about the proposed evaluation pro­
gram should be widely disseminated. 
Question and answer sessions should be 
encouraged. The evaluation program 
should be regarded as experimental and 
open to revision, and is best introduced 
slowly. Throughout the entire evaluation 
procedure, the privacy of the individual 
instructor should be guaranteed.
• Apply the data. Data gathered from 
the evaluation process should be related 
to the original purpose of the evaluation. 
If that purpose is to improve instruction, 
the data should indicate what improve­
ments seem necessary. This information 
can then be used to indicate the direction 
that changes must take. The data may 
lead to reward for outstanding instruc­
tion, a list of steps that an instructor can
take to improve ratings and teaching, a 
list of available instruction resources or 
a program of faculty development activi­
ties directed at improving instruction. The 
end result of the evaluation should be to 
improve instruction.
• Reassess the evaluation program. 
Opportunities for feedback are impor­
tant. Constructive criticisms can be used 
to improve the system and keep it rele­
vant to the needs of all involved.
Conclusions
Concern about the quality of instruc­
tion in medical schools has increased the 
emphasis on the importance of evaluat­
ing medical undergraduate teaching. Most 
methods of evaluation are directed at the
performance of individual instructors 
with the evaluative data frequently being 
supplied by students. When carefully 
planned and consistently implemented, 
student ratings of instruction can make 
a valuable contribution to the improve­
ment of surgical undergraduate teaching.
References
1. Provan JL, Calhoun J, Erlandson E: Undergradu- 
ate Surgical Education, Association for Surgical Educa­
tion, Springfield, 111., 1984
2. Doyle KO: Student Evaluation o f Instruction, Lexing­
ton, Toronto, 1975
3. RIPPEY RM: The Evaluation o f  Teaching in Medical 
Schools, Springer, New York, 1981
4. ROBINS AJ: Performance criteria for evaluation of med­
ical teachers. Med Educ 1977; 11: 58-64
5. Association of American Medical Colleges: Preliminary 
Report o f  the Faculty Development Survey, Washington, 
DC, 1977: 112-9
6. SELDIN P: Successful Faculty Development Program, 
Coventry Pr, New York, 1980
R .G . DANZINGER, MD, FACS, FRCSC
3. Development of the Undergraduate Teacher
Three components are necessary for 
effective undergraduate teaching in a 
department of surgery: (a) departmental 
organization and membership priority 
focused on teaching; (b) a clear under­
standing and appropriate utilization of all 
teaching methods, for example, lectures, 
large seminars or demonstrations, small 
seminars and bedside teaching; (c) the 
acquisition and maintenance of teaching 
and evaluation skills by all department 
members. The author discusses the 
advantages and disadvantages of the 
four principal teaching methods and the 
means of acquiring teaching and evalua­
tion skills that includes the use of 
professional educators.
Trois composantes sont necessaires a 
I'efficacite de I'enseignement de premier 
cycle dans un service de chirurgie: a) 
une organisation de service et des mem- 
bres orientes en priorite vers I'enseigne-
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ment; bl une connaissance nette et une 
utilisation appropriee de toutes les 
methodes d'enseignement telles que 
cours magistraux, grands seminaires ou 
demonstrations, petits seminaires et 
enseignement au lit du malade; c) 
I'acquisition et le maintien par tous les 
membres du service d'une competence 
en enseignement et en methodes deva­
luation. L'auteur commente les avanta- 
ges et desavantages des quatre principa­
l s  methodes d'enseignement et les 
moyens d'acquerir des competences en 
enseignement et en methodes devalua­
tion, y compris I emploi d'educateurs 
professionnels.
Development of the undergraduate 
teacher has three basic requirements: 
departmental requirements, without 
which the appropriate milieu for good 
teaching will not occur; an understand­
ing of the teaching methods involved in 
the interaction between surgeons and stu­
dents; the training of surgeons as 
teachers.
Departmental Requirements
First, all members of the department, 
particularly the department head, must 
consciously and outwardly acknowledge 
undergraduate teaching as a vital compo­
nent of their activities. With such recog­
nition, it is incumbent on the department 
to maintain yearly records that include all 
the assigned teaching activities of each 
member. Methods to evaluate the qual­
ity of teaching must be developed. Teach­
ing activity, both quality and quantity,
must be an essential component when 
considering academic advancement.
All new surgical staff must be aware of 
and accept their role as teachers of under­
graduate students. Each should obtain 
instruction on teaching methods within 
the first year of joining the department. 
All must be prepared to undergo evalua­
tion of their teaching activities and to 
have their skills upgraded at intervals.
Established staff surgeons must have 
their teaching role evaluated, and as a 
■ result should: (a) continue if they are per­
forming as expected by the department; 
(b) be “ streamlined” ; that is, they should 
be given undergraduate assignments that 
are appropriate to their skills and 
interests; (c) undergo upgrading of their 
teaching skills or (d) be dropped from the 
undergraduate teaching roster.
Surgeons who are in full-time academic 
positions should develop and constantly 
update a teaching curriculum vitae just as 
they and others have developed a curric­
ulum vitae that lists their scientific activi­
ties. This will serve to remind them of 
their responsibilities in undergraduate 
teaching and also will be an objective 
record of their pedagogic activities, 
knowledge and skills.
Teaching Methods
There are four methods of teaching 
with which most surgeons are involved: 
lectures, large seminars or demonstrations 
(25 or more students), small seminars (10 
or fewer students) and bedside teaching. 
All surgeons must be aware of current 
methods of student evaluation, since the 
method and style of evaluation influences
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the extent and content of what students 
learn.
All four of these teaching methods have 
similar requirements, if they are to be 
effective. There must be conscious 
preplanning, and this includes a list of the 
aims and objectives, an outline to high­
light the content of the teaching session 
(brief notes may be appropriate), a care­
ful selection of a few pertinent examples 
(perhaps using appropriate audiovisual 
techniques) and a time calculation to 
allow for a resume of material presented. 
The best style of presentation (a subject 
in itself) should be chosen. Finally, no 
teaching session should end without some 
form of student and teacher evaluation.
The Lecture
When skilfully planned and performed, 
this can be the best method of teaching. 
However, when not planned seriously and 
correctly, it can be an absolute disaster. 
The lecture is very economical of surgeon 
manpower. It allows the teacher to direct 
both emphasis and content and it allows 
presentation of unforgettable examples. 
The disadvantages of the lecture method 
are that the attention span of students sel­
dom exceeds 15 to 20 minutes; many lec­
tures suffer from too much detail; the 
style of presentation is critical (some lec­
turers are born with good style, many 
develop effective style with care and hard 
work, but a few may never develop the 
skills of personal presentation that lead 
to a good learning experience); and finally 
the lecture is an experience in passive 
learning — usually the students are not 
actively involved mentally in solving a 
problem or bringing the offered facts 
towards some positive conclusion.
Large Seminars or Demonstrations 
(25 Students or More)
The advantages of this method are that 
the students can be actively involved in 
learning, the instructor can direct the 
emphasis of discussion and content and 
there is opportunity for presentation of 
unforgettable examples. However, group 
dynamics are difficult (a group of more 
than 10 people frequently leaves out many 
members as participants); the seminar 
must be repeated several times to take in 
the whole class; the seminar increases sur­
geon manpower requirements which can 
lead to inconsistencies in presentation, 
and students and teachers must be trained 
in the dynamics of seminars.
Small Seminars (10 or Fewer Students)
This method provides an active learn­
ing experience for all students. Group 
dynamics are simpler and the instructor 
has much greater personal contact with 
individual students. Also there is oppor­
tunity for instant feedback. The disadvan­
tages of small seminars are that they must 
be repeated many times, so surgeon man­
power is greatly increased; complicated 
meeting-space arrangements must be 
made and usually more than one instruc­
tor is involved, leading to even greater 
inconsistencies in content and presen­
tation.
When students and surgeons are 
trained and comfortable with this 
method, students usually prefer this 
experience.
Bedside Teaching (Five or Fewer 
Students)
The major advantage with this type of 
teaching is that this is the Socratic method 
by which most surgeons have learned 
their clinical skills. Therefore, familiar­
ity allows the instructor to be at ease. 
These small-group sessions have all the 
advantages of the small seminars with the 
added advantage of a “ hands-on” 
experience for the student. The major dis­
advantage is the tremendous surgeon time 
required to teach large classes. All the 
other disadvantages of small seminars 
apply with the addition that clinical sur­
geons frequently have difficulty remem­
bering the level o f student or instruction 
that is needed — the emphasis when 
teaching junior students how to perform 
clinical skills is very different from that 
when discussing patient management with 
a group of clinical clerks.
Training of Surgeons as Teachers
Few physicians are born with the skills 
necessary to give quality teaching to all 
levels of medical students. Therefore, 
improved undergraduate teaching re­
quires that the instructors be educated in 
teaching methods and skills. These teach­
ing sessions for surgeons can be held out­
side or within the university or depart­
ment. They can include professional 
educators or surgeons who have had 
specific training. An essential component 
is the evaluation of each surgeon’s teach­
ing efforts to stimulate improvement in 
areas where teaching skills may not have 
been developed.
There are many different forms of 
external training. Some universities have 
held training courses, seeking attendance 
by interested physicians and surgeons 
from both inside and outside that partic­
ular university. There are national and 
international societies, such as the Associ­
ation for Surgical Education, whose sole 
purpose is to improve teaching and 
promulgate better teaching methods. Sur­
geons can learn these methods by attend­
ing meetings of such societies or courses 
or workshops arranged specifically for 
that purpose.
Internal training, within the parent
university, may take place within the 
faculty of medicine or another faculty. It 
may take the form of courses or work­
shops held annually. Universities, facul­
ties or departments may have professional 
educators. These may be physicians or 
graduates of education faculties. Such 
people can be an invaluable resource in 
organizing courses and workshops, giv­
ing personal assistance, and for individual 
teacher evaluation. Also, they frequently 
have skills in methods of audiovisual 
presentation that can be valuable to sur­
geon teachers. In many circumstances, the 
use of videotape to play back an instruc­
tor’s teaching efforts or time taken to play 
various roles in a seminar situation can 
be valuable aids in training surgeons for 
their role as teachers. Again, evaluation 
of teachers when done objectively and in 
the right atmosphere is an important 
teaching method.
Not to be forgotten is the acquisition 
of knowledge and skills by every teacher 
in methods of student evaluation. Evalu­
ation by multiple-choice questions, short 
answers or oral examinations will only be 
adequate if the teacher-evaluator under­
stands their nature, scope and limitations. 
In essence, the format of methods used 
for student evaluation has a very strong 
influence on the style by which students 
will study and learn; for example, they 
will “ cram” facts and practise “ wise 
guessing” for multiple-choice questions 
rather than learn principles which will 
have to be put into practice to “ manage 
a patient” for a short-answer test or oral 
examination.
Conclusions
Development of surgeons as effective 
undergraduate teachers requires three 
components.
• That the department recognizes the 
value of good teaching and creates a 
milieu in which excellence in teaching is 
encouraged.
• That all teachers understand the 
methods they will be using to teach stu­
dents and take the time to prepare teach­
ing assignments appropriately.
• That unless surgeons take the time to 
obtain training in the skills necessary for 
effective teaching, and constantly  
upgrade these skills, the role of depart­
ments of surgery in undergraduate edu­
cation will never advance.
Lastly, a successful teaching session in 
which the instructor has seen a group of 
students understand a problem and learn 
to apply that understanding in the solu­
tion of other problems that they will meet 
daily as clinical physicians, is every bit as 
rewarding (and perhaps much more 
important for the future) as experiencing 
a patient’s smooth recovery following 
successful surgery.
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Fatal, Overwhelming Sepsis After Splenectomy 
in the Community Hospital
Charts of all patients who underwent 
splenectomy between 1965 and 1981 at 
the Orillia Soldiers' Memorial Hospital 
were reviewed. At the end of 1983, the 
patient, relatives or family physician 
were contacted for follow-up. Eighty 
spleens were removed, 36 for medical 
reasons, 30 for trauma and 14 because 
of iatrogenic injury. Of the patients fol­
lowed up, 51 were alive and 13 had 
died. Three died in the postoperative 
period and seven died of unrelated 
causes. Three patients died of over­
whelming sepsis, 1, 3 and 7 years after 
splenectomy. If the three postoperative 
deaths are excluded and it is assumed 
none of the 16 untraced patients died of 
overwhelming sepsis, the incidence of 
death from this cause was 3.9%.
Les dossiers medicaux de tous les 
patients qui subirent une splenectomie 
au Orillia Soldier's Memorial Hospital 
entre 1965 et 1981 ont ete passes en 
revue. Puis, a la fin de 1983, on est 
entre en relation avec les patients, leurs 
proches ou leur medecin de famille pour 
fins de controle.
Quatre-vingt rates avaient 6te enle- 
vees, 36 pour des raisons medicales,
30 a cause d'un traumatisme et 14 pour 
lesions iatrogenes. De tous les patients 
pour qui un controle fut possible,
51 vivaient encore et 13 etaient deci­
des. Trois patients ont succombe dans la 
periode postoperatoire et sept sont morts 
de causes n'ayant aucun rapport avec la
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splenectomie. Trois patients sont morts 
d'infection fulgurante, respectivement 
1, 3 et 7 ans apres la splenectomie. A 
I'exclusion des trois deces postopera- 
toires, et en supposant qu'aucun des 
16 patients qui ne purent etre retraces 
ne soit mort d’infection fulgurante, la 
frequence des deces attribuables a cette 
cause de fut de 3.9%.
In 1678, Nicholaus Matthias, town sur­
geon of Colberg, carried out the first 
known splenectomy for trauma. He 
reported that the patient was well 6 years 
later. For centuries, splenectomy was con­
sidered an innocuous procedure with 
obvious salutary results. The first warn­
ing that the spleen may have an impor­
tant and irreplaceable function came in 
1919 when Morris and Bullock1 reported 
that splenectomized rats had a higher 
mortality from plague than their normal 
counterparts. In 1952, the first case 
reports of death from sepsis following 
splenectomy in children appeared,2 and 
by 1973 this was a recognized phenome­
non in children, associated with a mor­
tality of 2.5%.3 The first reports of simi­
lar phenomena in adults appeared in 
19774 and by 1981 it was well recognized 
that both groups shared a reported mor­
tality of 2.4% .5 By comparison, Miller 
and associates6 studied 1000 normal 
families for 5 years and found an overall 
serious sepsis rate of 0.1% with no 
deaths. Robinette and Fraumeni7 com­
pared 740 splenectomized veterans to 
similar nonsplenectomized counterparts 
and found six instances of fatal pneumo­
nia in the splenectomized group but none 
in the control group.
Evidence is beginning to accumulate 
that splenectomy places the patient at 
increased risk of death from overwhelm­
ing sepsis. The present study was under­
taken to document the incidence of such 
death in a community hospital, to com­
pare this incidence to that reported, to 
add this epidemiologic data to the litera­
ture and to examine whether only immu­
nocompromised patients were at risk or
whether “ normal” patients were also 
affected by splenectomy.
Patients and Methods
From the Department of Pathology of 
the Orillia Soldiers’ Memorial Hospital, 
we retrieved the charts of all patients who 
had undergone splenectomy from Jan. 1, 
1965 to Dec. 31, 1981. Splenectomy was 
considered medical when it was carried 
out electively in the absence of injury to 
the spleen. Splenectomy for splenic injury 
was considered surgical; injury caused by 
preoperative trauma was classified as 
traumatic, whereas injury to the spleen 
caused by inadvertent misadventure dur­
ing the course of abdominal surgery was 
classified as iatrogenic. Arbitrarily, we 
decided to include in the iatrogenic group 
those spleens removed as part of a 
planned procedure unrelated to the spleen 
(splenectomy concomitant with total pan­
createctomy or total gastrectomy). An 
attempt was made to follow up all 
patients to the end of 1983. Telephone, 
mail and the insuring agent were used to 
trace and contact the patient, the family 
or family doctor to ascertain the patient’s 
status. The cause of death was reviewed 
from a transcript of available records of 
those reported as dead.
Findings
During the 17 years under study 80 
splenectomies were carried out at the Oril­
lia Soldiers’ Memorial Hospital in 
patients 17 to 82 years old; 36 splenecto­
mies were for medical and 44 for surgi­
cal reasons. Of the latter group, 30 were 
for traumatic injuries and 14 iatrogenic 
(Table I). Follow-up revealed that 51 
patients were alive at the end of 1983. Six­
teen patients could not be traced. Thir­
teen patients had died since their splenec­
tomy. Three died in the immediate 
postoperative period of complications of 
their injury or associated operation; .of 
the other 10 who died, 3 died of over­
whelming sepsis (Table II). Six of the 13
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deaths occurred in other institutions. 
Excluding the three patients who died in 
the postoperative period, the minimal 
mortality from overwhelming sepsis fol­
lowing splenectomy in this review was 
3.9%. Death from overwhelming sepsis 
occurred once in each of the three 
categories, medical, traumatic and iatro­
genic, 1, 3 and 7 years after splenectomy. 
Pneumococcus was the infecting organ­
ism in each case. The following brief 
reports outline the clinical findings in 
patients in the series who died of sepsis 
or whose death was associated with infec­
tion. The case numbers refer to those in 
Table II.
Case Reports
Death From Overwhelming Sepsis 
Case 3.—A 79-year-old man underwent 
splenectomy in 1980 as the result of splenic rup­
ture from a motor vehicle accident. In 1983 he 
was admitted to another hospital with non­
specific symptoms. A rapid downhill course 
ensued; he died within 48 hours of admission. 
No specific diagnosis was made. Autopsy rev­
ealed bilateral pneumococcal pneumonia.
Case 9. —A 59-year-old woman underwent 
hiatal hernia repair in 1973. Inadvertent splenic 
injury led to a concomitant splenectomy. In 
1980 she came to the emergency department 
complaining of nausea and headache. Apart 
from a temperature of 37.9°C, no specific ab­
normalities were noted. She was treated symp­
tomatically and released. Eight hours later she 
was brought back dead. Autopsy showed 
extensive bilateral pneumonia and bilateral 
adrenal hemorrhage. Blood cultures grew 
Streptococcus pneumoniae.
Case 13.—A 23-year-old woman underwent 
elective splenectomy in 1980 for idiopathic 
thrombocytopenic purpura, unresponsive to 
medical management. In 1981 she was admit­
ted to another hospital with assumed urinary 
tract infection during pregnancy. Because of 
poor response to treatment, she was referred 
to a tertiary care centre where she was deli­
vered. Pneumonia was diagnosed and she died
of septic shock and pneumonia, confirmed by 
autopsy.
Infection Contributing to Death
Case 2.—A 21-year-old man underwent 
splenectomy, repair of a ruptured stomach and 
bilateral ruptured diaphragm because of 
trauma. Extensive irrigation and drainage of 
the contaminated abdomen and both chest 
cavities were carried out. Despite large doses 
of broad-spectrum antibiotics, he became sep­
tic 24 hours after operation; control of the sep­
sis was impossible. He was transferred to a ter­
tiary care centre where a subsequent operation 
for drainage of the abdominal and thoracic 
cavities was carried out. Body wall infection 
ensued and debridement was carried out. Nine 
days after injury he died in septic shock from 
sequelae of uncontrolled sepsis.
Case 7.—A 78-year-old woman underwent 
esophagogastrectomy and splenectomy for 
proximal gastric carcinoma. Histologic exami­
nation showed multicentric cancer with 
microscopic cancer at the resection line. Four 
months postoperatively, she underwent exci­
sion of the remaining stomach and pouch for­
mation. She did well for the first 48 hours 
postoperatively and then deteriorated rapidly 
with acidosis, oliguria and hypotension and 
died within 2 hours of the onset of symptoms. 
Autopsy revealed suppurative pancreatitis as 
well as postoperative atelectasis and minor 
pneumonia. No cultures were obtained.
Case 8.—A 21-year-old retarded woman 
underwent total gastrectomy and splenectomy 
because of volvulus of the stomach with infarc­
tion of both stomach and spleen. Subsequently, 
a stricture formed at the esophagoduodenal 
anastomosis, she failed to thrive and lost 
weight. Although dilatations were effective, she 
continued to regurgitate and died of aspiration 
pneumonia before corrective procedures could 
be carried out.
Case 12.—A 68-year-old man underwent 
splenectomy for idiopathic thrombocytopenic 
purpura. Three years later he was hospitalized 
at a tertiary care centre with small-bowel 
obstruction due to adhesions. The bowel per­
forated and after a difficult postoperative 
course he died.
T a b le  I I — C lin ic a l D a ta  on  P a t ie n t s  W h o  D ie d  A f t e r  S p le n e c to m y
S u rg ic a l in d ic a t io n s
G ro u p
T r a u m a t ic ,  c a s e  n o . -  
c a u s e /t im e lc a u s e  o f  d e a th
Ia t r o g e n ic ,
c a s e  n o . —  c a u s e /t im e lc a u s e  o f  d e a th
M e d ic a l  in d ic a t io n s , c a s e  n o . -  
c a u s e /t im e lc a u s e  o f  d e a th
Im m e d ia t e
p o s to p
1 —  M V A . D ie d  5  d p o s to p  o f  
a s s o c ia te d  in ju r ie s
2  —  M V A . D ie d  9  d  p o s to p  o f  
s e p s is
4  — T o t a l  p a n c r e a t e c to m y . D ie d  9  d p o s to p .  
S e q u e la e  o f  h e m o r rh a g e
S u b s e q u e n t ,
u n r e la te d
d e a th
5  —  LH  f o r  c a n c e r .  D ie d  2  y r  p o s to p  o f  m e ta s -  
ta s e s
6  -  LH  f o r  c a n c e r .  D ie d  4  y r  p o s to p , C V A
7  —  P ro x im a l g a s tr ic  c a n c e r . E s o p h a g o g a s tre c to m y  
a n d  s p le n e c to m y . E x c is io n  o f  re m a in in g  s to m a c h .  
D ie d  4  m o  p o s to p  o f  s u p p u ra t iv e  p a n c r e a t i t is
8  -  T o ta l  g a s tr e c t o m y  a n d  s p le n e c to m y  fo r  in f a r c ­
t io n  o f  s to m a c h  a n d  s p le e n . D ie d  2  V i  y r  p o s to p  
o f  a s p ir a t io n  p n e u m o n ia
1 0  -  H e m a c h r o m a to s is  a n d  H y p e r­
s p le n is m . D ie d  4  y r  p o s to p  o f  
h e a r t  f a i lu r e
1 1  —  R e t ic u lu m  c e ll s a r c o m a .
D ie d  9  m o  p o s to p  o f  s a rc o m a
1 2  —  IT P .  D ie d  3  y r  p o s to p  o f  
b o w e l p e r fo r a t io n  a f t e r  s m a ll-  
b o w e l  o b s t r u c t io n  d u e  to  
a d h e s io n s
O v e r w h e lm in g
s e p s is
3  —  M V A . D ie d  3  y r  p o s to p  
o f  p n e u m o n ia
9  -  H ia ta l  h e rn ia  re p a ir .  D ie d  7  y r  p o s to p  o f  
p n e u m o n ia
1 3  —  IT P .  D ie d  1 y r  p o s to p  o f  
p n e u m o n ia
M V A  *  m o to r  v e h ic le  a c c id e n t ,  L H  -  le f t  h e m ic o le c to m y , C V A  -  c e r e b r o v a s c u la r  a c c id e n t ,  IT P  -  id io p a th ic  th r o m b o c y to p e n ic  p u rp u ra .
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Discussion
This study confirms that overwhelming 
sepsis after splenectomy is a real, lethal 
entity in the adult population. The mini­
mum mortality is unexpectedly high at 
3.9%. Death is one of the leading reasons 
for inability to trace patients in such ser­
ies; there may be other patients among 
our 16 lost to follow-up who have died 
of overwhelming sepsis. Although it is 
reported that most deaths from this cause 
occur within the first 2 years after splenec­
tomy, only one of our patients died dur­
ing this time. The longest interval was 7 
years; death has been reported 25 years 
after splenectomy. Thus, it is quite pos­
sible that continued follow-up of the sur­
vivors may yield more deaths in the 
future. At the conclusion of our study, 
all patients, families or family doctors 
were warned of this hazard so that the 
patients could be immunized or receive 
antibiotic protection, or both. Since these
protective measures are now becoming 
routine, the incidence of overwhelming 
sepsis following splenectomy may be 
markedly altered in the future.
This study does not clearly exclude the 
contribution of an immunocompromised 
state to death from overwhelming sepsis 
after splenectomy. The immune response 
becomes depressed with advancing age. 
Patient no. 3 was 83 years old at the time 
of death, but patient no. 9 was only 66 
years old. Patient no. 13 was 24 years old 
and suffered from idiopathic throm­
bocytopenic purpura, a condition not 
generally associated with a depressed 
immune response. Although she had been 
treated with steroids, which suppress the 
immune response, the drugs had been 
withdrawn more than 1 year before her 
death. Thus, we believe that healthy 
patients as well as the immunocom­
promised are at risk of overwhelming sep­
sis after splenectomy.
In view of the unexpectedly high mor­
tality from overwhelming sepsis, we 
believe that if conditions permit, efforts 
to conserve traumatically injured spleens 
should be encouraged, even in the smaller 
community hospital.
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Management of Pancreatic Trauma
Between 1974 and 1984, 25 patients 
with pancreatic trauma were seen at 
three Regina hospitals. Eighteen had 
blunt injuries and 7 penetrating injuries. 
The mean injury severity score was 37 
and the mean age 24.5 years.
Management was nonoperative in six 
patients. Of the 19 treated surgically, 14 
underwent laparotomy and drainage, 2 
laparotomy without drainage and 3 pan­
creatic resection.
Complications related to pancreatic 
injury occurred in 11 patients. One 
patient died.
The results of this series suggest that 
the majority of patients with pancreatic 
injuries can be treated by laparotomy 
and drainage with a low mortality, but 
the complication rate is high. In select 
patients, visualization of the pancreatic
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duct may allow the surgeon to perform 
definitive surgical management at the ini­
tial procedure.
Entre 1974 et 1984, 25 victimes de 
traumatisme pancreatique ont ete vus 
dans trois hopitaux de Regina. Dix-huit 
patients avaient subi des contusions 
alors que 7 presentaient des plaies. La 
cote moyenne de gravite des blessures 
etait de 37 et I'age moyen des patients 
etait de 24.5 ans.
Six patients ont recu un traitement 
non chirurgical. Des 19 operes, 14 ont 
subi une laparotomie avec drainage,
2 une laparotomie sans drainage et 3 une 
resection pancreatique.
Des complications des lesions pancrea- 
tiques sont survenues chez 11 patients. 
Un patient est decede.
Dans ce groupe, les resultats indiquent 
que la majorite des victimes de blessures 
pancreatiques peuvent etre traitees par 
laparotomie avec drainage. La mortalite 
est faible mais le taux de complications 
est eleve. Chez des patients choisis, la 
mise en evidence du canal pancreatique 
peut permettre au chirurgien d'effectuer 
une reparation definitive des I'interven- 
tion initiale.
This paper retrospectively studies 25 cases 
of pancreatic trauma seen at three Regina
hospitals between 1974 and 1984. The 
objective was to review patient manage­
ment and to identify areas for improve­
ment.
Patients were included if they sustained 
blunt or penetrating trauma to the abdo­
men. Pancreatic injury must have been 
identified by radiologic studies, intraoper- 
atively or at autopsy, or by clinica, - 1 
dence of pancreatitis. Patients were also 
included if they had complications related 
to pancreatic trauma which was unrecog­
nized initially.
Patients
The 25 patients (18 men, 7 women) had 
a mean age of 24.5 years. Eighteen 
suffered blunt trauma and 7 penetrating 
trauma. The mean injury severity score 
was 37. Twelve patients were in shock at 
the time of admission.
Findings
Diagnosis
The diagnosis of pancreatic trauma was 
made by laparotomy in 18 patients, a per­
sistent elevation of the serum amylase 
level and a clinical course of post- 
traumatic pancreatitis in 1, by endoscopic 
retrograde cholangiopancreatography 
(ERCP) in 3 and at autopsy in 1. In two
VOLUME 28, NO. 4, JU LY 1985 /  THE CANADIAN JOURNAL OF SURGERY 359
cases, other radiologic studies (ultra­
sonography, computerized tomography, 
angiography) were used.
Distribution
The injuries to the pancreas were dis­
tributed as follows: body (seven patients), 
head (five), tail (four) and neck (three). 
In six patients, more than one region was 
involved; they included two patients 
whose entire pancreas was traumatized 
(Fig. 1). In blunt trauma, the most com­
monly injured region of the pancreas was 
the body, with the remainder of injuries 
being evenly distributed to the other 
regions. Penetrating trauma was evenly 
distributed to all regions of the pancreas.
Grading
Our patients in this survey were graded
FIG. 1—Distribution of traumatic injuries 
to pancreas.
Table 1—Classification of 
Pancreatic Injuries
Type of injury 1
Grade
2 3
Penetrating 4 1 2
Blunt 9 8 1
according to the classification of North- 
rup and Simmons' as follows: grade 1 — 
minimal pancreatic injury that requires 
simple drainage, grade 2 — significant 
pancreatic injury with ductal involvement 
and grade 3 — combined pancreatic and 
duodenal injuries (Table I).
Associated Injuries
For blunt injuries, 50% of the patients 
suffered a significant thoracic injury such 
as flail chest or pulmonary contusion 
(Table 11); 25% also suffered a diaphrag­
matic rupture. Three patients had major 
vascular injuries; one patient had a por­
tal vein laceration, one patient had com­
bined avulsion of the renal artery, renal 
vein, superior mesenteric artery and 
inferior mesenteric vein, and the third had 
partial avulsion of the celiac axis.
Table II—Associated Injuries in 12 Patients
With Blunt Trauma*
Type of injury No. %
Thoracic 6 50
Liver laceration 5 40
Diaphragmatic rupture 3 25
Major vascular injury 3 25
Duodenal perforation 2 16
Splenic rupture 2 16
Head injury 2 16
Skeletal trauma 2 16
Small-bowel perforation 1 8
Colonic perforation 1 8
Renal trauma 1 8
Mesenteric tear 1 8
*ln 6 patients with delayed presentation, the
associated injuries were not known.
Table Ill-Associated Injuries in
Seven Patients With Penetrating Trauma
Type of injury No. %
Liver laceration 6 86
Stomach perforation 4 57
Renal injury (minor) 3 43
Duodenal perforation 2 28
Major vascular injury 2 28
Splenic laceration 1 14
Skeletal trauma 1 14
For penetrating trauma (Table 111), 
associated injuries included stomach and 
duodenal perforations, major vessel 
injury and splenic laceration. Six patients 
had minor liver lacerations.
Management
Initial management was nonoperative 
in 6 patients and operative in 19. In 14 
patients, laparotomy and drainage of the 
lesser sac were carried out, 2 patients had 
laparotomy without drainage and in 3 the 
pancreas was resected.
Two of the patients initially managed 
by laparotomy and drainage had com­
bined pancreatic and duodenal injuries. 
One patient had an associated duodenal 
diversion procedure for duodenal trauma 
and the other patient with combined 
injury ultimately required a pancreatico- 
jejunostomy for pancreatic fistula.
For the patients who underwent pan­
creatic resection, two had distal pan­
createctomies for blunt trauma and one 
had pancreatoduodenectomy for a 
penetrating injury to the duodenum and 
pancreas.
Complications
In the nonoperative group there were 
six pancreatic complications. Pseudocysts 
developed in four patients, one patient 
had both a pseudocyst and fistula and 
another had post-traumatic pancreatitis. 
Investigation of four patients by ERCP 
showed pancreatic duct abnormalities 
consistent with post-traumatic deformity.
In patients in the operative group who 
had laparotomy with drainage, four pan­
creatic complications occurred — three 
fistulas and one pseudocyst. Investigation 
of three of these patients by ERCP 
showed pancreatic duct abnormalities 
related to previous trauma. There were no 
complications in the two patients who 
underwent laparotomy without drainage. 
In one of the patients who had pancreatic 
resection, a pancreatic abscess developed.
There was one death due to associated 
injuries.
Table IV-Summary of Other Reported Series of Pancreatic Trauma
Series
Review
period
No. of 
patients
Penetrating
trauma
No. of 
deaths
Blunt
trauma
No. of 
deaths
Overall 
mortality, %
Pancreatic 
complications, %
Graham and colleagues2 1 9 4 0 -1 9 7 7 448 348 58 100 15 15.6 45
Jones3 1 9 5 0 -1 9 7 7 300 226 46 74 13 20 10
Stone and colleagues4 1 9 5 1 -1 9 8 1 283 224 29 59 10 13.8 13
Freeark and colleagues5 1 9 5 2 -1 9 6 1 82 59 10 23 5 17
Sheldon and colleagues6 1 9 5 2 -1 9 6 8 56 33 10 23 6 29
Wilson and colleagues7 1 9 5 6 -1 9 6 5 84 45 12 39 15 32
Heitsch and colleagues8 1 9 6 3 -1 9 7 4 100 77 27 23 2 29
White and Benfield9 1 9 6 5 -1 9 7 1 63 36 5 27 1 10 30
Berni and colleagues10 1 9 7 1 -1 9 8 1 54 28 26 9 30
Cogbill and colleagues11 1 9 7 9 -1 9 8 2 44 29 _ 15 _ 18 44
Present series 1 9 7 4 -1 9 8 4 25 7 0 18 1 4 48
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None of the other 24 patients had sig­
nificant sequelae.
Discussion
The results of this series are compara­
ble to those of other reported series with 
regard to morbidity and mortality (Table 
IV211). A lower proportion of penetrat­
ing injuries and a higher proportion of 
blunt injuries were seen, which reflects the 
lower frequency of violent crimes and a 
higher frequency of industrial and motor 
vehicle accidents in our area. Twenty-four 
percent (6 of 25) of patients were initially 
managed nonoperatively and 76% (19 of 
25) were managed operatively.
Laparotomy in traumatized patients is 
generally undertaken because of unex­
plained hypotension, an acute abdomen 
or a positive peritoneal lavage. Because 
of the inherent difficulties in determining 
the presence of pancreatic injury preoper- 
atively (especially a solitary pancreatic 
injury12), the diagnosis is frequently 
made during surgery, which is indicated 
by injury to other organs.3,4,12 This was 
the case in 18 of the 25 patients reviewed 
in this series.
Multiple-organ injury is frequently 
associated with pancreatic injury.2'4,12 
The nature and extent of associated inju­
ries affects not only the prognosis,2'4,12 
but also the choice of surgical procedure 
used in treating the pancreatic injury.
The majority of patients with pan­
creatic injuries treated surgically in this 
series underwent only drainage of the 
lesser sac (14 of 19 patients). Several of 
these injuries were severe (four grade 2, 
two grade 3) and although the pancreatic 
complication rate was high, the overall 
mortality was low (4%). In view of this 
low mortality, for those patients whose 
general condition is unstable, adequate 
drainage of the lesser sac is an acceptable 
alternative in treating a pancreatic injury, 
particularly when more difficult and time- 
consuming procedures might jeopardize 
the patient’s life.
Berni and associates10 noted a reduc­
tion in pancreatic complications (fistula, 
abscess, pseudocyst, pancreatitis) from 
55% to 15% after the routine intraoper­
ative use of pancreatography was insti­
tuted. No postoperative deaths were 
reported during that period. These results 
are attributed to definitive surgical 
management at the initial laparotomy, 
which ductal evaluation allows the sur­
geon to perform.
In our series, there were major pan­
creatic complications in 48% overall and 
in 27% (4 of 14) of patients who under­
went laparotomy and drainage of the 
lesser sac. In three of the latter cases, 
delayed ERCP showed pancreatic duct 
disruption (in one case ERCP was not 
performed). We believe, therefore, that
in selected cases if the pancreatic injury 
is strongly suspected and if the patient is 
hemodynamically stable, intraoperative 
pancreatography may aid the surgeon in 
his choice of surgical procedure and 
thereby improve the patient’s outcome.
Occasionally, there are cases in which 
a delayed diagnosis of pancreatic injury 
is entertained.13,14 The patient may have 
suffered a solitary injury to the pancreas 
caused, for example, by a bicycle handle­
bar. The patient may present with con­
tinuing abdominal pain, persistent eleva­
tion of the serum amylase level or a 
pseudocyst. Evaluation of the pancreatic 
duct by ERCP early in the post-traumatic 
period may demonstrate ductal disrup­
tion, which would be a clear indication 
for surgical intervention.
Conclusions
This series has shown that the majority 
of patients with pancreatic trauma can be 
managed by pancreatic drainage with a 
low mortality. However, in accepting 
drainage as the initial surgical procedure, 
the surgeon must accept a high rate of 
pancreatic complications. In select 
patients, major ductal disruption can be 
identified at the initial operation, allow­
ing definitive surgery at that time.
A delay in diagnosis of major pan­
creatic injury leads to a high rate of pan­
creatic complications.
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SESAP IV Critique
ITEM 12
Barrett’s esophagus should be suspected in patients with strictures of the mid­
portion of the esophagus. However, the stricture is seldom in the upper third 
of the esophagus or above the level of the arch of the aorta. It occurs at the 
junction of squamous and columnar epithelium. Esophagitis is present at the 
level of the stricture. A Barrett’s ulcer, which is occasionally seen, occurs just 
below the squamocolumnar junction in the columnar-lined segment of the 
esophagus. A sliding esophageal hiatus hernia is present and believed to be part 
of the etiology. Acid peptic reflux, esophagitis, and a gradual replacement of 
the denuded squamous-lined esophagus by rapidly growing gastric mucosa are 
noted. The risk of malignancy in Barrett’s esophagus has been reported to range 
from 8% to 26%. ,— ,
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Prescribing Information
ZANTAC® INJECTION (ranitidine hydrochloride)
PHARMACOLOGICAL CLASSIFICATION
Histamine H2-receptor antagonist
ACTION
Ranitidine is a selective antagonist of histamine at gastric H2-receptor sites. Thus 
ranitidine inhibits both basal gastric secretions and gastric acid secretion induced 
by histamine, pentagastrin and other secretagogues. On a weight basis, ranitidine is 
between 4 and 9 times more potent than cimetidine. Inhibition of gastric acid secre­
tion has been observed following intravenous, intraduodenal and oral admin­
istration of ranitidine and it is dose related, a maximum response being achieved at 
an oral dose of 150 mg.
Pepsin secretion is also inhibited but secretion of gastric mucus is not affected. 
Ranitidine does not alter the secretion of bicarbonate or enzymes from the pancreas 
in response to secretin and pancreozymin.
Ranitidine is rapidly absorbed after oral administration, peak plasma concentra­
tions being achieved within 2 to 3 hours. These plasma concentrations are not 
significantly influenced by the presence of food in the stomach at the time of the 
oral administration nor by regular doses of antacids.
Bioavailability of ranitidine administered orally is approximately 50%. Serum 
protein binding of ranitidine in man is in the range of 10% to 19%. The elimina­
tion half-life is approximately 3 hours. The principal route of excretion is the urine 
(40% recovery of free and metabolised drug in 24 hours).
Intramuscular ranitidine is fully bioavailable in comparison to intravenous 
ranitidine. The median elimination half-life of ranitidine injection 50 mg, adminis­
tered intravenously or intramuscularly was found to be 140 minutes (range 120 to 
160 minutes.) The half-life of ranitidine in patients with renal dysfunction is 
prolonged. However, in a study of 27 patients with varying degrees of renal impair­
ment therapeutic plasma levels of ranitidine were shown to be achieved without 
risk of drug accumulation, using half the normal dose of ranitidine in patients with 
plasma creatinine concentration greater than 300 ^mols/litre.
There is a significant linear correlation between the dose administered and the 
inhibitory effect upon gastric acid secretion for doses up to 150 mg orally.
A plasma ranitidine concentration of 50 ng/mL has an inhibitory effect upon stimu­
lated gastric acid secretion of approximately 50%. Estimates of the ICS0 range from 
36 to 94 ng/mL. Following the administration of 150 mg ranitidine orally, plasma 
concentrations in excess of this lasted for more than 8 hours and after 12 hours the 
plasma concentrations were sufficiently high to have a significant inhibitory effect 
upon gastric acid secretion. In patients with duodenal ulcer, 150 mg ranitidine 
given by mouth every 12 hours significantly reduced mean 24 hour hydrogen ion 
activity by 69% and nocturnal gastric acid output by 90%.
Following intramuscular injection of 50 mg ranitidine, plasma concentrations 
in excess of 100 ng/mL were achieved within five minutes of administration and 
remained above this level for 4 to 6 hours.
Intravenous infusion of ranitidine in seriously ill patients at a rate of
0.125 mg/kg/hour produced a rise of intragastric pH between 5.6 and 7.0 after two 
hours and maintained this level over the test period. The volume of gastric secre­
tion was reduced by more than 55%. Doubling the infusion rate to 
0.25 mg/kg/hour produced no further increases in gastric acid inhibition.
A single 50 mg intravenous bolus dose of ranitidine produced significant acid 
inhibition 8 to 9 hours after administration. When 13 seriously ill patients with two 
or more risk factors (shock, sepsis, respiratory failure, jaundice, renal insufficiency 
and peritonitis) were treated with a 50 mg intravenous bolus dose of ranitidine 
followed by a continuous infusion of 0.2 mg/kg/hour the number of‘at risk’ days 
when gastric pH was less than 3.5 on three consecutive four-hourly aliquots, was 
approximately half that for placebo treated patients.
Furthermore, in respect of both 24 hour acidity and nocturnal acid output, 
ranitidine, 150 mg twice daily was superior to cimetidine 200 mg three times daily 
and 400 mg at night (P <0.001 and <0.05, respectively).
Ranitidine injection is well tolerated following intravenous administration at 
dose levels of up to 100 mg four times daily for ten days. These levels are in excess 
of those recommended for normal clinical use.
Treatment of volunteers with ranitidine 150 mg twice daily for 7 days did not 
cause bacterial overgrowth in the stomach.
Volunteers treated with ranitidine have reported no significant gastrointestinal 
or central nervous system side effects; moreover, pulse rate, blood pressure, electro­
cardiogram and electroencephalogram were not significantly affected in man 
following ranitidine administration.
In healthy human volunteers and patients, ranitidine did not influence plasma 
levels of the following hormones: cortisol, testosterone, estrogens, growth 
hormone, follicle stimulating hormone, luteinizing hormone, thyroid stimulating 
hormone, aldosterone or gastrin -  although like cimetidine, ranitidine reduced 
vasopressin output. Treatment for up to 6 weeks with ranitidine 150 mg twice 
daily by mouth did not affect the human hypothalamic-pituitary-testicular-ovarian 
or -adrenal axes.
At 50 mg intravenously, ranitidine had no effect on prolactin levels. Only at 
the 300 mg i.v. dose level was an increase in prolactin secretion, equivalent to that 
produced by 200 mg of cimetidine i.v., observed.
At the high dose levels used in the tolerance studies, minor, transient increases 
in serum alanine transaminase (ALT/SGPT) and aspartate transaminase 
(AST/SGOT) levels were observed in some patients. No other liver function tests 
were abnormal for these subjects and the cause and clinical significance of these 
findings are unknown.
Laboratory studies have shown that ranitidine has negligible affinity for the 
cytochrome P4So-linked hepatic mixed function oxidase system. In man, ranitidine 
treatment has been shown not to impair the metabolism of antipyrine, 
aminopyrine, warfarin or diazepam.
INDICATIONS AND CLINICAL USE
Zantac injection is indicated for the treatment of duodenal ulcer, benign gastric 
ulcer, post-operative ulcer, reflux esophagitis, Zollinger-Ellison syndrome and 
other conditions where reduction of gastric secretion and acid output is desirable. 
These include the prophylaxis of gastrointestinal haemorrhage from stress ulcera­
tion in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients 
with bleeding peptic ulcers and before general anaesthesia in patients considered to 
be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients 
during labour.
For appropriate cases Zantac Tablets are also available.
CONTRAINDICATIONS
There are no known contraindications to the use of Zantac (Ranitidine).
WARNINGS
Gastric ulcer -  Treatment with a histamine H2-antagonist may mask symptoms 
associated with carcinoma of the stomach and therefore may delay diagnosis of the 
condition. Accordingly, where gastric ulcer is suspected the possibility of malig­
nancy should be excluded before therapy with Zantac is instituted.
PRECAUTIONS
Use in pregnancy and nursing mothers - The safety of Zantac in the treatment 
of conditions where a controlled reduction of gastric secretion is required during 
pregnancy has not been established. Reproduction studies performed in rats and 
rabbits have revealed no evidence of impaired fertility or harm to the fetus due to 
Zantac. If the administration of Zantac during pregnancy is considered to be neces­
sary, its use requires that the potential benefits be weighed against possible hazards 
to the patient and to the fetus. However, therapeutic doses of Zantac administered 
to obstetric patients in labour or undergoing caesarean section have been without 
adverse effect on labour, delivery, or subsequent neonatal progress.
Ranitidine is secreted in breast milk in lactating mothers but the clinical 
significance of this has not been fully evaluated.
Use in impaired renal function -  Ranitidine is excreted via the kidney and in 
the presence of severe renal impairment, plasma levels of ranitidine are increased 
and prolonged. Accordingly, in the presence of severe renal impairment, clinicians 
may wish to reduce the oral dose to half of the usual dose taken twice daily, simi­
larly it is recommended that ranitidine injection be administered in doses of 25 mg 
to patients with renal dysfunction.
Children -  Experience with Zantac in children is limited and such use has not been 
fully evaluated in clinical studies. It has however been used successfully in children 
aged 8-18 years in doses up to 150 mg orally twice daily without adverse effect.
ADVERSE REACTIONS
No serious adverse effects have been reported to date in patients treated with 
Zantac. There has been no clinically significant interference with endocrine, 
gonadal or liver function, nor has the drug adversely affected the central nervous 
system even in elderly patients.
The incidence of adverse events among Zantac-treated patients (8.1%) was very 
little greater than that among placebo-treated patients (7.7%). Only five adverse 
events, namely, tiredness (0.38%), headache (0.90%), dizziness (0.32%), diarrhea 
(0.52%) and skin rashes (0.52%) had a greater incidence in the ranitidine treated 
group than in the control group.
A small proportion (1.99%) of patients treated with ranitidine injection experi­
enced itching or burning at the injection site. This reaction was mild and usually 
subsided within 10-15 minutes.
Headache was experienced by 2.54% of patients receiving ranitidine injection. 
The majority of these cases were not thought to be treatment-related. In some in­
stances the headache was thought to be due to over-rapid injection of ranitidine, 
and did not recur on rechallenge with slow intravenous injection. Similarly, some 
patients experienced nausea after rapid injection of the drug, but on subsequent 
occasions with slow-intravenous injection, experienced no ill-effects.
OVERDOSAGE
Zantac is very specific in action and accordingly no particular problems are 
expected following overdosage with the drug. Symptomatic and supportive therapy 
should be given as appropriate. If need be, the drug may be removed from the 
plasma by haemodialysis.
DOSAGE AND ADMINISTRATION
Adults: Zantac injection may be given either as a slow (over one minute) intra­
venous injection of 50 mg, which may be repeated every six to eight hours; or as an 
intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be 
repeated at six to eight hour intervals.
In the prophylaxis of haemorrhage from stress ulceration in seriously ill 
patients or the prophylaxis of recurrent haemorrhage in patients bleeding from 
peptic ulceration, parenteral administration may be continued until oral feeding 
commences. Patients considered to be still at risk may then be treated with Zantac 
tablets 150 mg twice daily.
In patients considered to be at risk of developing acid aspiration syndrome 
Zantac injection 50 mg may be given intramuscularly or by slow intravenous injec­
tion (over one minute) 45-60 minutes before induction of general anaesthesia.
Experience with Zantac in children is limited and it has not been fully eval­
uated in clinical studies -  see PRECAUTIONS.
AVAILABILITY
Zantac Injection is available as 2mL ampoules each containing 50 mg ranitidine 
(as hydrochloride) in 2mL solution for intravenous or intramuscular administra­
tion. Packages of 10 ampoules.
Zantac Tablets are available as white film-coated engraved ZANTAC 150 on 
one face and GLAXO on the other containing 150 mg ranitidine (as the 
hydrochloride), in packs of 28 & 56 tablets.
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Etiology of Choledochal Cysts: Two Instructive Cases
The etiology of choledochal cysts is con­
troversial. The authors report two cases 
which show that type 1 cysts (axial dila­
tation of the common bile duct and 
common hepatic duct) may be caused by 
a biliary web and that some 
choledochoceles (type 3 cyst) may actu­
ally be duodenal duplications (i.e., having 
an outer wall of smooth muscle lined 
with gastrointestinal mucosa and being 
adherent to the gut).
L'etiologie des kystes du choledoque est 
contestee. Les auteurs decrivent deux 
cas qui demontrent que les kystes de 
type 1 (dilatation axiale du choledoque et 
du canal hepatique commun) peuvent 
etre causes par un voile biliaire alors que 
certains choledochoceles (kystes de type 
3) sont possiblement des duplications 
duodenales (c. a d. qu'ils ont une paroi 
exterieure de muscle lisse tapissee par 
une muqueuse gastro-intestinale et qui 
est adherente a I'intestin).
Choledochal cysts are rare, fascinating 
lesions of the biliary tract. There are 
different types, which have been classi­
fied by several authors.1'4 The origin of 
these cysts is controversial. We present 
two case reports that may help in under­
standing the cause of types 1 and 3 
choledochal cysts.1,4
Case Reports
Case 1
A 70-year-old white woman complained of 
epigastric pain lasting for 4 days. The pain radi­
ated to the right upper quadrant and back and 
was associated with nausea and vomiting. She 
had had several similar episodes in the preced-
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ing 3 years. There was no history of jaundice 
or change in the colour of urine or stool.
On physical examination, tenderness with 
guarding was noted in the right upper quad­
rant. There were no other positive physical 
findings. Results of routine liver-function tests 
were normal. Ultrasonography showed a layer 
of “ sludge” in the gallbladder. The common 
bile duct was not dilated and no stones were 
seen in the gallbladder or the common bile 
duct. Oral cholecystography showed a “ non­
functioning” gallbladder on 2 successive days. 
The patient was advised to undergo 
cholecystectomy but refused and was dis­
charged. She did not return for follow-up.
The patient presented 2'h years later with 
sudden onset of epigastric pain which radiated 
around both sides to her back. In the interven­
ing time, she had noticed dark urine on several 
occasions, but she had not been jaundiced.
On physical examination, there was tender­
ness in the right upper quadrant with guard­
ing and, again, no other abnormal physical 
signs. The leukocyte count was 15.2 x 109/L , 
the serum glutamic oxaloacetic transaminase 
level was 144 U /L (normal less than 40 U /L)
and the alkaline phosphatase 195 U /L  (normal 
less than 100 U /L); the total serum bilirubin 
level was 90 /rmol/L, most of which was direct 
reacting. The serum amylase level was normal.
A bdom inal u ltrasonography  showed 
enlarged hilar bile ducts. The gallbladder did 
not contain stones or sludge.
A percutaneous cholangiogram (Figs. 1 and 
2) showed that the common hepatic duct was 
dilated (diameter 2 cm). The duct appeared to 
narrow superiorly towards the bifurcation (Fig. 
1) and to be bulbous close to the junction of 
the common hepatic and common bile ducts. 
The common bile duct appeared normal and 
dye entered the duodenum. The cystic duct was 
long and tortuous. No stones were seen in the 
gallbladder (Fig. 2). The main right and left 
hepatic ducts also appeared normal.
At laparotomy, a small, firm mass was felt 
in the porta hepatis. The common hepatic duct 
was dilated and bulbous at its lower end where 
it joined a common bile duct that looked nor­
mal. When the dilated common hepatic duct 
was opened, it was found to end in a fine 
mucosal web with a central orifice 2 mm in 
diameter that communicated with the common
FIG. 1—Case 1. Percutaneous cholangiogram shows that common hepatic duct is dilated 
at lower end and tapers sharply at upper end. Hepatic ducts appear normal. Cystic duct is tor­
tuous but empties into normal common bile duct. Dye entered duodenum readily.
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bile duct. A sound could not be passed up into 
the left side of the liver from the opened com­
mon hepatic duct. Choledochoscopy showed 
that the left hepatic duct was extremely 
stenotic. What had been taken as the left 
hepatic duct on the percutaneous transhepatic 
cholangiogram was in fact a branch of the right 
hepatic duct that passed to the left. The orifice 
of the true left hepatic duct was stenosed. The 
incision in the common hepatic duct was 
extended upwards through the stenosis and 
many pigmented stones were evacuated from 
the left hepatic duct. An opening was then 
made in the left lateral hepatic duct in the 
lateral segment of the left hepatic lobe after 
its position had been located with a sound 
introduced through the common duct. Many 
more stones were removed through the second 
incision. A T tube was placed in the left lateral 
hepatic duct and a Roux-en-Y choledochoje- 
junostomy was performed, anastomosing the 
jejunum to the left hepatic duct, the area of 
stricture and the common hepatic duct (Fig. 
3). The gallbladder was also removed. It con­
tained no stones.
The patient’s postoperative course was 
uncomplicated. Two years after the operation, 
she was asymptomatic and liver-function tests 
gave normal results.
Comment
The filmy partition at the junction of the 
common hepatic and common bile ducts com­
pletely separated the lumina of the two struc­
tures except for the small 2-mm opening. This 
had led to moderate dilatation of the common 
hepatic duct but had not obstructed bile 
flow substantially. It is unlikely that this web
would have been discovered if the patient had 
not had symptoms from the intrahepatic stric­
ture and stones.
This case indicates that type 1 cyst may arise 
as a result of a choledochal web or membrane. 
In most of these cases, the web would proba­
bly not be demonstrable because by the time 
it became symptomatic and surgery was indi­
cated, secondary inflammation, ulceration and 
even stone formation could have occurred and 
obscured the original cause. It is impossible to 
be sure of the cause of left hepatic duct stric­
ture and stones, but a reasonable possibility is 
the presence of a second congenital area of nar­
rowing as the initial lesion.
Case 2
A 27-year-old white woman had a history of 
intermittent, crampy, abdominal pain and 
melena present for 1 week. On physical exami­
nation, the right upper quadrant was mildly 
tender and a mass was palpable in that area. 
The hemoglobin level was 46 g/L. Ultrasono­
graphy showed a cystic mass in the right upper 
quadrant. At endoscopy, the gastric antrum 
appeared to be twisted and the pylorus com­
pressed. The duodenum could not be entered. 
No mucosal lesions were seen. An upper gas­
trointestinal series showed that the duodenum 
was dilated with a large mass arising from the 
posteromedial wall and a coiled-spring sign 
typical of small-bowel intussusception (Fig. 4). 
The intussusception later reduced spontane­
ously (Fig. 5). Shortly after admission, an 
arteriogram was performed (Fig. 6).
At operation, the intussusception was found 
to be reduced. The duodenum was enlarged 
and a cystic mass could be palpated through
FIG. 2—Case 1. Later film shows gallbladder filling. “ Point of communication” in dia­
gram indicates site of small opening between common hepatic and common bile ducts found 
at operation, not observation made on film.
FIG. 3—Case 1. Postoperative T-tube cholangiogram. True main left hepatic duct can be 
seen. Dye enters bowel through hepaticojejunostomy. For clarity, connection to bowel is not 
shown on figure.
the duodenal wall. The common bile duct and 
pancreatic duct were cannulated and the medial 
wall of the duodenum was incised over the 
mass, revealing a cystic structure 5 cm in 
diameter (Fig. 7). This structure was incised 
and found also to have a mucosa and contain 
many stones (Fig. 8). There was a small com­
munication (1.5 mm) to the common bile duct, 
which was closed. The duodenal wall overly­
ing the cystic structure was excised with mar­
supialization of the base to the duodenal wall. 
The patient’s postoperative recovery was 
smooth and 6 years later she is free of gastroin­
testinal symptoms; results of liver-function 
tests and upper gastrointestinal series are 
normal.
FIG. 4—Case 2. Upper gastrointestinal ser­
ies. Gastric antrum and pylorus are at upper 
right corner. Duodenum is dilated and shows 
coiled-spring sign.
FIG. 5—Case 2. Later film after reduction 
of intussusception showing intraduodenal mass 
arising from medial wall.
FIG. 6—Case 2. Hepatic arteriogram failed 
to reveal site of hemorrhage but showed avas­
cular area near duodenum.
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Comment
The cyst wall consisted of a well-developed 
mucosal layer of duodenal type epithelium, a 
lamina propria and muscularis mucosae. It also 
contained submucosa and muscularis externa. 
The latter was poorly developed but clearly 
presented using stains for muscle. The speci­
men also contained all layers of the true duode-
FIG. 7—Case 2. At operation, medial wall 
of second part of duodenum can be seen 
stretched over underlying cystic structure. 
Large catheter has been inserted into lumen of 
third part to indicate its position. Small 
catheter enters ampulla.
num which had been excised where it had been 
stretched over the cyst (Fig. 9).
This lesion, commonly referred to as a 
choledochocele, presented with intussusception 
resulting in blood loss over a 1-week period. 
It was an example of a type 3 cyst.
Discussion
Biliary cysts were originally divided 
into three groups by Alonso-Lej and as­
sociates.1 Type 1, an axial dilatation of
FIG. 8—Case 2. Medial wall of duodenum 
and cyst wall have been incised. Cyst was lined 
by mucosa w hich grossly appeared identical to 
duodenal mucosa. Metal sound enters bile duct 
through ampulla and small white catheter is in 
pancreatic duct. Stones contained in cyst are 
shown.
the common bile duct and common 
hepatic duct, is the most common type. 
Type 2 is a saccular dilatation off the side 
of the common bile duct and is less com­
mon. Type 3, the choledochocele, is the 
least common of the three original types. 
Two additional types are now accepted: 
Caroli’s disease is considered to be a type 
of choledochal cyst.3 Todani and 
colleagues4 described a fifth type which 
combines intrahepatic and extrahepatic 
cysts.
Our first patient had the common type 
1 cyst that accounts for approximately 
85% of choledochal cysts.5 Classically, 
the cystic dilatation begins at the level of 
the cystic duct and ends abruptly in the 
lower common bile duct. The proximal 
biliary tree may be slightly dilated but 
usually the intrahepatic ducts are normal. 
The distal common bile duct below the 
abrupt termination of the cyst is usually 
narrow.6 Type 1 cysts may extend into 
the common hepatic duct and, in fact, 
primarily involve this duct, as in our case; 
the common bile duct may be normal dis­
tal to the cyst.5
EPITHELIUM 
AND LAMINA 
PROPRIA
MUSCULARIS
MUCOSAE
MUSCULARIS ___
EXTERNA
------  MUSCULARIS
EXTERNA
SUBMUCOSA
MUSCULARIS
MUCOSAE
EPITHELIUM 
AND LAMINA 
PROPRIA •—
FIG. 9—Case 2. Photomicrograph of duodenal and cyst walls. Note that all layers of intestinal wall are present in cyst wall although 
muscularis externa of cyst wall is rudimentary. Trichome stain for smooth muscle was used. It colours smooth muscle red and fibrous tissue 
green (left, original magnification X 20; right, original magnification X 35).
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The etiology of type 1 cysts is unknown 
but it is reasonable to assume that they 
are due to distal obstruction or a weak­
ness of one section of the wall of the duct, 
or both. Either factor could be congeni­
tal or acquired. Although weakness of the 
wall has been suggested by at least two 
authors,1,2 there is no substantial evi­
dence that this is the case. On the other 
hand, there is evidence that distal obstruc­
tion is important. Ono and colleagues7 
found that the zone of distal narrowing 
often described in cholangiograms from 
patients with type 1 cysts is actually the 
pancreatic duct. The common bile duct 
appears to join the pancreatic duct several 
centimetres proximal to the ampulla.7'9 
This anomalous junction was present in 
58% of adult type 1 cysts. The case 
reported here likewise suggests that type 
1 cysts can be caused by obstruction. To 
our knowledge, this is the first report of 
a web being responsible for this lesion. 
A second similarity to Ono’s observations 
is that the point of obstruction in our case 
was also at the junction of ducts. Ono and 
associates described the obstruction as 
being at the point where the common bile 
duct joins the pancreatic duct. In our 
case, it was where the common bile duct 
bifurcated into the cystic duct and the 
common hepatic duct.
Whether the 42% of type 1 cysts not 
due to the anomalous common bile duct- 
pancreatic duct junction, described by 
Ono and associates, might be due to 
mucosal web in the common bile duct 
would be very difficult to ascertain. Most 
type 1 cysts are causing symptoms when 
they are diagnosed. Inflammation, ulcer­
ation and stone formation secondary to 
obstruction would likely preclude any ac­
curate estimation of the initiating cause, 
if it were a web. Our observation was pos­
sible only because a second, symptomat­
ic lesion was present.
The presence of biliary calculi in con­
genital cysts is not unusual.10 Approxi­
mately 90% of patients older than 30 
years have stones in their cysts. There also 
seems to be an association between biliary 
cysts and intrahepatic calculi, especially 
in the left hepatic duct.9 The treatment 
of type 1 cysts has been reviewed exten­
sively in the literature and will not be 
repeated here. The value of making a 
counter-incision in the left hepatic duct, 
well out into the biliary tree, for intra­
hepatic stones is perhaps worth emphasiz­
ing.11 This maneuver is frequently easy 
and permits backflushing and endoscopy 
of the distal biliary tree, and generally 
facilitates removal of all the stones in this 
difficult situation.
Our second case report brings the num­
ber of choledochoceles reported in the 
world literature to 21. Various names 
have been given to this cystic dilatation 
of the terminal bile duct. Alonso-Lej and 
colleagues1 classified it as a type 3
choledochal cyst, implying that it arises 
from the choledochus. Recently, several 
authors12'15 have questioned the origin of 
this anomaly because of differences in 
epidemiologic findings, clinical presenta­
tion and, most importantly, pathological 
features when compared with other 
biliary cysts. Flanigan5 has pointed out 
that the choledochocele usually occurs in 
older patients than do other biliary cysts. 
Ninety-two percent of all biliary cysts oc­
cur in patients younger than 30 years but 
the mean age for the choledochocele is 32 
years.12'13 The most frequent symptoms 
in type 1 cysts are jaundice 64%, abdomi­
nal mass 58% and pain 55%. However, 
in patients with choledochoceles, abdomi­
nal pain is uniformly present and usually 
associated with nausea and vomiting; 
jaundice has been reported only in 25% 
of cases and in only two cases (9%) was 
there a palpable mass.12'13 Four patients 
had recurrent pancreatitis14 and one 
presented with melena.15 In our case, 
bleeding was associated with a small- 
bowel intussusception, whereas in the 
other patient who presented with this 
symptom, the problem was diffuse inter­
stitial hemorrhage in the cyst wall.14 
There was no hemorrhage in the cyst wall 
in our case. To our knowledge, this is the 
first case in which intussusception was 
associated with a choledochocele.
The are too few cases of choledo­
chocele to be sure of the best method of 
diagnosis. Ultrasonography, upper gas­
trointestinal series, endoscopy and com­
puterized tomography are all used. Arteri­
ography is not usually required and was 
performed in our case as a very early 
investigation because the patient pre­
sented with gastrointestinal bleeding and 
endoscopy did not reveal the cause of the 
hemorrhage. Intravenous cholangiogra­
phy has been used to demonstrate the 
communication between the cyst and the 
biliary tree;13 however, this is an incon­
sistent way to make the diagnosis.12
The major reason for reporting this 
case is to discuss the origin of this type 
o f choledochal cyst. Scholz and 
colleagues13 have pointed out that there 
appear to be two varieties. In one there 
is an axial dilatation along the length of 
the common bile duct within the duodenal 
wall and in the other a saccular dilatation 
off the side of the common bile duct 
within the duodenal wall. Wearn and 
Wiot12 reported on the mucosal histol­
ogy of the choledochocele in 20 cases. If 
our case is included, then 14 of the 20 
were lined by duodenal mucosa, 4 by 
biliary mucosa, 2 by a combination and 
in 2 cases,15 the mucosa was not 
described.
Several theories have been proposed for 
the etiology of these lesions. Wheeler16 
suggested that the cause is similar to that 
of a ureterocele with obstructive balloon­
ing of the intramural segment of the com­
mon bile duct. Sterling17 demonstrated 
four diverticula of the distal common bile 
duct in 17 cadavers. This suggests that it 
may form as a congenital choledochal 
cyst, but involving the intramural segment 
of the common bile duct. Scholz and 
colleagues13 suggested that it was a pul­
sion diverticulum produced by contrac­
tion of the common bile duct and ampul- 
lary components of the sphincter of Oddi. 
Any one of these theories could explain 
the choledochoceles lined with biliary 
mucosa but do not explain the cause of 
cysts lined with duodenal mucosa. Several 
authors12'14'18 have suggested the possi­
bility that the choledochocele is a duo­
denal duplication that, due to pressure or 
some other phenomenon, comes into 
communication with the common bile 
duct. In order to be classified as a dupli­
cation, the cyst should have an outer wall 
of smooth muscle lined with gastrointes­
tinal mucosa and be intimately adherent 
to the gut.19 Wearn and Wiot12 found 
duodenal mucosa on both sides separated 
by fibrous vascular stroma. However, the 
cyst from our patient not only had duo­
denal mucosa but readily identifiable sub­
mucosa and muscularis externa, that is, 
all the layers of the intestinal wall, thus 
qualifying it as a duplication cyst.
It seems that two varieties of chole­
dochoceles exist. One is a choledochal 
cyst described by Alonso-Lej, involving 
the intramural portion of the common 
bile duct. Its origin is unknown and is 
similar to type 1 cysts elsewhere in the 
biliary tree, differing only in that the cyst 
is located in the intramural portion of the 
common bile duct. The other type 
originates as a duodenal duplication and 
develops a fistula to the intramural seg­
ment of the common bile duct.
The treatment of choledochoceles is 
surgical although one case20 has been 
successfully managed endoscopically. Of 
prime importance is that the common bile 
duct and pancreatic ducts are identified 
early and protected. Excision of the 
majority of the cyst wall and overlying 
duodenal mucosa with marsupialization 
of the base seems to be satisfactory.
Conclusions
These two case reports have extended 
our understanding of the genesis of 
choledochal cysts. The first case demon­
strates that a filmy mucosal web in the 
bile duct may act as an obstructing lesion, 
initiating proximal dilatation and type 1 
cysts. The second case indicates that duo­
denal duplications are one possible vari­
ety of choledochocele.
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Surgery for Coronary Artery Disease in Patients 
With Diabetes Mellitus
The results o f surgery fo r occlusive coro­
nary artery disease were studied in 600 
consecutive, unselected patients who 
underw ent aortocoronary bypass grafting 
between Jan. 1, 1977 and Dec. 31, 
1982. Forty (7% ) o f these patients had 
diabetes m ellitus, requiring medication. 
Sixteen o f the 4 0  patients were insulin- 
dependent, the remainder required oral 
hypoglycem ic agents. The frequency of 
previous m yocardial in farction, hyperten­
sion and peripheral vascular disease in 
the groups o f nondiabetic and diabetic 
patients w as 38 %  and 62 .5% , 12%  and 
2 2 .5% , and 10 .5%  and 25%  respec­
tive ly. There was no significant d iffe r­
ence in the rate o f unstable angina, 
triple-vessel disease, emergency surgery, 
le ft ventricu lar dysfunction , myocardial 
in farction perioperatively and hospital 
m orb id ity or m orta lity  in the tw o  groups. 
On coronary angiography, 82%  o f coro­
nary arteries in diabetic patients were 
graded as being small or moderate in 
size (less than 2 mm in diameter); at 
operation, 62%  o f these arteries were 
found to  be 2 mm or more in diameter.
From the Division o f  Cardiovascular and 
Thoracic Surgery, University Hospital, 
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A t a mean fo llow -up  o f 3 .9  years and 
3 .7  years in the nondiabetic and diabetic 
patients respective ly (range from  1 to  6 
years), no s ign ifican t d ifference w as 
noted w ith  regard to  relief o f sym ptom s 
or survival in the tw o  groups. It is con­
cluded th a t d iabetic patients w ith  coro ­
nary artery disease can be offered 
bypass surgery w ith  good short-term  and 
m edium -term  results.
On a etudie les resultats chirurgicaux de 
6 0 0  patients consecutifs. non choisis, 
sou ffran t d 'occ lus ion  des coronaires, qui 
on t subi un pontage aorto-coronarien 
entre le 1er janvier 1977 e t le 31 
decembre 1982. Quarante (7%) malades 
sou ffra ien t de diabete sucre necessitant 
m edication. Seize de ces 4 0  patients 
eta ient insulino-dependants alors que les 
autres prenaient des hypoglycem iants 
oraux. La frequence des in farctus du 
m yocarde precedents, de I'hypertension 
et des maladies vasculaires peripheriques 
pour les patients non diabetiques et 
diabetiques eta ient respectivem ent de 
38%  et 6 2 .5 % , 12%  et 22 .5% , et 
10 .5%  et 25% . On n ’a note aucune 
difference sign ifica tive  entre les deux 
groupes dans le taux d 'angine instable, 
de trip le  occlusion coronarienne, de 
chirurgie d 'urgence, d 'insuffisance ven- 
triculaire gauche, d 'in fa rc tus  peroper- 
atoire et de m orbidite ou m ortalite 
hospitaliere. A  i'angiographie 
coronarienne, 82%  des coronaires des 
patients diabetiques ont ete jugees de
calibre pe tit ou moyen (moins de 2 mm 
de diam&tre) on a decouvert a I'operation 
que 6 2 %  des artferes avaient un diam etre 
de 2 mm  ou plus.
Apres des surveillances m oyennes de 
3 .9  e t 3 .7  annees pour les patients non 
d iabetiques et diabetiques respective­
m ent (avec une dispersion de 1 a 6 ans), 
on n 'a  note aucune d ifference s ign ifica ­
tive  entre  les deux groupes en ce qui a 
tra it au soulagem ent des sym ptom es ou 
a la survie. On conc lu t que le pontage 
aorto-coronarien peut etre o ffe rt au 
pa tien t d iabetique coronarien avec 
I'espo ir de bons resulta ts a cou rt et 
m oyen term e.
The adverse effects of diabetes mellitus 
on the coronary circulation and the 
higher incidence of cardiovascular events 
in diabetic patients have been well docu­
mented.1-8 However, the issue remains 
controversial with some studies5,9-11 dis­
puting the influence of diabetes and its 
duration on the extent of coronary artery 
disease.
The short-term results of coronary 
artery bypass grafting in diabetic patients 
have not supported the skepticism of phy­
sicians referring these patients for sur­
gery.9,11-13 To examine the value of 
myocardial revascularization in diabetic 
patients, we have reviewed our experience 
with coronary artery bypass surgery in 
600 consecutive patients over 6 years.
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Patients and Methods
The study comprised an analysis of 
preoperative, surgical and postoperative 
data of 600 consecutive patients who 
underwent coronary artery bypass graft­
ing for ischemic heart disease between 
Jan. 1, 1977 and Dec. 31, 1982. These 
include all elective and emergency oper­
ations for myocardial revascularization 
only. All operations were performed by 
the same surgical team using a uniform, 
standard technique.
Forty (7%) of these patients (32 men, 
8 women) had adult-onset diabetes mel- 
litus that required medication. A fasting 
blood glucose value of less than 7.8 
mmol/L was considered normal. Routine 
glucose tolerance tests were not per­
formed. Sixteen (40%) of the diabetic pa­
tients were insulin-dependent. Patients 
who had “ diet-controlled diabetes melli- 
tus” and normal blood glucose levels were 
not included in the diabetes group.
In-patient and follow-up information 
was obtained by chart review and patient 
contact. Risk factors and results were 
analysed with the x2 test and Student’s t- 
test using the Minitab Statistical Package 
(Penn State University, Duxbury Press, 
North Scituhee, Mass.) on a DEC system 
10 computer (Digital Equipment Corp., 
Maynard, Mass.). Results of patient sur­
vival are reported by the actuarial 
method. A p value of less than 0.05 was 
considered significant.
Fig. 1 shows the age and sex distribu­
tion of the total group. There was no sig­
nificant difference in the age and sex dis­
tribution between the diabetic and 
nondiabetic patients.
Fig. 2 shows the incidence of risk fac­
tors, known to be of value in predicting 
survival.14 The incidence of previous 
myocardial infarction, judged by resting 
electrocardiographic findings, hyperten-
FIG. 1—Age and sex distribution of 600 
patients studied. White bars = women 
(n = 95), dotted bars = men (n = 505).
sion (blood pressure greater than 140/90 
mm Hg) and peripheral vascular disease 
diagnosed from history and physical ex­
amination, was significantly higher in the 
diabetic patients, p < 0.01, p < 0.05 and 
p < 0.01 respectively. There was no ap­
preciable difference between the two
groups in the incidence of triple-vessel dis­
ease as shown by selective coronary 
angiography, the presence of unstable 
angina and left ventricular dysfunction 
studied by left ventriculography and wall- 
motion studies (i.e., three or more 
hypokinetic or akinetic segments).
FIG. 2—Risk factors in diabetic (hatched bars) and nondiabetic (dotted bars) patients. Ml 
= myocardial infarction, PVD = peripheral vascular disease, LVD = left ventricular dys­
function.
FIG. 3—Number of grafts by sex. White bars = women (n = 95), dotted bars = men 
(n = 505).
Table 1-Hospital Mortality and Morbidity in 
Nondiabetic and Diabetic Patients
Nondiabetics, Diabetics,
no. (%) no. (%>
Perioperative myocardial infarction 21 (3.751 2(5)
Hospital morbidity 42 (7.5) 2(5)
Hospital mortality 21 (3.75) 1 (2.5)
»
<
-t
A
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The number of grafts placed, by sex, 
in the total patient population is shown 
in Fig. 3. The average numbers of grafts 
placed in the nondiabetic (n = 473) and 
diabetic (n = 32) men were 3.2 and 2.4 
respectively (p < 0.05). No significant 
difference was noted in the average num­
bers of grafts placed in women, in the 
nondiabetic (n = 87) and diabetic 
(n = 8) patients (2.6 and 2.8 respec­
tively).
The preoperative coronary angiograms 
of the 40 diabetic patients were studied 
and compared with those of 96 nondia­
betic patients matched for age, sex and 
risk factors. Coronary artery diameter 
was measured in the two groups of 
patients near the middle segment of the 
artery at a site judged suitable for inser­
tion of the bypass graft. The measure­
ment was made by comparison with a 
calibrated measuring grid on the films or 
by comparison with the known luminal 
diameter of the selective coronary injec­
tion catheter on the same film frame. 
Intraoperatively, coronary artery size was 
measured by gently introducing calibrated 
probes into the coronary arteriotomy.
Hospital mortality refers to death 
within 30 days of operation or during the 
same hospital admission. Morbidity 
relates to delay in convalescence or hospi­
tal discharge due to poor pulmonary 
function, persistent atrial arrhythmias, 
wound infection or perioperative 
myocardial infarction.
Results
The incidence of perioperative 
myocardial infarction and hospital mor­
bidity and mortality in the two groups of 
patients is shown in Table I. Wound 
infections occurred in 23 (4.1%) nondia­
betic patients and in 1 (2.5%) diabetic. 
The only hospital death in the diabetes
FIG. 4—Percentage of patients free of angi­
nal symptoms at intervals up to 6 years after 
operation. Circles = nondiabetics, crosses = 
diabetics.
group was a 61-year-old woman with two 
previous myocardial infarctions, severe 
triple-vessel disease and unstable angina. 
She died of left ventricular failure secon­
dary to a perioperative myocardial infarc­
tion and renal failure.
Figs. 4 and 5 show the follow-up results 
with respect to relief of symptoms and 
survival over a period of 6 years (mean, 
3.9 years in nondiabetic patients and 3.7 
years in diabetics). There were no signifi­
cant differences in the two groups of 
patients.
Only 18% of the coronary arteries in 
diabetic patients were found preopera- 
tively to be 2 mm or more in transverse 
diameter. The corresponding figure for 
nondiabetic patients was 61%. Intraoper­
ative measurement showed that 62% of 
the coronary arteries in the diabetic 
patients and 68% in nondiabetics were 2 
mm or more in diameter.
Discussion
Several studies based on patho­
logical1517 and angiographic data5’6,18 
have compared the extent of coronary 
artery disease in diabetic and nondiabetic 
patients. They showed that diabetics had 
more severe coronary artery disease, as 
demonstrated by the prevalence of triple­
vessel involvement, and more diseased 
and occluded coronary arteries per 
patient. Vigorito and associates6 have 
demonstrated more severe compromise of 
left ventricular segmental wall contraction 
and a higher frequency of postinfarction 
left ventricular aneurysms in diabetics. 
This was not related to the extent of coro­
nary artery disease or to the development 
of collaterals and it is unlikely related to 
distal coronary artery disease, because 
Dortimer and associates18 could not 
show that distal coronary artery disease 
is more common in diabetic patients. A 
possible explanation would be the effect 
of an inherent myocardial factor.8’9'19
These angiographic studies supplement 
the epidemiologic data,1,2,10 suggesting
FIG. 5—Actuarial survival in diabetic 
(crosses) and nondiabetic (circles) patients after 
coronary artery bypass grafting.
that diabetes mellitus is an independent 
risk factor for coronary artery disease. As 
a result, physicians have often been skep­
tical about the role of coronary artery 
bypass grafting in these patients.
However, several surgical series9,11,13 
have failed to show a relation between 
diabetes mellitus and the extent of coro­
nary artery disease. Chychota and 
associates13 did show a significantly 
greater mean flow rate through vein grafts 
in nondiabetic patients, 71 mL/min com­
pared with 54 mL/min in diabetics. 
Verska and Walker,9 however, did not 
find any difference in the mean flow rates 
in the two groups, raising doubts about 
any difference in the microcirculation of 
the myocardium between diabetic and 
nondiabetic patients.
The results of coronary artery bypass 
grafting in diabetics have been encourag­
ing.9'11'13 Diabetes mellitus, either alone 
or in combination with other risk factors, 
does not seem to affect graft patency ad­
versely or to influence the progression of 
disease in bypassed arteries.11
In our own series, the number of dia­
betic patients who underwent bypass 
grafting was low (7%) compared with 
that (31%) in the series reported by 
Verska and Walker.9 We also found a 
higher incidence of previous myocardial 
infarction, hypertension and peripheral 
vascular disease in our diabetics. 
However, the severity of coronary artery 
disease as judged by the rate of triple­
vessel involvement was similar in the two 
groups, as was the occurrence of unsta­
ble angina and left ventricular dys­
function.
An interesting finding was the dis­
crepancy between angiographic assess­
ment of vessel diameter and the operative 
findings. Even though only 18% of coro­
nary arteries in diabetic patients were 
graded preoperatively as 2 mm or more 
in diameter (compared with 61% in non­
diabetics), at operation 62% were found 
to be 2 mm or larger in diameter. This 
poor correlation between angiographic 
and operative findings was not found in 
the nondiabetic group. Small calibre 
should not be a specific contraindication 
to coronary artery bypass in diabetic 
patients in view of the likely underestima­
tion of coronary artery diameter. The rea­
son for this discrepancy in artery size is 
unclear. It may, in part, be related to 
underfilling due to slow flow rate in addi­
tion to proximal disease but there was no 
indication at operation of more diffuse 
disease in the diabetic patients.
The incidence perioperatively of 
myocardial infarction, morbidity, includ­
ing wound infection, and mortality was 
similar in both our groups, although 
some9’13'20 have reported more infective 
and other complications in diabetic 
patients.
VOLUME 28, NO. 4, JULY 1985 /  THE CANADIAN JOURNAL OF SURGERY 369
The beneficial role o f surgery in the 
management of coronary artery disease 
is well established.14,21 In diabetic 
patients (including those with juvenile- 
onset diabetes), the results o f coronary 
artery bypass have not been any differ­
ent, at least in the short term.9,11,13,22 In 
our series, with a mean follow-up of 3.9 
years and 3.7 years in nondiabetic and 
diabetic patients respectively (range from 
1 to 6 years), the results o f coronary 
artery bypass, as judged by relief of 
symptoms and survival, have been equally 
encouraging.
Conclusions
Although some risk factors are more 
prominent in diabetic patients, they do 
not adversely affect the outcome of coro­
nary artery bypass grafting. The value of 
coronary angiography in diagnosing 
small-vessel disease is questionable; there 
appears to be a greater discrepancy 
between angiographic and surgical find­
ings in diabetic patients. Patients suffer­
ing from diabetes mellitus can therefore 
be offered coronary revascularization 
with good short-term and medium-term 
results.
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SURGICAL EDUCATION AND SELF-ASSESSM ENT PROGRAM NO. 5
A Standard Pre-Op Procedure for Thousands of Surgeons.
As a surgeon, you face tests of your 
ability every day,., but none are 
more important than the tests you 
undertake yourself.
Thaf s why the American Col lege of 
Surgeons' Surgical Education and 
Self-Assessment Program (SESAP) can 
claim more than 65,000 enrollments 
representing all surgical specialties. 
SESAP V -  The Most Comprehensive 
and Individualized Continuing 
Medical Education Program 
Available to Surgeons.
SESAP V is the result of three years' 
intensive review and research con­
ducted by 47 nationally-recognized 
surgical authorities. The flexible for­
mat provides highly individualized 
self-assessment in 17 major surgical 
categories,
SESAP V reflects the most contem­
porary clinical advances in surgery.
It offers hundreds of probing ques­
tions... and a Syllabus with detailed 
rationales and references for each 
answer.
With an expanded Patient Man­
agement Problem (PMP) section, a 
confidential computer-scoring op­
tion, and individualized assessment 
reports, SESAP V is the most practical 
and comprehensive self-assessment 
program available to surgeons.
A Challenge to Your Analytic Skills.
SESAP V is more than a simple 
exercise in seif-study, More than 400 
multiple-choice items test your ability 
to analyze data as well as identify 
factual information. And each of the 
ten PMPs is designed to test your 
patient management skills rigorously, 
Accompanying this interrogative are
nearly 200 illustrations, X-rays, charts, 
graphs, and diagnostic prints.
A Chance to Compare Your 
Performance with Peers.
SESAP V gives you a chance to 
determine confidentially your stand­
ing among other participating col­
leagues. After you've completed the 
program, you'll receive a compara­
tive scale [The Norm Tables) based 
on the computer-scored perform­
ance of SESAP V participants. You 
may then rank your personal assess­
ment score in relation to other results.
An Invaluable Preparation for 
Recertification.
SESAP V may be especially valu­
able if you are a candidate for 
recertification in general surgery. The 
content of the multiple-choice sec­
tion is quite similar to the recertifica­
tion examination as developed by 
the American Board of Surgery. 
Whether you're a board-certified 
surgeon facing recertification in the 
next three years, a resident, or a 
surgeon who makes an effort to take 
surgical boards voluntarily, SESAP V 
offers an authoritative review.
Credits for Continuing Medical 
Education (CME).
Earning Continuing Medical Edu­
cation credits is always an important 
consideration when determining 
which continuing education program 
to pursue. SESAP V participants who 
complete the entire program earn 
85 credit hours in Category 1 toward 
the Physician's Recognition Award of 
the American Medical Association.
A Positive Experience for You and 
Your Patients.
More than 90% of past SESAP 
participants surveyed said the experi­
ence was "valuable" or "extremely 
valuable" in helping to maintain 
personal standards of surgical excel­
lence. Nearly 80% felt that their 
participation has helped them pro­
vide better care for their patients. 
And virtually all SESAP participants 
said the program has played an 
important role in their personal CME 
agenda.
SESAP V: Keeping You in a Class 
By Yourself.
For more information about SESAP V 
or to enroll, call or write to the 
American College of Surgeons.
Return to:
SESAP V
American College 
of Surgeons
55 East Erie Street 
Chicago, Illinois 60611
Yes, I'd like to learn more about SESAP V. 
Please send me, without obligation or cost, 
a detailed Prospectus.
Address
City/Stcrte/Zip
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Beware of Breast Fibroadenomas in Middle-Aged Women
On first examination of 8512 Quebec 
area women from 40 to 59 years of age 
who participated in the National Study of 
Breast Cancer Screening, the prevalence 
of fibroadenoma was 8.3 per 1000. In 
two women, a carcinoma was disco­
vered within their fibroadenoma — 
intraductal carcinoma in one and an 
infiltrating ductal carcinoma in the other. 
Clinical and histopathologic findings are 
described and the prognosis and treat­
ment discussed. The peak age of women 
at the time of diagnosis of a fibroade­
noma is in their twenties while for those 
with a fibroadenoma containing a carci­
noma, it is in the forties. For patients 
under 25 years, excision can be post­
poned for a few months since spontane­
ous regression may occur and the risk of 
breast cancer is small at that age. For 
older women, treatment should not be 
delayed.
A  Texamen initial de 8512 femmes de la 
region de Quebec agees de 40 a 59 ans 
participant d I'Etude canadienne sur le 
depistage du cancer du sein, la preva­
lence du fibroadenome etait de 8.3 pour 
1000. Chez deux participantes, un carci- 
nome a ete decouvert a I’interieur du 
fibroadenome. II s'agissait dans le pre­
mier cas d'un carcinome intracanalaire et 
dans le deuxieme d'un carcinome cana- 
laire infiltrant. Les resultats des examens 
cliniques et histologiques sont indiques. 
Le pronostic et le traitement de tels cas 
consideres comme rares sont discutes.
Le mode de I'age au diagnostic des 
patientes avec un fibroadenome est dans 
la vingtaine alors qu'il est dans la qua- 
rantaine pour celles qui ont un fibro­
adenome contenant un carcinome. Pour 
les femmes de moins de 25 ans, I'exci- 
sion peut etre differee de quelques mois.
From the *Breast Screening Centre, 
tDepartment o f Pathology and %Depart- 
ment o f  Community Health, Hopital du 
Saint-Sacrement, Quebec, PQ
Accepted fo r  publication Feb. 22, 1985
Reprint requests to: Dr. Luc Deschenes. 
Hopital du Saint-Sacrement, 1050, chemin 
Ste-Foy, Quebec, PQ C IS 4L8
Chez les plus agees, elle ne doit pas etre 
retardee.
In a letter to the Lancet, 1 we reported 
two cases of breast carcinoma arising in 
a fibroadenoma. In this report we 
describe our findings and discuss the 
management of such cases in more detail.
Subjects and Sources of Data
The lesions were discovered at the ini­
tial examination of 8512 Quebec area par­
ticipants in the National Study of Breast 
Cancer Screening. The protocol for this 
study has been published by Miller and 
colleagues.2 Eligible for the study are all 
women aged 40 to 59 years who have not 
had breast cancer, have not undergone 
mammography in the previous 12 
months, are not currently pregnant and 
give informed consent to participate.
Data were extracted from the Breast 
Screening Centre files and the Saint- 
Sacrement Hospital surgery and pathol­
ogy reports.
Results
The frequency of fibroadenoma found 
at the first screening was 8.3 per 1000 
women, 10.8 per 1000 in the 40- to 
44-year age group and 6.3 per 1000 for
women aged 50 to 59 years. Two par­
ticipants in the latter group were found 
to have a carcinoma developing within 
their fibroadenoma.
Case Reports
Case 1
This unmarried 51-year-old postmenopausal 
woman had no family history of breast cancer. 
She was randomly assigned to the group of 
patients who underwent mammography and 
physical examination annually.
No mass was found on palpation. Mammo­
graphy showed a small nodule, suggestive of 
a cyst, and a few microcalcifications in the 
upper, inner quadrant of the right breast.
The screening centre’s consultant surgeon 
recommended an excisional biopsy.
Grossly, the biopsy specimen consisted of a 
well-circumscribed, white, rubbery, ovoid nod­
ule, 1.6 cm in diameter. Microscopically, sec­
tions of the nodule showed polypoid intraduc­
tal proliferation of connective stroma, 
characteristic of a fibroadenoma. The stroma 
was inactive and sclerotic. Some ducts were 
obliterated by an epithelial proliferation with 
obvious features of malignant tissue. There was 
no stromal infiltration (Fig. 1). The diagnosis 
was noninfiltrating ductal carcinoma of the 
breast confined to a fibroadenoma.
Segmental mastectomy was performed. No 
residual neoplastic tissue was found in the mul­
tiple sections of the specimen.
At follow-up 49 months after operation, the 
patient was well with no evidence of recurrence.
FIG. 1—(A) Edge of nodule showing features of fibroadenoma. Carcinomatous prolifera­
tion obstructs some ducts (hematoxylin-phloxine-saffron, original magnification X 10). (B) Detail 
of neoplastic epithelium. Note cribriform pattern and disorganized multilayered epithelium with 
projecting spurs (hematoxylin-phloxine-saffron, original magnification x 250).
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Case 2
This 53-year-old woman had given birth to 
the first of her five children when she was 19 
years old. She was postmenopausal and had 
no family history of breast cancer. She was ran­
domly allocated to the group of patients who 
underwent annual physical examination only.
The patient stated that she had been under 
medical supervision for the last 8 years because 
of a lump in her left breast. She had been told 
repeatedly that this lump was benign and did 
not need further investigation. Palpation rev­
ealed a well-delineated, freely movable mass, 
typical of a fibroadenoma, located just above 
the areola of the breast.
The consultant surgeon recommended mam­
mography and a fine-needle aspiration biopsy 
followed by surgical excision. The patient 
accepted only excisional biopsy.
Grossly, the biopsy specimen consisted of a 
well-circumscribed, white, rubbery nodule, 1.5 
cm in diameter. Microscopically, the periph­
ery of the nodule was characteristic of a 
fibroadenoma with loose proliferation of con­
nective stroma around ducts. The inner part 
of the specimen was occupied by a well- 
delineated malignant epithelial proliferation, 
confined to the fibroadenoma. Its centre was 
largely necrotic and hemorrhagic with some 
remnants of loose stroma infiltrated by the car­
cinoma (Fig. 2). These findings led to a diag­
nosis of poorly differentiated infiltrating duc­
tal carcinoma of the breast confined to a 
fibroadenoma.
Segmental mastectomy was performed with 
dissection of axillary nodes. A microscopic 
intraductal carcinoma, involving only one duct, 
was discovered close to the biopsy site. All eight 
nodes examined histologically were free of 
cancer. The patient received radiotherapy 
postoperatively: a total dose of 4000 rad to the 
supraclavicular region and 5000 rad to the 
remaining breast, axilla and the internal mam­
mary lymph nodes over 5 weeks at 25 sessions.
At follow-up 26 months after operation, the 
patient is well with no sign of recurrence.
Discussion
Carcinoma developing in a fibroade­
noma is thought to be rare.3 Harrington 
and Miller,4 in 1940, reported 15 such 
cases from the Mayo Clinic, providing 
details on only 3. The largest series, that 
of McDivitt and associates,5 included 26 
patients. With a few exceptions,6'8 other 
reports are based on only one or two 
women.9'21
Sixty-four cases of carcinoma in a 
fibroadenoma, including our 2, have been 
appropriately documented.22 Among 
these cases, the frequency of lobular 
neoplasia (62%) is clearly higher than that 
of ductal carcinoma (38%). Among duc­
tal carcinomas, 44% were noninvasive 
com pared with 72% for lobular 
lesions.22
Prognosis
The prognosis of this condition is 
usually favourable,5'7,8 because the fibro­
adenoma is readily discovered on palpa­
tion, leading to early detection of the 
cancer within.7'8 Owing to the small 
numbers, the prognosis of malignant 
lesions developing in a fibroadenoma has 
never been compared to that of similar 
lesions in nonfibromatous breast tissue. 
There is little reason to believe that it is 
any different.8 However, one cannot 
exclude the possibility that the invasive 
potential of a cancer might be thwarted 
when it grows in a fibroadenoma.
Treatment o f  Ductal Carcinoma in a 
Fibroadenoma
We elected to treat our first patient by 
segmental mastectomy, but there is still 
no consensus as to the best treatment of 
intraductal carcinoma, whether it is 
within a fibroadenoma or not.8,23’24 Sur­
geons face a dilemma because of two 
opposing considerations: the high prob­
ability of multifocality of the cancer 
versus the need to avoid unnecessary
mutilation. In 1967, McDivitt and 
colleagues5 reported that, out of six 
patients with noninfiltrating ductal car­
cinoma developing in a fibroadenoma, 
three underwent a radical mastectomy 
and three a wide local excision. Recently, 
one of us (L.D.) asked five Canadian sur­
geons about their choice of treatment in 
such cases. He received five different 
answers: modified radical mastectomy, 
simple mastectomy with or without axil­
lary node sampling and local excision with 
or without postoperative radiotherapy. At 
its September 1984 meeting, the clinical 
trials committee of the National Surgical 
Adjuvant Breast Project (NSABP) indi­
cated it was contemplating a randomized 
clinical trial of treatment for noninvasive 
ductal breast cancer. Meanwhile, sur­
geons will have to base their choice of 
treatment on their knowledge and 
experience, on the particulars of each case 
and on discussions with each patient.
Our second patient underwent segmen­
tal mastectomy with axillary dissection 
followed by radiotherapy. In their ran­
domized clinical trial, Veronesi and 
associates25 compared such a treatment 
to Halsted’s mastectomy in patients with 
small cancers of the breast and no palpa­
ble axillary lymph nodes. Disease-free and 
overall survival were the same in the two 
groups.
Management o f  Breast Fibroadenoma
The peak age at diagnosis in women 
with breast fibroadenoma is the third 
decade.3 For patients with a carcinoma 
arising in a fibroadenoma, it is the fifth 
decade (mean age 43.4 years, ranging 
from 15 to 69 years).5'8’22'26 Management 
of a fibroadenoma depends on age. At all 
ages, we routinely perform a fine-needle 
aspiration biopsy for palpable breast 
lesions.27 For women under 25 years of 
age with a cytologically confirmed 
fibroadenoma, excision can be delayed 
for a few months since spontaneous 
regression may occur and risk of breast 
cancer is small at that age. For older 
women, immediate excision is manda­
tory. The procedure can be done under 
local anesthesia on an outpatient basis. 
Microscopic examination of the specimen 
will confirm the diagnosis of fibroade­
noma and detect malignant change.19 
Physicians should be aware that carci­
noma can indeed develop within a 
fibroadenoma.
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Tile and Robert McMurtry, the 11th International 
Conference on Hoffmann® External Fixation 
will be combined with the University of 
Toronto's Orthopedic Trauma Course.
Please send all inquiries to the Course Secretary:
Dr. James F. Kellam
c/o Sunnybrook Medical Center
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Esophageal Web Associated With Zenker’s Diverticulum: 
a Possible Cause of Continuing Dysphagia 
After Diverticulectomy
A 67-year-old man with upper 
esophageal dysphagia thought to be 
caused by a large Zenker's diverticulum 
was found to have an esophageal web at 
the time of diverticulectomy and 
cricopharyngeal myotomy. The web was 
divided by sharp dissection. Untreated, 
this thin web would almost certainly 
have resulted in dysphagia postopera- 
tively. The authors therefore recommend 
routine open diverticulectomy for the 
management of Zenker's diverticulum, to 
allow inspection of the esophageal lumen 
for concomitant disease and palpation of 
the cricopharyngeal muscle at the time 
of myotomy.
Un voile oesophagien a ete decouvert au 
moment d'une diverticulectomie avec 
myotomie cricopharyngee chez un 
homme de 67 ans souffrant d'une 
dysphagie oesophagienne que Ton 
croyait due a un gros diverticule de 
Zenker. Le voile fut divise par dissection 
vive. Non traite, ce mince voile aurait 
presque a coup sur entraine une 
dysphagie postoperatoire. Les auteurs 
recommandent done la diverticulectomie 
ouverte systematique comme traitement 
du diverticule de Zenker, afin de permet- 
tre une inspection de la lumifere oesopha­
gienne visant a identifier toute maladie 
concomitante et a palper le muscle crico- 
pharynge au moment de la myotomie.
Dysphagia in patients with pharyngo­
esophageal (Zenker’s) diverticulum is 
generally caused by preferential passage 
of food into the diverticulum, compress­
ing the cervical esophagus. However,
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other causes of upper esophageal and 
pharyngeal dysphagia exist, such as 
esophageal webs, neuromuscular dis­
orders, the presence of foreign bodies, 
extrinsic pressure and tumours. We 
describe a patient with Zenker’s divertic­
ulum and a coexisting upper esophageal 
web. If the Zenker’s diverticulum in this 
patient had been treated in the usual 
fashion by diverticulectomy without 
opening the diverticulum and visualizing 
the esophageal lumen, dysphagia would 
undoubtedly have occurred postopera- 
tively.
Case Report
A 67-year-old man complained of dyspha­
gia for solids, with food sticking in his cervi-
FIG. 1—Upper esophagus and gastro­
esophageal junction on barium swallow. Large 
Zenker’s diverticulum (large arrow) and slid­
ing hiatus hernia (small arrow) are seen. 
Gastroesophageal reflux was noted at 
fluoroscopy.
cal esophagus. This symptom, present for 6 
months, had been increasing in severity. 
Associated symptoms included regurgitation of 
undigested food, particularly at night, accom­
panied by coughing and choking spells. He also 
complained of water brash and heartburn, 
which were not relieved by elevating the head 
of the bed, antacids or cimetidine (300 mg four 
times a day). Bending and straining exacer­
bated the heartburn.
Physical examination did not reveal any 
abnormality. The hemoglobin value was 150 
g/L, hematocrit 50%, leukocyte count 8.7 x 
lOVL and serum electrolyte levels were nor­
mal. The chest film was also normal. Roent­
genography after barium swallow showed a 
large Zenker’s diverticulum, measuring 2 x 2.5 
cm, as well as a sliding hiatus hernia with gas­
troesophageal reflux (Fig. 1). The esophageal 
scintiscan showed marked dysmotility, espe­
cially in the upper third of the esophagus, and 
reflux occurred during the study.
Since medical measures failed to improve the 
patient’s reflux and the diverticulum caused 
worsening dysphagia, a combined operative 
procedure was planned to correct both condi­
tions.
Preoperatively, an attempt to pass a nasogas­
tric tube failed. A diverticulectomy and 
cricopharyngeal myotomy were performed 
through an oblique incision along the anterior 
border of the left sternocleidomastoid muscle. 
The omohyoid muscle was transected and the 
thyroid gland and trachea were mobilized 
medially and superiorly. The carotid sheath 
and sternocleidomastoid were retracted later­
ally. The recurrent laryngeal nerve was identi­
fied throughout the procedure. A large 
esophageal diverticulum was noted, arising just 
proximal to the cricopharyngeal muscle. The 
diverticulum was dissected from surrounding 
tissue down to its neck, and its apex was 
opened. An unsuspected, thin mucosal web was 
seen, extending 1.5 cm from the right 
posterolateral wall to the left posterolateral 
wall of the esophagus. The web projected 
anteriorly 0.5 cm into the lumen of the esopha­
gus at the level of the cricopharyngeal muscle 
(Fig. 2) and obstructed the distal esophageal 
lumen. It was therefore divided and the edges 
were oversewn with 3-0 chromic catgut suture. 
A finger was placed through the apex of the 
diverticulum into the distal esophagus and the 
myotomy performed. The diverticulum was 
excised, closing the esophagus with chromic 
catgut in the mucosal layer and silk in the mus- 
cularis. The neck wound was drained and 
closed. An abdominal approach to the 
esophageal hiatus allowed the posterior fixa-
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tion and sphincter calibration (Hill) procedure 
to be performed.
Postoperative recovery was smooth and the 
patient remains well without dysphagia or 
reflux symptoms 12 months later.
Discussion
Zenker’s diverticula and esophageal 
webs are uncommon conditions; both can 
cause pharyngeal and upper esophageal 
dysphagia. Two percent of patients who 
complain of dysphagia have a Zenker’s 
diverticulum which is well demonstrated 
by a standard barium swallow,1 and 
12% have esophageal webs.2 However, 
the true incidence of webs is unknown 
because standard roentgenographic tech­
niques are not sensitive enough to pick up 
this condition.3 Cineradiographic tech­
niques improve the detection of this 
lesion.4
Barium swallow in our patient showed 
a Zenker’s diverticulum that was the pre­
sumed cause of dysphagia. The delayed 
passage of barium in the diverticulum and 
distortion of the anatomy obscured the 
web. Cineradiography was not per­
formed.
Endoscopic visualization of esophageal 
webs with therapeutic dilation is the treat­
ment of choice for this condition. 
However, endoscopic evaluation of 
esophageal diverticula can be hazardous, 
especially if the diverticulum is large 
and the diverticular orifice lies in the 
same plane as the esophagus. Even an 
experienced endoscopist may confuse the 
lumen of the diverticulum with that of the 
esophagus and attempts to pass the endo­
scope distally may result in perforation.
FIG. 2—Operative findings. Zenker’s diver­
ticulum has been opened at its apex. Mucosal 
web is identified on right posterolateral wall 
of esophagus distal to mouth of diverticulum.
Both webs and diverticula are asso­
ciated with numerous other conditions. 
Esophageal webs have been associated 
with iron deficiency anemia (Plummer- 
Vinson syndrome), cancer, glossitis, 
thyroid disease, ulcerative colitis, rheuma­
toid arthritis, pernicious anemia, epider­
molysis bullosa and pemphigoid. Zen­
ker’s diverticula occur frequently in 
patients with hiatus hernia and reflux, as 
in our patient, and less commonly in 
patients with achalasia, cancer of the 
esophagus and polyps in the cervical 
esophagus. There are, however, no 
reports of an upper esophageal web coex­
isting with a Zenker’s diverticulum.
Esophageal webs consist of squamous 
epithelium, are usually thin, smooth and 
arise on the anterior wall of the cervical 
esophagus at or just below the crico­
pharyngeal muscle, and they may be mul­
tiple.5 The web in this patient arose in a 
similar location except that it was on the 
posterolateral wall. Grossly, it was exactly 
like those identified and frequently 
treated endoscopically.
Both diverticula and esophageal webs 
may cause dysphagia. It is unclear in our 
patient with multiple esophageal abnor- •* 
malities whether the diverticulum or the 
web caused the progressive dysphagia, but 
both probably contributed. Zenker’s 
diverticulectomy is usually performed 
without opening the diverticulum and 
visualizing the esophageal lumen. This 
may be done with a stapling technique6 
or by more traditional suture methods.7 
Either way, this would certainly have 
resulted in early postoperative dysphagia 
in our patient.
We have adopted the technique of rou­
tinely opening the apex of the diverticu­
lum and inspecting the esophageal lumen. 
This allows the surgeon digitally to pal­
pate the cricopharyngeal muscle before 
and after myotomy. The myotomy is per­
formed with the operator’s finger placed 
in the lumen of the esophagus through the 
cricopharyngeal muscle; this allows excel­
lent control of the extent and depth of the 
myotomy. With this approach and antibi­
otic prophylaxis, we have not had a sin­
gle case of esophageal fistula or stenosis, 
or any wound infection requiring incision 
and drainage.
A mercury-filled bougie passed through 
the cricopharyngeal muscle to act as a 
stent at the time of myotomy has been 
used by some surgeons. In this patient it 
would have been difficult to pass the bou­
gie without opening the esophagus since 
the web deflected the nasogastric tube 
into the diverticulum. Even with the 
diverticulum open and under direct 
vision, the nasogastric tube deflected 
laterally at the level of the web. Attempts 
at blind passage of the bougie preopera- 
tively might have resulted in inadvertent 
perforation of the diverticulum. Intra­
operative placement would have been 
technically possible by manually guiding 
the bougie. However, in our opinion the 
diverticulum should be opened routinely, 
thereby allowing both inspection of the 
esophageal lumen and palpation of the 
cricopharyngeal muscle.
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The simple question, “ Why does arterioscle­
rosis cause narrowing of the arterial lumen 
(atherosclerosis obliterans) in many patients 
while in others dilatation of the arterial wall 
(aneurysm) occurs?” , does not have a ready 
answer. The first two chapters of this book 
attempt to shed light on this question by sum­
marizing current knowledge of the pathophysiol­
ogy and biomechanics of aneurysm formation. 
Since the bibliography cites references up to 
1980, the more recent developments in genetics 
and in collagen structure are not covered. 
Nevertheless, these superb reviews should help 
busy vascular surgeons to keep abreast of the 
extensive information accumulating on this 
subject. The discussion ranges from nutrition 
of the arterial wall to the role of the 
hydrodynamic frequency phenomenon on the 
evolution of aneurysms.
Discussions on the relatively rare occurrence 
of aneurysms in the carotid and subclavian 
arteries are practical, and include illustrative 
case reports. To list poststenotic dilatation due 
to thoracic outlet compression under “ false 
aneurysm” is misleading since it contradicts the 
definition of pseudoaneurysms made earlier in 
the book. The consensus is that aneurysms and 
symptomatic poststenotic dilatations in this 
region should be repaired, but whether asymp­
tomatic poststenotic dilatation should also be 
resected has not been answered. For the lat­
ter, the authors suggest that resection of the 
rib to relieve compression, without further vas­
cular procedures, would be adequate.
The surgical treatments of aortic arch and 
thoracoabdominal aortic aneurysms continue 
to present a major technical challenge. Craw­
ford bases his discussion in this chapter on his 
wide experience and excellent results. The sur­
gical tour de force depicted so well in the illus­
trations and the text indicates the goals that 
can be achieved with modern surgery. 
Aneurysms in the renal and visceral arteries are 
relatively small and are frequently asympto­
matic until complications such as rupture or 
thrombosis occur. Preservation of the tissue 
nourished by the involved artery, such as the 
kidney, liver and intestine, is of particular 
importance during reparative procedures. 
Whether the newer diagnostic techniques such 
as computerized axial tomography and ultra­
sonography will identify more of these lesions 
at an earlier stage and therefore allow treat­
ment before they rupture, as postulated by the 
author, remains to be seen.
The chapter on abdominal aortic aneurysms, 
which is the most common aneurysm repaired 
surgically, is useful to both novice and sea­
soned vascular surgeons. The discussions 
on avoiding distal thromboembolism, dealing 
with horseshoe kidney during aortic aneurysm 
resection and preventing spinal cord and other 
neurologic complications are “must” readings
for vascular surgeons in this society that is 
increasingly litigation conscious.
Finally, sepsis associated with aneurysms, a 
dreaded complication with high morbidity and 
mortality, is presented with an in-depth review 
of experimental and clinical data. The ration­
ale for using antibiotics prophylactically and 
therapeutically, as well as the various options 
available to the surgeon dealing with this com­
plication, are described. Although the styles 
and depths of coverage vary somewhat in this 
multiauthored book, it seems to have success­
fully met the authors’ objective of producing 
a “ most useful resource for the sophisticated 
practicing physician” . The basic pathophysiol­
ogy and the useful tidbits in surgical techniques 
should also make this book valuable to resi­
dents training in vascular surgery.
R ay C -J. C h iu , m d , p h  d , frcsc
Senior Surgeon,
Division of Cardiovascular
and Thoracic Surgery,
The Montreal General Flospital,
Montreal, PQ 
H3G 1A4
ATLAS OF BRONCHITIS. Konrad Morgen- 
roth and Michael T. Newhouse. (Translated 
by H .P . Schleiss.) 106 pp. PVG Phar- 
mazeutische Verlagsgesellsehaft, Munchen; 
Butterworth Scientific, Boston, 1983. 
S49.95 (US). ISBN 0-407-00279-0.
This book comprises mostly illustrations of the 
histologic features of bronchitis as seen through 
the fiberoptic bronchoscope. These are sup­
plemented by superb drawings and electron 
photomicrographs. Although it provides a 
good overall review of the pathologic features 
of bronchitis, this book should not be consi­
dered as an atlas of bronchoscopy. No data are 
presented to correlate these features with func­
tional respiratory testing or with radiologic 
images. In the preface, the authors point out 
that fiberoptic bronchoscopy has allowed the 
clinician to assess the morphology of the bron­
chial mucosa more readily and to relate this 
to the clinical and physiological state of the 
patient. We are not aware of any data correlat­
ing the exact physiopathology of bronchitis and 
bronchoscopy; the inflammatory reaction 
found in bronchitis frequently begins as a 
peripheral process not visible through the 
fiberoptic bronchoscope, but nevertheless alters 
respiratory function. We also believe that it is 
difficult to evaluate the response to medication, 
such as bronchodilators, by fiberoptic bron­
choscopy. Finally, even if bronchitis is com­
monly seen during evaluation of lung diseases 
in general, one should not conclude from this 
book that bronchitis is necessarily an indica­
tion for fiberoptic bronchoscopy.
This book may be helpful to those interested 
in the different types of bronchitis if it is read 
in its entirety, but the reader will find gaps in 
coverage if the text is used as a reference. Mor­
phologic aspects of bronchitis are well 
presented, but in our opinion the functional 
aspect of this disease are more important clin­
ically than the bronchoscopic findings.
P ier r e  P a g e , m d , fr c sc , facc  
J e a n - J acqu es G a u t h ie r , m d , fr c pc
Cardiovascular and Thoracic Surgery 
and Pulmonary Medicine,
Hopital du Sacre-Coeur,
5400, boul. Gouin ouest,
Montreal, PQ 
H4J 1C5
HANDBOOK OF CANCER DIAGNOSIS 
AND STAGING. A Clinical Allas. Seth A. 
Gorg and Susan Rosenthal. 271 pp. Illust. 
John Wiley & Sons, Inc., Somerset, 
NJ, 1984. $29.95 (US). ISBN 0-471- 
87073-0.
A unique text this brings together in a concise, 
yet sufficiently detailed, fashion the tools that 
are available to evaluate a patient with cancer, 
so that the clinician can provide the most effec­
tive treatment. In the past 10 to 12 years there 
has been tremendous progress in the field of 
imaging, most of which is radiologic in nature 
but also includes nonradiologic procedures 
such as ultrasonography and nuclear magnetic 
resonance imaging.
The text is divided into five major sections. 
The first deals with imaging modalities for 
diagnosis and staging of cancer, including each 
of the more sophisticated radiologic proce­
dures: angiography, barium gastrointestinal 
studies, computerized tomography, endoscopic 
retrograde cholangiopancreatography, lym­
phography, myelography, nuclear imaging of 
bone, brain and liver, nuclear magnetic 
resonance scanning, ultrasonography, tom o­
graphy, urography and percutaneous biopsy. 
There is a brief description on how the exami­
nation is performed, the indications for the 
procedure, what form of patient preparation 
is required, the risks of the procedure and 
approximate cost assessment in relative terms.
The second chapter consists of a brief dis­
cussion of the methods used in evaluating cer­
tain specific sites and includes mediastinal and 
retroperitoneal lymph nodes, hepatic masses, 
liver nodules, obstructive jaundice and pelvic 
masses.
In the third chapter is a more detailed dis­
cussion of cancer in various organs of the body 
to include, in each case, description o f the 
TNM tumour staging. This section is excel­
lently done and illustrates the value of the var­
ious imaging procedures in properly staging the 
cancer. The authors stress the importance of 
the TNM classification, which achieves a 
degree of uniformity and clarity. Failure to 
evaluate fully the extent of disease can lead to 
serious, even tragic errors in management.
The problem of patients with cancer of 
unknown origin is briefly considered while the 
final chapter deals with the diagnostic evalua-
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tion of oncologic emergencies, including such 
conditions as the superior vena cava syndrome, 
increased intracranial pressure, spinal cord 
compression, cardiac tamponade and bilateral 
ureteral obstruction.
This is a well-conceived, well-written hand­
book on the subject of cancer diagnosis and 
staging. The various diagnostic modalities are 
well presented and in many cases beautifully 
illustrated. There are flow diagrams for evalu­
ating patients with suspected cancer in various 
organs and regions in the body with excellent 
images to demonstrate the pathologic features 
and their extent. The only criticism that can 
be levelled at this book is that the descriptive 
text and particularly that dealing with tech­
niques is, for the most part, too brief. For this 
reason the usefulness of this handbook is res­
tricted to medical students and junior interns, 
and to primary care physicians and surgeons 
who have been unable to keep pace with the 
virtual explosion of recent diagnostic and imag­
ing procedures now available to evaluate the 
patient with cancer.
E dw ard  J . Ta b a h , m d , frcsc
Department of Surgery,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ 
H3A 1A1
M ANUAL OF PREOPERATIVE AND  
POSTOPERATIVE CARE. 3rd ed. Com­
mittee on Pre and Postoperative Care. 
American College of Surgeons. Editorial 
Subcommittee, Stanley J. Dudrick, Chair­
man, Arthur E. Baue, Ben Eiseman, Lloyd 
D. MacLean, Marc E. Rowe and George 
F. Sheldon. 822 pp. Illust. YV.B. Saunders 
Company Canada Limited, Toronto, 1983. 
$45. ISBN 9-7216-1164-8.
In its third edition, this manual, which is spon­
sored by the American College of Surgeons, 
has been largely rewritten. There are many new 
contributors as well as 11 new chapters. It is 
separated into four parts on the basics, the 
pediatric surgical patient, the organ systems 
and special patient problems. The chapters in 
all parts are short and precisely written, allow­
ing the reader to update quickly his knowledge 
of both the basic and practical aspects of pre- 
and postoperative care. The section on organ 
systems contains excellent updates on the con­
struction and management of alimentary tract 
stomas, conditions that are helped by splenec­
tomy, the preparation of patients who must 
undergo thyroidectomy for Grave’s disease and 
the management of those who undergo 
adrenalectomy for various adrenal gland 
lesions. The topic of surgical nutrition has been 
expanded into two chapters — enteral and 
parenteral nutrition; they cover in good detail 
the rapid expansion of the nutritional field dur­
ing the past several years.
Although relatively short, this book covers 
a surprising number of surgical topics. It is 
clearly intended for practising surgeons and 
senior residents, as a high level of background 
knowledge and experience is required for most 
chapters. While some might find the detail too 
scanty, the book will serve most surgeons as 
an excellent update for pre- and postoperative 
care and as a reference for special situations.
J o h n  H . D u f f , m d , frcsc
Division of General Surgery,
University Hospital,
London, Ont.
N6A 5A5
OPERATIVE SURGERY. H. Dudley, W. 
Posies and D. Carter. 647 pp. Illust. But- 
terworths, London, Toronto, 1983 (price 
not stated). ISBN 0-407-00656-7.
Whenever a book is into its fourth edition, 
there is always the danger that only a few cos­
metic changes have been made. However, such 
criticism cannot be levelled at this book. In 
fact, the material covered has been expanded 
to include almost the complete gamut of oper­
ations performed in the increasingly sophisti­
cated specialty of colonic and rectal surgery. 
Many leading authorities have contributed to 
this edition.
This is not a textbook of theory; instead, it 
was prepared as a “ how to do it”  reference. 
Since there are many controversial aspects, the 
editors often commissioned more than one 
author to detail how a certain operation should 
be done or to describe more than one opera­
tion to correct a given abnormality.
Divided into several sections, the first part 
of the book deals with basic technique. The 
chapter on colonoscopy is very concise and 
helpful, and is the most beneficial for the least 
reading to a would-be endoscopist. The chap­
ters on anastomoses provide a fine mixture of 
theoretical and practical considerations essen­
tial to the construction of a sound anastomo­
sis. The various options of anastomotic con­
struction are well described and illustrated, 
including special techniques to be used when 
different diameters of bowel lumen are 
encountered.
The next section is devoted entirely to stoma 
construction. It points out that attention to 
minute detail is mandatory in the construction 
of a well-functioning stoma. Recommendations 
for fitting and care of the appliance are given 
— a valuable aid to the surgeon working 
without the help of an enterostomal therapist.
The section on inflammatory bowel disease 
includes a particularly strong segment that 
describes successful resection for diverticular 
disease. The newest operation, restorative proc­
tocolectomy with an ileal reservoir, as recom­
mended by the late Sir Alan Parks, is outlined, 
but consideration might also have been given 
to the alternative technique of the J-pouch.
A new and valuable section is devoted to 
emergency problems. Methods of handling a 
disrupted anastomosis and principles and tech­
niques used to manage trauma to the large 
bowel are summarized. Bleeding from the 
spleen during mobilization of the splenic flex­
ure is not uncommon. A detailed method for 
this procedure is described and will prove use­
ful to the surgeon. Management of large-bowel 
obstruction is explained.
In the section on cancer, alternatives to 
hand-sewn anastomoses are shown. Greater 
detail of stapled anastomotic techniques would 
have been useful, especially their pitfalls and 
complications. Peranal operative techniques 
are especially helpful as many surgeons are not 
familiar with these specialized methods. I took 
exception to the statement that most surgeons 
would undertake an abdominoperineal excision 
for a squamous cell carcinoma of the anal
canal; more appropriate, less radical treatment 
should be recommended. Specialized proce­
dures such as transsphincteric resection of 
neoplasms and pull-through procedures are 
described in more detail than is necessary. Since 
the introduction of the circular stapler the 
role of these techniques has diminished and 
in any event they have been popular in the 
hands of a few.
Throughout the book, sprinkled editorial 
comments are used to inform the reader of an 
alternative method of treatment or as a means 
of polite disagreement with the author. The one 
repeated approach which astounded me was the 
strong recommendation for the left parame­
dian incision.
The broad range of standard operative 
procedures for the correction of common 
anorectal problems is included. There are 
several topics that should have been covered, 
such as the Delorme repair for rectal prociden­
tia, approaching retrorectal tumours in adults 
and managing patients with anal stenosis. 
Nevertheless, this book is well assembled, easy 
to read, extremely well illustrated and will be 
valuable to anyone performing colorectal sur­
gery. Even the experienced surgeon will find 
tips that will prove useful.
P h il ip  H . G ord o n , m d , fa c s , frcsc
Division of General Surgery,
The Sir Mortimer B. Davis-
Jewish General Hospital,
Montreal, PQ 
H3T 1E2
STAPLING IN SURGERY. Felicien M.
Steichen and Mark M. Ravitch. 418 pp.
Illust. Year Book Medical Publishers, Inc.,
Chicago, 1984. $81.25 (US). ISBN 0-8151-
7108-0.
Mechanical stapling devices have been around 
for a long time. It is only in the past decade, 
however, as the instruments became easy to 
use, reliable, and ultimately disposable, that 
surgeons have enthusiastically embraced them. 
Stapling has now become so widespread that 
some surgical teachers are concerned that 
trainees may not get adequate exposure to con­
ventional suturing techniques. In contrast to 
the plethora of texts on surgical handicraft, 
there is a real lack of a modern, reliable and 
objective manual on stapling. Surgeons have 
taught themselves, using journal articles and 
the manufacturers’ brochures. Steichen and 
Ravitch, pioneers of American stapling and 
surgeons of great experience and distinction, 
have collaborated to produce the first modern 
text devoted to stapling. Unfortunately, this 
long-awaited text is disappointing.
The first part of the book is a historical 
review comprising more than 100 pages. It is 
comprehensive, extensively referenced and will 
interest the student of surgical history. The sec­
tion is profusely illustrated, but unfortunately 
many of the old drawings have lost clarity with 
reproduction. The remainder of the book 
describes the experience with and use of sta­
plers in the different anatomic areas in which 
the general surgeon operates. There are chap­
ters on urologic and gynecologic procedures 
and on operations for morbid obesity. Surpris­
ingly, the use of staplers in vascular surgery 
has been excluded. The introduction of this 
section, perhaps the most interesting part of
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all, is a review of the authors’ experience with 
over 1000 cases up to 1976. This portion of the 
book is also profusely illustrated and here the 
drawings are generally clear and helpful. The 
authors are obviously determined to be ency­
clopedic. The references are exhaustive but 
exhausting for the reader. By not excluding a 
single published report on stapling, the book 
provides a remarkably up-to-date bibliography; 
but this also makes it difficult to read and 
ensures its early obsolescence. The wealth of 
detail is more than most surgeons need or wish. 
Moreover, the interminable cataloguing of 
authors’ names, dates and numbers of proce­
dures is tedious.
This is not a book with which to settle down 
for a comfortable evening read. Nor, regret­
tably, is it a step-by-step instruction manual. 
The stapling neophyte is still better served by 
the manufacturers’ hand-outs.
The authors do not indicate for whom the 
book is intended. For its historical value the 
book certainly deserves a place in the hospital 
library but few surgeons will wish to acquire 
it for themselves.
M ax  M . C o h e n , m d , frcsc
Member,
Editorial Board.
Professor of Surgery,
University of Toronto,
Ste. 440,
600 University Ave.,
Toronto, Ont.
M5G 1X5
THE SURGERY OF TUMORS OF BONE 
AND CARTILAGE. 2nd ed. Ralph C. 
Marcove. 218 pp. Illust. Grune & Stratton, 
Inc., Orlando, Fla., 1984. $49.50 (U.S.) 
ISBN 0-8089-1656-4.
This book is a monograph rather than textbook 
because it covers only those topics that are of 
particular interest to the author. It must, there­
fore, be read with this in mind.
In the preface, the reader becomes aware 
almost immediately that the style is going to 
be anecdotal and based on one surgeon’s 
experience.
The author organizes the book into evalua­
tion of the patient, therapeutic procedures he 
uses and specific tumours with which he has 
had extensive experience. The organization can 
be criticized in that the specific chapters on 
bone tumours do not follow the same format. 
For each tumour, different aspects are empha­
sized according to the author’s interest. For 
example, in a chapter on therapeutic proce­
dures, \ 'h  pages are devoted to a detailed 
description of en-bloc resection of the medial 
region of the clavicle because the author has 
done this procedure on three occasions. There 
is also a tremendous emphasis throughout on 
the use of cryosurgery. While this is the 
author’s particular area of expertise, its over­
emphasis is a bit tedious when reference to 
alternatives is so brief.
Marcove also makes anecdotal statements 
about other forms of surgical therapy in order 
to dismiss them as being ineffective, but he 
does not back these statements up with data 
or references. For example, in the chapter on 
giant-cell tumours he states that “ the results 
of en bloc excision are poor” but does not sub­
stantiate this sweeping statement. In fact, the 
chapter on giant-cell tumours concerns his 
results with cryosurgery. This type of dismis­
sal of other forms of surgical therapy without 
factual support is quite upsetting to the reader 
who deals with bone tumours.
The black-and-white reproductions of histo­
logic findings are not really of value; they 
should either be in colour or omitted com­
pletely. The reproduction of roentgenograms 
is variable. Some diagrams of surgical proce­
dures are too small to interpret and the label­
ling is too small to read. The author goes into 
some details about his own surgical procedures 
but does not provide quite enough detail for 
the reader to use these portions of the text as 
an operative manual.
The chapter on therapeutic procedures again 
emphasizes cryosurgery, the Tikhoff-Linberg 
procedure and en-bloc excision of tumours 
around the knee with prosthetic replacement. 
These are, of course, procedures that Marcove 
has written about extensively in the literature. 
Although he refers to his articles throughout 
the text, he makes very few references to arti­
cles on the same subject by other authors. 
Moreover, data given in the text are taken from 
his own articles, some of which are not up to 
date, and he does not seem to have made any 
attempt to update the data for this particular 
book. Marcove has, however, many interest­
ing ideas and because of this, some of the chap­
ters are particularly interesting, such as those 
on aneurysmal bone cyst, giant-cell tumour, 
chondrosarcoma, Ewing’s sarcoma and osteo­
genic sarcoma.
The value of this monograph is only to the 
orthopedic surgeon who is interested in how 
Marcove treats specific bone tumours. It is not 
to be used as a reference text and will be of 
little value to medical students or even trainees 
in orthopedics, who need a much broader 
picture.
A llan  E . G ro ss, m d , frcsc
Professor of Surgery,
University of Toronto,
Chief, Orthopedic Service,
Combined Toronto General Hospital/
Mount Sinai Hospital,
Ste. 437,
600 University Ave.,
Toronto, Ont.
M5G 1X5
TRA NSIENT ISCHEM IC ATTACKS. 
Science and Practice of Surgery, V ol. 3. 
Edited by Peter J. Morris and Charles 
Warlow. 412 pp. Illust. Marcel Dekker, 
New York, 1982. Price not stated. ISBN 
0-8247-1447-4.
Morris and Warlow have brought together an 
international collection of recognized authori­
ties on occlusive cerebrovascular disease in an 
attempt to assemble in one text the current state 
of knowledge on transient ischemic attacks. In 
this attempt they generally have succeeded. The 
majority of the chapters are well written and 
comprehensive, limited by the year of publi­
cation, with few references past 1980, and mul­
tiple authors, resulting in variable quality.
Harrison’s chapter on the pathophysiology 
of transient focal neurologic events is excellent. 
He considers there to be two factors, a cerebral 
lesion and a vascular lesion; he discusses each
one and its clinical implications. In two very 
good, complementary chapters, Thomas and 
Mitchell discuss the hyperviscosity syndromes 
and the difficulties of consistently finding a 
platelet abnormality in patients with transient 
ischemic attacks. The chapter on the cardiac 
causes of neurologic dysfunction is good and 
includes an excellent discussion of the risks and 
benefits of anticoagulation with Coumadin in 
the treatment of cardiac sources of emboli. 
Wilson presents the clinical features and 
differential diagnoses of transient ischemic 
attacks, making a valid point that computer­
ized tomography should precede angiography 
to rule out other causes of transient cerebral 
dysfunction. The excellent chapter on neu­
roradiology is followed by a comprehensive one 
on noninvasive imaging techniques.
The management of patients with transient 
ischemic attacks secondary to atherosclerotic 
thromboembolism is controversial with only 
rare agreement between any two authors. 
Warlow, in the chapter on medical manage­
ment, stresses the control of risk factors, espe­
cially hypertension, and evaluates the use of 
anticoagulants and antiplatelet agents. A good 
chapter on the techniques of carotid endar­
terectomy by Thompson and Tackington fol­
lows. M orris briefly sum m arizes the 
pathophysiology of vertebrobasilar ischemia 
then concisely describes the various surgical 
approaches used to improve blood flow to the 
posterior circulation. Barnett provides an excel­
lent chapter on extracranial to intracranial 
arterial bypass surgery, describing the indica­
tions for its use and outlining the collabora­
tive extracranial and intracranial bypass trial.
This book emphasizes the lack of experimen­
tal models for and hard clinical data on tran­
sient ischemic attacks. Many widely held 
assumptions and caveats are based on anecdo­
tal reports and small, uncontrolled series of 
patients. Of the many opinions expressed in the 
various chapters, some are peculiarly British 
and not universally agreed upon. The use of 
general anesthesia for angiography and 
intraoperative shunting during carotid endar­
terectomy is not of proven benefit. A few chap­
ters do not attain the standard set by the 
remainder of the book, such as those on the 
epidemiology and pathology of cerebral 
atherosclerosis, kinking of the carotid arter­
ies and surgery on the asymptomatic lesion.
The most striking aspect of this text is the 
importance of a transient ischemic attack to 
the patient and the subsequent increased risk 
of cerebral or myocardial infarction. The 
reduction of this risk has excited considerable 
interest and this text is the result of that 
interest. Some questions have been answered, 
but many more remain unanswered. The edi­
tors have appreciated this uncertainty, hoping 
that these unknowns will be the stimulus for 
ongoing, future research.
This book is a valuable addition to the liter­
ature and will also be of value to any student, 
clinician or scientist interested in occlusive 
cerebrovascular disease.
S.J. P e e r l e ss , m d , frcsc
Professor and Chairman,
Division of Neurosurgery,
Department of Clinical Neurological Sciences, 
University o f Western Ontario,
London, Ont.
N6A 5A5
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cellent golf and curling facilities. One hour's drive to 
Lake Huron and the University of Western Ontario, 
and 1-1/2 hours' to Georgian Bay and Blue- 
Mountain skiing. Time to establish practice is flexi­
ble. New office facilities under construction. Con­
tact: Dr. F. Ellingham, A dm inistra tor, The 
Listowel Memorial Hospital, 255 Elizabeth St. 
E., Listowel, ON N4W 2P5. -S85-25
CLINICAL BURN FELLOWSHIP -  A 6-month or 
12-month clinical burn fellowship is available at 
the regional adult Burn Centre at the Wellesley 
Hospital, beginning January 1, 1986. The unit is 
a new, 10-bed, ultramodern burn centre. Position 
tota lly  funded. Research grants and laboratory 
space available. For more information contact : 
Dr. Walter J. Peters, Suite 224, Turner Wing, 
Wellesley Hospital, 160 Wellesley St. E., Toron­
to, ON M4Y 1J3. -S 8 5 -2 0
GENERAL SURGEON —  Required by the Manito­
ba Clinic, a large multispecialty group in Winnipeg, 
Manitoba. Applicants must have obtained, or be 
eligible and willing to sit the specialty examina­
tions of the Royal College of Physicians and 
Sugeons of Canada. Preference will be given to 
applicants who have successfully completed ad­
ditional training in a subspecialty. For further in­
formation and details write to the : Chairman, 
Manitoba Clinic, 790 Sherbrook St., Winnipeg, 
MB, Canada R3A 1M3 S85-23
SURGEON: ON —  Listowell, serving a referral 
population of 18 000 people in the north end of 
Perth County of Ontario, will require a general 
surgeon in 1986 to replace retiring surgeon who has 
been in the community for 15 years. The town has a 
population of 5000 people and is the centre of com­
merce for a prosperous dairy and cattle area. The 
hospital is well equipped and operates 87 beds. 
There are nine family physicians in Listowel. Ex-
NEUROSURGEON
The Moncton Hospital, a teaching 540-bed regional hospital, 
is looking for an additional neurosurgeon to join tw o active staff 
neurosurgeons.
The hospital, currently undergoing a $50 million redevelopment 
project, serves as the Neurological and Trauma Centre to a popu­
lation base of over 500 000 people.
Candidates should be eligible for licensure in the Province of New 
Brunswick, and be certified with the Royal College of Physicians 
and Surgeons of Canada.
Applications may be submitted in confidence to :
Dr. Ginette Gagne-Koch 
Medical Director 
The Moncton Hospital 
135 MacBeath Avenue 
Moncton, NB
E1C6Z8 -S 85-21
KIDNEY FOUNDATION 
RESEARCH FELLOWSHIPS 
ALBERTA, CANADA 1986-87
Applications invited fo r Postdoc­
to ra l M ed ica l F e llo w sh ip s  in 
Nephrology or Urology to  run con­
currently from  July 1, 1986 at the 
University of Alberta, Edmonton and 
the University of Calgary (Faculty of 
Medicine).
Interdisciplinary training in basic 
research and/or clinical investigation 
available. Programs provide oppor­
tun ity  fo r full enrollment in School 
o f Graduate Studies.
Salary concordant w ith  qualifica­
tions and prior training to  maximum 
$35 000  per annum.
Fellowship is for 1 year, but 2nd 
year application anticipated.
For application forms contact : 
Kidney Foundation of Canada, A l­
berta Branch, 208, 8540  —  109  
Street, Edmonton, Alberta T6G 
1E6.
APPLICA TIONS POSTMARKED 
AFTER SEPTEMBER 16, 1985 WILL 
NOT BE ACCEPTED. -S 8 5 -2 2
ORTHOPEDICS -  NS
The Aberdeen Hospital is seeking an individual w ith 
leadership capabilities to establish a Department of Or­
thopedic Services.
The Aberdeen is a fully accredited regional hospi­
tal located in New Glasgow, Nova Scotia near the 
Northumberland Strait. The hospital has recently com­
pleted phase I of renovation and reconstruction which 
includes a new Physiotherapy Department. It is an­
ticipated that phase II w ill commence in the near fu ­
ture, which will consist of upgrading and expansion 
o f existing patient care areas and departments.
Applicants are invited to apply for this challenging 
opportunity and are asked to send resume to :
The Administrator 
Aberdeen Hospital 
New Glasgow, NS B2H 3S6
S85-024
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